A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Dementia With Lewy Bodies
Phase: PHASE2
Conditions: Dementia With Lewy Bodies
Sponsor: EIP Pharma Inc

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 1 of 58 
EIP Pharma, Inc. 
Confidential 
(,33+$50$,1&
&/,1,&$/678'<35272&2/
7LWOH
,QYHVWLJDWLRQDO
3URGXFW
'HYHORSPHQW3KDVH
(,36WXG\1XPEHU
,1'1XPEHU
1&71XPEHU
(XGUD&71XPEHU
'DWH9HUVLRQ
6SRQVRU$GGUHVV
$ 3KDVH E &OLQLFDO 6WXG\ RI WKH 3 $OSKD .LQDVH ,QKLELWRU
1HIODPDSLPRGLQ3DWLHQWVZLWK'HPHQWLDZLWK/HZ\%RGLHV'/%
1HIODPDSLPRG
E
(,31)'

1&7

-XQH9HUVLRQ([86
(,33KDUPD,QF
3DUN3OD]D6XLWH
%RVWRQ0$86$
&21),'(17,$/
7KLVGRFXPHQWFRQWDLQVFRQILGHQWLDOLQIRUPDWLRQ$Q\XVHGLVWULEXWLRQRUGLVFORVXUHZLWKRXWWKHSULRUZULWWHQ
FRQVHQWRI(,33KDUPD,QFLVVWULFWO\SURKLELWHGH[FHSWWRWKHH[WHQWUHTXLUHGXQGHUDSSOLFDEOHODZVRUUHJXODWLRQV
3HUVRQVWRZKRPWKHLQIRUPDWLRQLVGLVFORVHGPXVWEHLQIRUPHGWKDWWKHLQIRUPDWLRQLVFRQILGHQWLDODQGPD\QRWEH
IXUWKHUGLVFORVHGE\WKHP

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 2 of 58 
EIP Pharma, Inc. 
Confidential 
632162535272&2/$33529$/3$*(


6LJQDWXUH

-RKQ-$ODP0'
6SRQVRU5HVSRQVLEOH3HUVRQ

&(2(,33KDUPD,QF
7LWOH


'DWH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 3 of 58 
EIP Pharma, Inc. 
Confidential 
,19(67,*$725¶66,*1$785(2)$*5((0(173$*(

,KDYHUHDGWKHSURWRFRODQGRQEHKDOIRIP\LQVWLWXWLRQDJUHHWRFRPSO\ZLWKDOOWKHFRQGLWLRQVDQG
LQVWUXFWLRQVFRQWDLQHGLQWKLVWKHSURWRFRODQGZLWKDOODSSOLFDEOHUHJXODWLRQV


6LJQDWXUH


3ULQFLSDO,QYHVWLJDWRUSULQWHGQDPH

7LWOH

,QVWLWXWLRQ

$GGUHVV



7HOHSKRQHQXPEHU

'DWH


EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 4 of 58 
EIP Pharma, Inc. 
Confidential 
6321625&217$&7,1)250$7,21
6SRQVRU5HVSRQVLEOH3HUVRQ
DQG6WXG\'LUHFWRU
-RKQ-$ODP0'
3DUN3OD]D6XLWH
%RVWRQ0$86$
7HOHSKRQH
(PDLO38TMDODP#HLSSKDUPDFRP38T
&RQWUDFW5HVHDUFK2UJDQL]DWLRQ
:RUOGZLGH&OLQLFDO7ULDOV
0HGLFDO0RQLWRU
%HWK$QQ+D\QHV0':RUOGZLGH&OLQLFDO7ULDOV
6HULRXV$GYHUVH(YHQW5HSRUWLQJ
:RUOGZLGH&OLQLFDO7ULDOV

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 5 of 58 
EIP Pharma, Inc. 
Confidential 
6<1236,6
6WXG\7LWOH
$3KDVHE&OLQLFDO6WXG\RIWKH3$OSKD.LQDVH,QKLELWRU1HIODPDSLPRGLQ3DWLHQWV
ZLWK'HPHQWLDZLWK/HZ\%RGLHV'/%
3URWRFRO1XPEHUGDWH
9HUVLRQ
(,31)'9HUVLRQ([860DUFK
6WXG\3KDVH
E
6WXG\&HQWHUV
$SSUR[LPDWHO\VWXG\FHQWHUVLQWKH8QLWHG6WDWHV861HWKHUODQGVDQG8.
,QGLFDWLRQ
'HPHQWLDZLWK/HZ\%RGLHV'/%
6WXG\2EMHFWLYH
7KHSULPDU\REMHFWLYHLVWRGHPRQVWUDWHWKHHIILFDF\RIQHIODPDSLPRGFRPSDUHGWR
SODFHERDVDWUHDWPHQWIRU'/%DVDVVHVVHGE\WKH&OLQLFDO'HPHQWLD5DWLQJ6FDOH6XP
RI%R[HV&'56%
7KHVHFRQGDU\REMHFWLYHVDUHWR
x 
'HPRQVWUDWHWKDW QHIODPDSLPRGLPSURYHVPRWRUIXQFWLRQLQSDWLHQWVZLWK'/%
FRPSDUHGWRSODFHERDVDVVHVVHGE\WKH7LPHG8SDQG*R7HVW78*
x 
'HPRQVWUDWHWKDWQHIODPDSLPRGLPSURYHVFRJQLWLRQFRPSDUHGWRSODFHERDV
DVVHVVHGE\D'/%VSHFLILF1HXURSV\FKRORJLFDO7HVW%DWWHU\17%LQSDWLHQWV
ZLWK'/%7KH17%LVFRPSULVHGRI
o 
&RJVWDWH'HWHFWLRQWHVW'(7
o 
&RJVWDWH,GHQWLILFDWLRQWHVW,'1
o 
&RJVWDWH2QH&DUG/HDUQLQJWHVW2&/
o 
&RJVWDWH2QH%DFNWHVW21%
o 
/HWWHU)OXHQF\7HVW
x 
'HPRQVWUDWHWKDWQHIODPDSLPRGLPSURYHVJOREDOFRJQLWLRQIXQFWLRQDQG
EHKDYLRUGLVHDVHVWDWXVHYDOXDWHGE\DFOLQLFLDQZLWKFDUHJLYHULQSXWFRPSDUHG
WRSODFHERLQSDWLHQWVZLWK'/%DVDVVHVVHGE\WKH$O]KHLPHU¶V'LVHDVH
&RRSHUDWLYH6WXG\±&OLQLFDO*OREDO,PSUHVVLRQRI&KDQJH$'&6&*,&

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 6 of 58 
EIP Pharma, Inc. 
Confidential 
6WXG\2XWFRPH0HDVXUHV
3ULPDU\RXWFRPHPHDVXUH
x 
&KDQJHLQ&'56%LQQHIODPDSLPRGWUHDWHGVXEMHFWVFRPSDUHGWRWKHSODFHER
WUHDWHGVXEMHFWV
6HFRQGDU\RXWFRPHPHDVXUHV
x 
&KDQJHLQ78*LQQHIODPDSLPRGWUHDWHGVXEMHFWVFRPSDUHGWRSODFHER
UHFLSLHQWV
x 
&KDQJHLQWKHFRPSRVLWHVFRUHRIWKH17%LQFOXGLQJWHVWVRIDWWHQWLRQH[HFXWLYH
IXQFWLRQDQGYLVXDOOHDUQLQJLQQHIODPDSLPRGWUHDWHGVXEMHFWVFRPSDUHGWR
SODFHERUHFLSLHQWV
x 
$'&6&*,&VFRUHDW:HHNLQQHIODPDSLPRGWUHDWHGVXEMHFWVFRPSDUHGWR
SODFHERUHFLSLHQWV
$VH[SORUDWRU\RXWFRPHPHDVXUHVWKHHIIHFWVRIQHIODPDSLPRGUHODWLYHWRSODFHERZLOOEH
HYDOXDWHGYLDFKDQJHVLQ'HPHQWLD&RJQLWLYH)OXFWXDWLRQV6FDOH'&)6VHOHFWGRPDLQV
RIWKHLWHP1HXURSV\FKLDWULF,QYHQWRU\13,LQFOXGLQJGHSUHVVLRQG\VSKRULD
DSDWK\KDOOXFLQDWLRQVDQGDJLWDWLRQDJJUHVVLRQKDOOXFLQDWLRQVIUHTXHQF\[VHYHULW\VFRUH
ZLWKLQWKH13,LQVXEMHFWVZKRUHSRUWKDOOXFLQDWLRQVDWEDVHOLQHVOHHSDQGQLJKWWLPH
EHKDYLRUFKDQJHZLWKLQWKH13,0'683'56PRWRUH[DPLQDWLRQ3DUW,,,VFRUH
EHWDIXQFWLRQDOFRQQHFWLYLW\DQGLQDOSKDUHDFWLYLW\RQTXDQWLWDWLYH((*DQGEDVDO
IRUHEUDLQDWURSK\E\VWUXFWXUDO05,
1XPEHURI6XEMHFWV
VXEMHFWVDUHSODQQHGWREHHQUROOHG
6XEMHFW3RSXODWLRQ
6XEMHFWVDJHG\HDUVZLWKSUREDEOH'/%E\FRQVHQVXVFULWHULD0F.HLWKHWDO
LQFOXGLQJDSRVLWLYH'D7VFDQDQGD&'5*OREDO6FRUHRIRU,IWKH'D7VFDQLV
QHJDWLYHEXWWKHVXEMHFWKDVKLVWRULFDOSRO\VRPQRJUDSK\36*YHULILHG5(0VOHHS
EHKDYLRUDOGLVRUGHU5%'WKLVZLOODOVRTXDOLI\DVSUREDEOH'/%
,QFOXVLRQ&ULWHULD
 0HQDQGZRPHQDJHG\HDUV
 6XEMHFWLVZLOOLQJDQGDEOHWRSURYLGHZULWWHQLQIRUPHGFRQVHQW
 3UREDEOH'/%E\FRQVHQVXVFULWHULD0F.HLWKHWDOLQFOXGLQJDSRVLWLYH
'D7VFDQ,IWKH'D7VFDQLVQHJDWLYHEXWWKHVXEMHFWKDVKLVWRULFDO
SRO\VRPQRJUDSK\36*YHULILHG5(0VOHHSEHKDYLRUDOGLVRUGHU5%'WKLVZLOO
DOVRTXDOLI\DVSUREDEOH'/%
 &'5*OREDO6FRUHOHVVWKDQDW6FUHHQLQJ
 ,IWKHSDWLHQWLVFXUUHQWO\UHFHLYLQJFKROLQHVWHUDVHLQKLELWRUWKHUDS\WKHSDWLHQWPXVW
KDYHUHFHLYHGVXFKWKHUDS\IRUJUHDWHUWKDQPRQWKVDQGRQDVWDEOHGRVHIRUDWOHDVW
ZHHNVDWWKHWLPHRIUDQGRPL]DWLRQ([FHSWIRUUHGXFLQJWKHGRVHIRUWROHUDELOLW\
UHDVRQVWKHGRVHRIFKROLQHVWHUDVHLQKLELWRUPD\QRWEHPRGLILHGGXULQJWKHVWXG\,I
WKHSDWLHQWLVQRWFXUUHQWO\UHFHLYLQJFKROLQHVWHUDVHLQKLELWRUWKHUDS\EXWUHFHLYHG
VXFKWKHUDS\SUHYLRXVO\WKDWWKHUDS\PXVWKDYHEHHQGLVFRQWLQXHGDWOHDVWPRQWKV
SULRUWRUDQGRPL]DWLRQ0HPDQWLQHWKHUDS\LVDOORZHGLILWKDGEHHQVWDUWHGDWOHDVW
PRQWKVSULRUWRUDQGRPL]DWLRQDQGWKHSDWLHQWLVDOVRUHFHLYLQJFKROLQHVWHUDVH
LQKLELWRUWKHUDS\PHPDQWLQHPRQRWKHUDS\LHZLWKRXWFRQFRPLWDQWFKROLQHVWHUDVH
LQKLELWRUWKHUDS\LVH[FOXGHG

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 7 of 58 
EIP Pharma, Inc. 
Confidential 
 1RUPDORUFRUUHFWHGH\HVLJKWDQGDXGLWRU\DELOLWLHVVXIILFLHQWWRSHUIRUPDOODVSHFWV
RIWKH FRJQLWLYHDQGIXQFWLRQDODVVHVVPHQWV
 1RKLVWRU\RIOHDUQLQJGLIILFXOWLHVWKDWPD\LQWHUIHUHZLWKWKHLUDELOLW\WRFRPSOHWHWKH
FRJQLWLYHWHVWV
 5HFHLYHGYDFFLQDWLRQIRU6$56&R9XQOHVVPHGLFDOFRQWUDLQGLFDWLRQVSUHYHQW
EHLQJYDFFLQDWHGRUKDVDKLVWRU\RIQDWXUDOLQIHFWLRQ
 0XVWKDYHUHOLDEOHLQIRUPDQWRUFDUHJLYHU
([FOXVLRQFULWHULD
 'LDJQRVLVRIDQ\RWKHURQJRLQJFHQWUDOQHUYRXVV\VWHP&16FRQGLWLRQRWKHUWKDQ
'/%LQFOXGLQJEXWQRWOLPLWHG WRSRVWVWURNHGHPHQWLDYDVFXODUGHPHQWLD
$O]KHLPHU¶VGLVHDVH$'RU3DUNLQVRQ¶VGLVHDVH3'
 3ODVPDSWDXUHVXOWDERYHWKHWKUHVKROGWKDWLQGLFDWHVHYLGHQFHRISDWKRORJ\
DVVRFLDWHGZLWK$O]KHLPHU¶VGLVHDVHDW6FUHHQLQJ
 6XLFLGDOLW\GHILQHGDVDFWLYHVXLFLGDOWKRXJKWVZLWKLQPRQWKVEHIRUH6FUHHQLQJRUDW
%DVHOLQHGHILQHGDVDQVZHULQJ\HVWRLWHPVRURQ WKH&6656RUKLVWRU\RI
VXLFLGHDWWHPSWLQSUHYLRXV\HDUVRULQWKH,QYHVWLJDWRU¶VRSLQLRQDW VHULRXVULVNRI
VXLFLGH
 2QJRLQJPDMRUDQGDFWLYHSV\FKLDWULFGLVRUGHUDQGRURWKHUFRQFXUUHQWPHGLFDO
FRQGLWLRQWKDWLQWKHRSLQLRQRIWKH,QYHVWLJDWRUPLJKWFRPSURPLVHVDIHW\DQGRU
FRPSOLDQFHZLWKVWXG\UHTXLUHPHQWV
 'LDJQRVLVRIDOFRKRORUGUXJDEXVHZLWKLQWKHSUHYLRXV\HDUV
 3RRUO\FRQWUROOHGFOLQLFDOO\VLJQLILFDQWPHGLFDOLOOQHVVVXFKDV K\SHUWHQVLRQEORRG
SUHVVXUH!PP+JV\VWROLFRUPP+J GLDVWROLFP\RFDUGLDOLQIDUFWLRQZLWKLQ
PRQWKVXQFRPSHQVDWHG FRQJHVWLYHKHDUWIDLOXUHRURWKHUVLJQLILFDQW
FDUGLRYDVFXODUSXOPRQDU\ UHQDOOLYHULQIHFWLRXVGLVHDVHLPPXQHGLVRUGHURU
PHWDEROLFHQGRFULQHGLVRUGHUVRURWKHUGLVHDVHWKDWZRXOGLQWHUIHUHZLWKDVVHVVPHQW
RIGUXJVDIHW\
 $VSDUWDWHDPLQRWUDQVIHUDVH$67RUDODQLQHDPLQRWUDQVIHUDVH$/7!îWKHXSSHU
OLPLWRIQRUPDO8/1WRWDOELOLUXELQ!î8/1 DQGRU,QWHUQDWLRQDO1RUPDOL]HG
5DWLR,15!
 .QRZQKXPDQLPPXQRGHILFLHQF\YLUXVKHSDWLWLV%RUDFWLYH KHSDWLWLV&YLUXV
LQIHFWLRQ
 3DUWLFLSDWHGLQDVWXG\RIDQLQYHVWLJDWLRQDOGUXJOHVVWKDQVL[ZHHNVRUKDOIOLYHVRI
DQLQYHVWLJDWLRQDOGUXJZKLFKHYHULVORQJHU EHIRUHHQUROOPHQWLQWKLVVWXG\
 +LVWRU\RISUHYLRXVQHXURVXUJHU\WRWKHEUDLQZLWKLQWKHSDVWILYH\HDUV
 ,IPDOHZLWKIHPDOHSDUWQHUVRIFKLOGEHDULQJSRWHQWLDOXQZLOOLQJRUXQDEOHWR
DGKHUHWRFRQWUDFHSWLRQUHTXLUHPHQWVVSHFLILHG LQWKHSURWRFRO
 ,IIHPDOHZKRKDVQRWKDVQRWUHDFKHGPHQRSDXVH!\HDUSUHYLRXVO\RUKDVQRWKDGD
K\VWHUHFWRP\RUELODWHUDORRSKRUHFWRP\VDOSLQJRRRSKRUHFWRP\KDVDSRVLWLYH
SUHJQDQF\WHVWUHVXOWGXULQJ6FUHHQLQJDQGRULVXQZLOOLQJRUXQDEOHWRDGKHUHWRWKH
FRQWUDFHSWLRQUHTXLUHPHQWVVSHFLILHGLQWKHSURWRFRO
6WXG\'UXJ'HWDLOV
1HIODPDSLPRGPJFDSVXOHRUPDWFKLQJSODFHERFDSVXOHV

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 8 of 58 
EIP Pharma, Inc. 
Confidential 
'XUDWLRQRI7UHDWPHQW
6FUHHQLQJZLQGRZRIGD\VXQOHVV'D7VFDQLVUHTXLUHGLQZKLFKFDVH6FUHHQLQJ
ZLQGRZPD\EHH[WHQGHGWRGD\VZHHNVRIWUHDWPHQWDZHHNIROORZXSYLVLWIRU
DWRWDORIXSWRZHHNVRIVWXG\SDUWLFLSDWLRQ
6XEMHFWVZKRFRPSOHWHWKHZHHNWUHDWPHQWSKDVHZLOOEHRIIHUHGWKHRSSRUWXQLW\WR
FRQWLQXHLQDZHHNRSHQODEHOH[WHQVLRQWUHDWPHQW%DVHGRQWKHUHVXOWVRIWKHGRXEOH
EOLQGWUHDWPHQWSKDVHRIWKHVWXG\(,33KDUPDZLOOZRUNZLWKHDFKFRXQWU\WRSURYLGH
DFFHVVWRWUHDWPHQWDIWHUFRPSOHWLRQRIWKHH[WHQVLRQSKDVHLIWKHUHLVDFOHDUEHQHILW
6WXG\'HVLJQDQG0HWKRGV
7KLVLVD3KDVHEK\SRWKHVLVWHVWLQJPXOWLFHQWHUUDQGRPL]HGGRXEOHEOLQGSODFHER
FRQWUROOHGVWXG\RIQHIODPDSLPRGYHUVXVPDWFKLQJSODFHERUDQGRPL]HGDGPLQLVWHUHG
ZLWKIRRGIRUZHHNVLQVXEMHFWVZLWK'/%6XEMHFWVZLOOUHFHLYHFDSVXOHVSHUGD\
7,'ZLWKIRRGLHZLWKWKHPRUQLQJPLGGD\DQGHYHQLQJPHDOVRIHLWKHU
QHIODPDSLPRGPJRUSODFHER'RVHVVKRXOGEHDGPLQLVWHUHGDWOHDVWKRXUVDSDUW
)ROORZLQJFRPSOHWLRQRILQIRUPHGFRQVHQWSURFHGXUHVVXEMHFWVZLOOHQWHUWKH6FUHHQLQJ
SKDVHRIWKHVWXG\
2QHWRWZR6FUHHQLQJYLVLWVDUHSODQQHGGXULQJZKLFKVDIHW\VFUHHQLQJPHDVXUHVZLOOEH
XQGHUWDNHQDVZHOODVVRPHFRJQLWLYHDVVHVVPHQWVZLOOEHSHUIRUPHGSHU6FKHGXOHRI
$VVHVVPHQWV$SODVPDVDPSOHIRUS7DXDQDO\VLVZLOODOVREHREWDLQHGDW6FUHHQLQJ
DQGDQDO\]HGIRUHOLJLELOLW\SXUSRVHV6FUHHQLQJZLOOEHFRQGXFWHGZLWKLQGD\VEHIRUH
%DVHOLQH'D\,ID'D7VFDQLVUHTXLUHGWRGHWHUPLQHVWXG\HOLJLELOLW\6FUHHQLQJPD\
EHH[WHQGHGWRGD\V
2QFHHOLJLELOLW\LVFRQILUPHGVXEMHFWVZLOOEHVWUDWLILHGE\EDFNJURXQGGHPHQWLDWKHUDS\
RQHRIWKUHHVWUDWDQRFKROLQHVWHUDVHLQKLELWRUWKHUDS\FKROLQHVWHUDVHLQKLELWRUWKHUDS\
DORQHRUFKROLQHVWHUDVHLQKLELWRUWKHUDS\SOXVPHPDQWLQHWKHUDS\DQGUDQGRPO\DVVLJQHG
RQDEDVLVWRQHIODPDSLPRGPJ7,'RUSODFHERIRUWKHZHHNWUHDWPHQWSHULRG
,QYHVWLJDWRUVDQGVXEMHFWVZLOOEHEOLQGHGWRWKHWUHDWPHQWDVVLJQPHQW
'RVLQJZLOOVWDUWRQ'D\IROORZLQJFRPSOHWLRQRIDOOEDVHOLQHSURFHGXUHV'XULQJWKH
ZHHNWUHDWPHQWSHULRGVXEMHFWVZLOOUHWXUQWRWKHFOLQLFHYHU\ZHHNVIRUWKHILUVWPRQWK
DQGWKHQHYHU\ZHHNVWKHUHDIWHU$)LQDO6WXG\9LVLWLH)ROORZ8S9LVLWZLOOEH
FRQGXFWHGZHHNVGD\VDIWHUFRPSOHWLRQRIVWXG\GUXJRUDIWHUWKH(DUO\
7HUPLQDWLRQ(7YLVLW6HHWKH6FKHGXOHRI$VVHVVPHQWVIRUGHWDLOVUHJDUGLQJZKHQ
DVVHVVPHQWVDUHFRQGXFWHG
7KHUDS\
1HIODPDSLPRGPJFDSVXOHVRUPDWFKLQJSODFHERFDSVXOHVZLOOEHDGPLQLVWHUHGRUDOO\
7,'ZLWKIRRGIRUZHHNV6XEMHFWZLOOUHFHLYHPDWFKLQJE\VL]HDQGFRORUFDSVXOHV
WKDWFRQWDLQHLWKHUPJQHIODPDSLPRGRUSODFHER6XEMHFWVZLOOEHVWUDWLILHGE\VWDWXVRI
EDFNJURXQGGHPHQWLDWKHUDS\RQHRIWKUHHVWUDWDQRFKROLQHVWHUDVHLQKLELWRUWKHUDS\
FKROLQHVWHUDVHLQKLELWRUWKHUDS\DORQHRUFKROLQHVWHUDVHLQKLELWRUWKHUDS\SOXVPHPDQWLQH
WKHUDS\DQGWKHQUDQGRPL]HG
'RVHVPXVWEHWDNHQZLWKLQPLQXWHVIROORZLQJDPHDORUVQDFN'RVHVVKRXOGEHWDNHQ
DWDSSUR[LPDWHO\WKHVDPHWLPHHDFKGD\WKURXJKRXWWKHVWXG\DQGDWOHDVWKRXUVDSDUW
6XEMHFWVFRPSOHWLQJWKHZHHNSODFHERFRQWUROOHGPDLQSRUWLRQRIWKHVWXG\ZLOOEH
RIIHUHGDQDGGLWLRQDOZHHNVRIQHIODPDSLPRGWUHDWPHQWRQDQRSHQODEHOEDVLV
'DWDDQG6DIHW\
0RQLWRULQJ%RDUG'60%
7KHUHZLOOEHDQLQGHSHQGHQW'DWDDQG6DIHW\0RQLWRULQJ%RDUG'60%UHVSRQVLEOHIRU
RYHUVHHLQJWKHVDIHW\RIKXPDQVXEMHFWVLQWKLVFOLQLFDOWULDO7KH'60%ZLOOLQFOXGHDW

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 9 of 58 
EIP Pharma, Inc. 
Confidential 
OHDVWWKUHHPHPEHUVWZRFOLQLFLDQVZLWKH[SHULHQFHZLWKGHPHQWLDFOLQLFDOWULDOV
RQHRIZKLFKZLOOEHWKHFKDLUDQGRQHVWDWLVWLFLDQ0HPEHUVRIWKH'60%ZLOOEH
VHSDUDWHIURPPHPEHUVRIWKHVWXG\WHDPDQGVLWHWHDPV7KH'60%&KDUWHUZLOOEH
UHYLHZHGDQGDGRSWHGE\WKH'60%LWZLOOEHDVWDQGDORQHGRFXPHQW

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 10 of 58 
EIP Pharma, Inc. 
Confidential 
7$%/(2)&217(176
632162535272&2/$33529$/3$*( 
,19(67,*$725¶66,*1$785(2)$*5((0(173$*( 
6321625&217$&7,1)250$7,21 
6<1236,6 
7$%/(2)&217(176 
/,672)7$%/(6 
/,672)$%%5(9,$7,216 
 
,1752'8&7,21 
 
6FLHQWLILF5DWLRQDOH 
 
3UH&OLQLFDO3KDUPDFRORJ\5HVXOWV 
 
3ULRU&OLQLFDO([SHULHQFH 
 
2%-(&7,9(6 
 
3ULPDU\2EMHFWLYH 
 
6HFRQGDU\2EMHFWLYHV 
 
([SORUDWRU\2EMHFWLYHV 
 
,19(67,*$7,21$/3/$1 
 
2YHUDOO6WXG\'HVLJQDQG3ODQ
 
6XEMHFW5HFUXLWPHQW 
 
6FUHHQLQJ 
 
7UHDWPHQW3HULRG 
 
(DUO\7HUPLQDWLRQ(7 
 
([WHQVLRQ7UHDWPHQW 
 
'LVFXVVLRQRI6WXG\'HVLJQ 
 
5DWLRQDOHIRU'RVH6HOHFWLRQ 
 
6(/(&7,212)678'<3238/$7,21 
 
,QFOXVLRQ&ULWHULD 
 
([FOXVLRQ&ULWHULD 
 
5HPRYDORI6XEMHFWVIURP7UHDWPHQW 
 
75($70(176$'0,1,67(5(' 
 
'RVLQJ 
 
'RVH0RGLILFDWLRQV,QWHUUXSWLRQVRU'LVFRQWLQXDWLRQ 
 
3DFNDJLQJDQG/DEHOLQJ 
 
6WXG\'UXJ6XSSO\6WRUDJHDQG+DQGOLQJ 

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 11 of 58 
EIP Pharma, Inc. 
Confidential 
 
'UXJ$FFRXQWDELOLW\'LVSRVDO5HWXUQRU5HWHQWLRQ6WXG\'UXJ 
 
7UHDWPHQW&RPSOLDQFH 
 
0HWKRGRI$VVLJQLQJ6XEMHFWVWR7UHDWPHQW*URXS 
 
6WXG\%OLQGLQJDQG%UHDNLQJWKH%OLQG 
 
3ULRUDQG&RQFRPLWDQW7KHUDS\ 
 
&RQWUDFHSWLRQDQG3UHJQDQF\ 
 
)HPDOH&RQWUDFHSWLRQ 
 
0DOH&RQWUDFHSWLRQ 
 
3UHJQDQF\ 
 
678'<$66(660(176$1'352&('85(6 
 
6FKHGXOHRI$VVHVVPHQWV 
 
6WXG\$VVHVVPHQWV 
 
%DVHOLQHDQG'LVHDVH&KDUDFWHULVWLFV 
 
0DJQHWLF5HVRQDQFH,PDJLQJ05, 
 
'D7VFDQLIUHTXLUHG 
 
&OLQLFDO2XWFRPH(YDOXDWLRQV 
 
3K\VLFDO([DPLQDWLRQDQG9LWDO6LJQV 
 
(OHFWURHQFHSKDORJUDSK\((* 
 
/HDG(OHFWURFDUGLRJUDP 
 
&OLQLFDO/DERUDWRU\$VVHVVPHQWV 
 
3KDUPDFRNLQHWLFV3. 
 
%LRPDUNHU7HVWLQJ 
 
:LWKGUDZDORI6XEMHFWV 
 
$'9(56((9(176$1'6(5,286$'9(56((9(1766$)(7<
5(3257,1* 
 
'HILQLWLRQVDQG&ULWHULD 
 
$GYHUVH(YHQWV 
 
6HULRXV$GYHUVH(YHQWV 
 
8QH[SHFWHG$GYHUVH'UXJ5HDFWLRQV 
 
$EQRUPDO/DERUDWRU\9DOXHV 
 
$VVHVVLQJ,QWHQVLW\DQG5HODWLRQVKLS 
 
5HSRUWLQJ3URFHGXUHVDQG5HTXLUHPHQWV 

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 12 of 58 
EIP Pharma, Inc. 
Confidential 
 
$GYHUVH(YHQWV$( 
 
6HULRXV$GYHUVH(YHQWV6$( 
 
'$7$0$1$*(0(17$1'67$7,67,&$/$1$/<6,6 
 
'DWD0DQDJHPHQWDQG4XDOLW\$VVXUDQFH&RQVLGHUDWLRQV 
 
6DPSOH6L]H 
 
$QDO\VLV6HWV 
 
6DIHW\ 
 
(IILFDF\ 
 
,QWHULP$QDO\VLV 
 
678'<0$1$*(0(17 
 
(WKLFVDQG&RQVHQW 
 
5HJXODWLRQVDQG*XLGHOLQHV 
 
,QGHSHQGHQW(WKLFV&RPPLWWHH 
 
,QIRUPHG&RQVHQW 
 
,QGHPQLILFDWLRQ 
 
'LVFRQWLQXDWLRQRIWKH6WXG\E\WKH6SRQVRU 
 
6WXG\'RFXPHQWDWLRQ 
 
6WXG\0RQLWRULQJDQG$XGLWLQJ 
 
8VHRI6WXG\)LQGLQJV 
 
3XEOLFDWLRQV 
 
5HFRUGLQJ$FFHVVDQG5HWHQWLRQRI6RXUFH'DWD 
 
3URWRFRO9LRODWLRQV 
 
'DWDDQG6DIHW\0RQLWRULQJ%RDUG'60% 
 
5()(5(1&(6 

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 13 of 58 
EIP Pharma, Inc. 
Confidential 
/,672)7$%/(6

7DEOH
1HIOPDSLPRG3KDVH&OLQLFDO6WXGLHV!ZHHNV7UHDWPHQW'XUDWLRQ«««««
7DEOH
,QFLGHQFHRI7UHDWPHQW(PHUJHQW$GYHUVH(YHQWV7($(VUHSRUWHGDW!LQFLGHQFHLQ
!ZHHNWUHDWPHQWGXUDWLRQVWXGLHVLQ$'RU'/%«««««««««««««
7DEOH 
&<3$,QKLELWRUV
7DEOH 
&<3$,QGXFHUV 
7DEOH 
6FKHGXOHRI$VVHVVPHQWV7UHDWPHQW3KDVH
7DEOH
6FKHGXOHRI$VVHVVPHQWV([WHQVLRQ3KDVH«««««««««««««««««
7DEOH 
&OLQLFDO/DERUDWRU\$QDO\WHV

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023  
Page 14 of 58 
 
EIP Pharma, Inc. 
Confidential 
/,672)$%%5(9,$7,216
$EEUHYLDWLRQ
'HILQLWLRQ
$'
$O]KHLPHU¶VGLVHDVH
$'5
$GYHUVHGUXJUHDFWLRQ
$(
$GYHUVHHYHQW
$/7
$ODQLQHDPLQRWUDQVIHUDVH
$32(
$SROLSRSURWHLQ(
$33
$P\ORLGSUHFXUVRUSURWHLQ
$67
$VSDUWDWHDPLQRWUDQVIHUDVH
$8&
$UHDXQGHUWKHWLPHFRQFHQWUDWLRQFXUYH
%,'
ELVLQGLHWZLFHDGD\
&)7
&DWHJRU\)OXHQF\7HVW
&,%,&SOXV
&OLQLFLDQ,QWHUYLHZ%DVHG,PSUHVVLRQRI&KDQJHSOXVFDUHJLYHULQWHUYLHZ
&/
&OHDUDQFH
&16
&HQWUDOQHUYRXVV\VWHP
&6)
&HUHEURVSLQDOIOXLG
&6656
&ROXPELD6XLFLGH6HYHULW\5DWLQJ6FDOH
&7
&RPSXWHGWRPRJUDSK\
&<3
&\WRFKURPH3
'(7
&RJVWDWH'HWHFWLRQWHVW

'/%
'HPHQWLDZLWK/HZ\%RGLHV
'60%
'DWDDQG6DIHW\0RQLWRULQJ%RDUG
(&*
(OHFWURFDUGLRJUDP
H&5)
(OHFWURQLFFDVHUHSRUWIRUP
('&
(OHFWURQLFGDWDFDSWXUH
(7
(DUO\7HUPLQDWLRQ
)'$
)RRGDQG'UXJ$GPLQLVWUDWLRQ
*$6
*RDO$WWDLQPHQW6FDOH
,%
,QYHVWLJDWRU%URFKXUH
,&)
,QIRUPHG&RQVHQW)RUP
,&+
,QWHUQDWLRQDO&RXQFLOIRU+DUPRQL]DWLRQ
,'1
&RJVWDWH,GHQWLILFDWLRQ7HVW

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 15 of 58 
EIP Pharma, Inc. 
Confidential 
$EEUHYLDWLRQ
'HILQLWLRQ
,(&
,QGHSHQGHQW(WKLFV&RPPLWWHH
,1'
,QYHVWLJDWLRQDO1HZ'UXJ
,15
,QWHUQDWLRQDOQRUPDOL]HGUDWLR
,57
,QWHUDFWLYH5HVSRQVH7HFKQRORJ\
/)7
/LYHUIXQFWLRQWHVW
0$3
0LWRJHQDFWLYDWHGSURWHLQ
0$3.Į
SPLWRJHQDFWLYDWHGSURWHLQNLQDVHDOSKD
0HG'5$
0HGLFDO'LFWLRQDU\IRU5HJXODWRU\$FWLYLWLHV
0050
0L[HG0RGHO5HSHDWHG0HDVXUHV
006(
0LQL0HQWDO6WDWH([DPLQDWLRQ
05,
0DJQHWLFUHVRQDQFHLPDJLQJ
0:0
0RUULV:DWHU0D]H
13,
LWHP1HXURSV\FKLDWULF,QYHQWRU\
17%
1HXURSV\FKRORJLFDO7HVW%DWWHU\
2&/
&RJVWDWH2QH&DUG/HDUQLQJWHVW
21%
&RJVWDWH2QH%DFN7HVW
SĮ
0LWRJHQDFWLYDWHGSURWHLQNLQDVH
3'
3DUNLQVRQ¶VGLVHDVH
3.
3KDUPDFRNLQHWLF
36*
3RO\VRPQRJUDSK\
S7DX
T((*
3KRVSKRWDX
4XDQWLWDWLYHHOHFWURHQFHSKDORJUDSK\
5%'
5(0VOHHSEHKDYLRUDOGLVRUGHU
6$(
6HULRXVDGYHUVHHYHQW
6$3
6WDWLVWLFDO$QDO\VLV3ODQ
63(&7
6LQJOHSKRWRQHPLVVLRQFRPSXWHGWRPRJUDSK\
7,'
7KUHHWLPHVGDLO\
78*
7LPHG8SDQG*R7HVW
8/1
8SSHUOLPLWRIQRUPDO
86
8QLWHG6WDWHV


EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 16 of 58 
EIP Pharma, Inc. 
Confidential 
 
,1752'8&7,21
 
6FLHQWLILF5DWLRQDOH
7KLVLVDGRXEOHEOLQGSODFHERFRQWUROOHGZHHNFRQILUPDWRU\3KDVHEWUHDWPHQWVWXG\RI
QHIODPDSLPRGPJDGPLQLVWHUHGWLPHVGDLO\7,'LQVXEMHFWVZLWK'HPHQWLDZLWK/HZ\%RGLHV
'/%7KHSULPDU\REMHFWLYHRIWKLVVWXG\LVWRGHPRQVWUDWHWKHHIILFDF\RIQHIODPDSLPRGFRPSDUHGWR
SODFHERDVDWUHDWPHQWIRU'/%DVDVVHVVHGE\WKH&OLQLFDO'HPHQWLD5DWLQJ6FDOH6XPRI%R[HV&'5
6%
'/%LVFRPPRQUHSUHVHQWLQJXSWRRIWKHGHPHQWLDSRSXODWLRQZLWKDQHVWLPDWHGWR
RQHPLOOLRQDIIHFWHGLQGLYLGXDOVLQWKH8QLWHG6WDWHV867KHUHLVHYLGHQFHWKDWWKHSURJQRVLVLVHYHQ
PRUHVHYHUHWKDQRWKHUGHPHQWLDGLVRUGHUVLQFOXGLQJ$O]KHLPHU¶VGLVHDVH$''/%LVFKDUDFWHUL]HGE\
SURJUHVVLYHGHPHQWLDDQGIOXFWXDWLQJFRJQLWLRQGHILFLWVLQPHPRU\DWWHQWLRQVOHHSGLVWXUEDQFHVYLVXDO
KDOOXFLQDWLRQDQG3DUNLQVRQLVPWUHPRUJDLWGLVWXUEDQFH6HH0F.HLWKHWDO
7KHUHDUHQRWUHDWPHQWVDSSURYHGIRUWKHXQGHUO\LQJGLVHDVHSURFHVVDQGRQO\V\PSWRPDWLFWUHDWPHQWVIRU
SDUNLQVRQLDQV\PSWRPV$OWKRXJKQRWDSSURYHGIRU'/%FKROLQHVWHUDVHLQKLELWRUVSURYLGHPRGHVW
LPSURYHPHQWLQFRJQLWLYHIXQFWLRQDQGUHGXFHKDOOXFLQDWLRQIUHTXHQF\DQGDVVXFKDWULDORI
FKROLQHVWHUDVHLQKLELWRUWKHUDS\LVDWWHPSWHGLQPRVWSDWLHQWV'HVSLWHWKHDYDLODELOLW\RIWUHDWPHQW
SDWLHQWVZLWK'/%KDYHDJUHDWHUUDWHRIFRJQLWLYHGHFOLQHLQFXUKLJKHUKHDOWKFDUHFRVWVKDYHORQJHU
KRVSLWDOL]DWLRQVUHSRUWORZHUTXDOLW\RIOLIHDQGKDYHFDUHJLYHUVZLWKKLJKHUOHYHOVRIGLVWUHVVZKHQ
FRPSDUHGZLWKSDWLHQWVZLWK$'0XHOOHUHWDO
1HIODPDSLPRGLVDKLJKO\VSHFLILFLQKLELWRURIWKHLQWUDFHOOXODUHQ]\PHPLWRJHQDFWLYDWHGSURWHLQNLQDVH
SĮ,QWKHEUDLQSĮUHJXODWHVLQIODPPDWLRQWKURXJKHIIHFWVRQPLFURJOLD0RUHRYHUXQGHU
FRQGLWLRQVRIVWUHVVDQGGLVHDVHSĮLVDOVRH[SUHVVHGLQQHXURQVDQGRIWKHYDULRXVSLVRIRUPVWKHĮ
LVRIRUPLVWKHPRVWLPSRUWDQWUHJXODWRURIWKHVWUHVVUHVSRQVHLQQHXURQV/DZVRQHWDO,QWKH
QHXURQSĮDOVRDSSHDUVWRSOD\DFULWLFDOUROHLQLQIODPPDWLRQGULYHQWR[LFLW\WRV\QDSVHV3ULHWRHWDO
$VDUHVXOWRIWKLVXQGHUVWDQGLQJSPLWRJHQDFWLYDWHGSURWHLQNLQDVHDOSKD0$3.ĮKDVEHHQ
UHFRJQL]HGDVDOHDGLQJWKHUDSHXWLFWDUJHWWRLPSURYHV\QDSWLFIXQFWLRQDQGV\QDSWLFSODVWLFLW\IRUDEURDG
UDQJHRIFHQWUDOQHUYRXVV\VWHP&16GLVRUGHUV&RUUrDHWDO6DQGHUVHQHWDO
,QWKHFRQWH[WRIWKHPDMRUGHPHQWLDV$'DQG'/%HPHUJLQJHYLGHQFHLQGLFDWHVWKDWWKHGRZQVWUHDP
SDWKRORJLFDOWDUJHWRIG\VUHJXODWHGSĮDFWLYDWLRQLVDSURWHLQFDOOHG5DE5DELVDPDMRUUHJXODWRURI
HQGRF\WRVLVDQGHDUO\HQGRVRPDOIXQFWLRQDQGH[WHQVLYHVFLHQWLILFOLWHUDWXUHGRFXPHQWVWKHFULWLFDOUROHV
RI5DELQDQLPDOPRGHOVRIGHPHQWLD1L[RQ;XHWDOZLWKDEQRUPDO5DEDFWLYDWLRQ
OHDGLQJWRHQGRO\VRVRPDOG\VIXQFWLRQUHVXOWLQJLQV\QDSWLFG\VIXQFWLRQDQGZLWKSURORQJHGDFWLYDWLRQ
QHXURGHJHQHUDWLRQSDUWLFXODUZLWKUHVSHFWWRFKROLQHUJLFQHXURQV3HQVDOILQLHWDO$VSĮLVD
NQRZQ5DEDFWLYDWRUDQGUHJXODWRURIHQGRVRPDOHQGRF\WLFIXQFWLRQ&DYDOOLHWDO0DFHHWDO
QHIODPDSLPRGZDVHYDOXDWHGIRUDFWLYLW\DJDLQVW5DEDFWLYDWLRQ1HIODPDSLPRGWUHDWPHQW
UHYHUVHG5DEHQGRVRPDOHQODUJHPHQWin vitroLQKXPDQ'RZQ6\QGURPH'6ILEUREODVWVDQGin vivo
LQEUDLQVDPSOHVIURPDQDQLPDOPRGHORIGHPHQWLDVHH6HFWLRQEHORZ
1HIODPDSLPRGKDVEHHQHYDOXDWHGLQ'/%LQDQH[SORUDWRU\3KDVHDVWXG\-LDQJHWDO7KLV
H[SORUDWRU\3KDVHDGRXEOHEOLQGSODFHERFRQWUROOHGSDUDOOHOJURXSZHHNWUHDWPHQWVWXG\HQUROOHG
SDWLHQWVZLWKPLOGWRPRGHUDWH'/%(,31)'$VDQH[SORUDWRU\LHK\SRWKHVLV
JHQHUDWLQJVWXG\QRGHILQLWLYHFRQFOXVLRQVUHJDUGLQJFOLQLFDOHIILFDF\FRXOGEHLQIHUUHGIURPWKHUHVXOWV

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 17 of 58 
EIP Pharma, Inc. 
Confidential 
+RZHYHUQHIODPDSLPRGGHPRQVWUDWHGSRWHQWLDOFOLQLFDODFWLYLW\RQPXOWLSOHFOLQLFDOHQGSRLQWVZKLFKWKH
FXUUHQWFOLQLFDOVWXG\ZLOODWWHPSWWRFRQILUP
%ULHIO\6WXG\GHPRQVWUDWHGDSRVLWLYHWUHDWPHQWHIIHFWRQWKHSULPDU\RXWFRPHPHDVXUHZLWK
VLJQLILFDQWSOLQHDUPL[HGPRGHOIRUUHSHDWHGPHDVXUHV0050FOLQLFDOO\UHOHYDQWHIIHFWVL]H
LPSURYHPHQWLQFRJQLWLRQLQVXEMHFWVUHFHLYLQJPJQHIODPDSLPRGWKUHHWLPHVGDLO\7,'FRPSDUHGWR
WKRVHUHFHLYLQJSODFHERDVDVVHVVHGE\D1HXURSV\FKRORJLFDO7HVW%DWWHU\17%FRPSRVHGRIVSHFLILF
FRJQLWLYHWHVWVGHVLJQHGWRDVVHVVDWWHQWLRQDQGH[HFXWLYHIXQFWLRQ6LJQLILFDQWSRVLWLYHWUHDWPHQWHIIHFWV
RIPJ7,'QHIODPDSLPRGUHODWLYHWRSODFHERZHUHDOVRVHHQRQDQ$WWHQWLRQ&RPSRVLWHWKDWLQFOXGHG
WHVWVZLWKLQWKH17%WKDWPHDVXUHGLQIRUPDWLRQSURFHVVLQJVSHHG6LJQLILFDQWSRVLWLYHHIIHFWVZHUHQRW
VHHQRQHLWKHUWKH17%RURQWKHDWWHQWLRQFRPSRVLWHLQWKHIXOOHIILFDF\SRSXODWLRQDQDO\VLVLQZKLFKDOO
SDWLHQWVUHFHLYLQJQHIODPDSLPRGLQFOXGLQJSDWLHQWVZKRUHFHLYHGDORZHUGRVHRIPJ%,'ZHUH
LQFOXGHGLQWKHDQDO\VLV+RZHYHUVLJQLILFDQWSRVLWLYHWUHDWPHQWHIIHFWVUHODWLYHWRSODFHERZHUHVHHQLQ
WKHIXOOHIILFDF\SRSXODWLRQDQDO\VLVLHLQFOXGLQJWKRVHUHFHLYLQJQHIODPDSLPRG7,'RUWZLFHGDLO\
RQFRJQLWLRQDQGIXQFWLRQDVHYDOXDWHGE\WKH&OLQLFDO'HPHQWLD5DWLQJVFDOHVXPRIER[HV&'56%
S YVSODFHERIURP0050DQDO\VLVDQGRQPRWRUIXQFWLRQDVDVVHVVHGE\WKH7LPHG8SDQG*R
7HVW78*S YVSODFHERIURP0050DQDO\VLV,QVHFRQGDU\DQDO\VHVDGRVHRIPJ7,'
GHPRQVWUDWHGVLJQLILFDQWLPSURYHPHQWFRPSDUHGWRSODFHERRQWKHSULPDU\HQGSRLQW17%FRPSRVLWH
S WKH$WWHQWLRQ&RPSRVLWHS &'56%S DQGWKH78*WHVWS 
1HIODPDSLPRGZDVZHOOWROHUDWHGLQWKHVWXG\ZLWKQRHDUO\WHUPLQDWLRQVRU6$(VLQSDWLHQWVUHFHLYLQJ
PJ7,''HWDLOVRIWKHFOLQLFDOWULDOUHVXOWVDUHSURYLGHGLQWKH,QYHVWLJDWRU%URFKXUH
7KHSULPDU\REMHFWLYHRIWKLVVWXG\LVWRGHPRQVWUDWHWKHHIILFDF\RIQHIODPDSLPRGFRPSDUHGWRSODFHER
DVDWUHDWPHQWIRU'/%DVDVVHVVHGE\WKH&OLQLFDO'HPHQWLD5DWLQJ6FDOH6XPRI%R[HV&'56%
 
3UH&OLQLFDO3KDUPDFRORJ\5HVXOWV
7KHUHDUHQRDFFHSWHGSUHFOLQLFDOPRGHOVRI'/%+RZHYHUWKHSUHFOLQLFDOGDWDREWDLQHGZLWK
QHIODPDSLPRGWRGDWHSURYLGHHYLGHQFHRILWVDFWLYLW\DJDLQVWVSHFLILFSDWKRSK\VLRORJLFDVSHFWVRI'/%
UHJDUGHGDVWKHPRVWLPSRUWDQWGULYHUVRIGLVHDVHH[SUHVVLRQVSHFLILFDOO\V\QDSWLFG\VIXQFWLRQDQG
IRUHEUDLQFKROLQHUJLFQHXURQDOGHJHQHUDWLRQ7RREWDLQSUHFOLQLFDOSURRIRISULQFLSOHQHIODPDSLPRGZDV
WHVWHGIRUDWWHQXDWLRQRIDJHGHSHQGHQWGHFOLQHLQKLSSRFDPSDOIXQFWLRQLQIHPDOH)LVFKHUUDWV$ODP
ZKHUHWKHGHILFLWVLQ0RUULVZDWHUPD]H0:0SHUIRUPDQFHVKDYHEHHQDUJXHGWREHGXHWR
GHILFLHQWFKROLQHUJLFLQSXWIURPWKHEDVDOIRUHEUDLQWRWKHKLSSRFDPSXV'LFNLQVRQ$QVRQ
1HIODPDSLPRGDGPLQLVWHUHGRUDOO\WZLFHSHUGD\%,'IRUZHHNVIXOO\UHYHUVHGWKHVSDWLDOOHDUQLQJ
GHILFLWVLQWKH0:0WHVWLQ±PRQWKROGUDWVZLWKLGHQWLILHGFRJQLWLYHGHILFLWVGHPRQVWUDWLQJLWV
DELOLW\WRUHYHUVHWKHIXQFWLRQDOFRPSRQHQWRIEDVDOIRUHEUDLQFKROLQHUJLFG\VIXQFWLRQ
7RDGGUHVVLWVDELOLW\WRSUHVHUYHFKROLQHUJLFQHXURQVQHIODPDSLPRGZDVWHVWHGLQ7VPLFHWKDWPRGHO
'RZQV\QGURPH'6DQGGHYHORSDQHXURGHJHQHUDWLYHSDWKRORJ\LQFOXGLQJEDVDOIRUHEUDLQFKROLQHUJLF
GHJHQHUDWLRQDQGHQGRF\WLFDEQRUPDOLWLHV-LDQJHWDO 7KLVSDWKRORJ\LVSDUWLFXODUO\UHOHYDQWWR
'/%EHFDXVHDVQRWHGDERYHLWLVFRQVLGHUHGWREHDGLVHDVHRIIRUHEUDLQFKROLQHUJLFQHXURQDO
GHJHQHUDWLRQ)XMLVKLURHWDO7VPLFHZHUHWUHDWHGE\RUDOJDYDJHIRUGD\VEHJLQQLQJDW±
PRQWKVRIDJHZKHQFKROLQHUJLFQHXURQDOORVVLVGHYHORSLQJDQGHQGRVRPDOSDWKRORJ\LVHYLGHQW
ZLWKHLWKHUQHIODPDSLPRGPJNJ%,'RUYHKLFOH:LOGW\SHPLFHZHUHVLPLODUO\WUHDWHGIRU
FRPSDULVRQ1HIODPDSLPRGWUHDWPHQWUHYHUVHGWKHQHXURGHJHQHUDWLYHSKHQRW\SHUHVWRULQJFKROLQHUJLF
QHXURQFRXQWVLQWKHPHGLDOVHSWDOQXFOHXV061WROHYHOVFRPSDUDEOHWRWKRVHLQZLOGW\SHPLFHZLWK

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 18 of 58 
EIP Pharma, Inc. 
Confidential 
QHXURQVVWDLQLQJSRVLWLYHIRUFKROLQHDFHW\OWUDQVIHUDVH&K$7VKRZLQJDPRUHQRUPDOPRUSKRORJ\-LDQJ
HWDO$OVRUHYHUVHGE\QHIODPDSLPRGWUHDWPHQWLQ7VPLFHZHUHHQGRVRPDODEQRUPDOLWLHVDV
LQGLFDWHGE\FRUWLFDOFRXQWVRIPHGLXPDQGODUJH5DEHDUO\HQGRVRPHVPYVYHKLFOH7KHVH
ILQGLQJVGHPRQVWUDWHWKHSRWHQWLDORIQHIODPDSLPRGWREHGLVHDVHPRGLI\LQJLQDGLVHDVHVXFKDV'/%
WKDWLVGULYHQE\EDVDOIRUHEUDLQFKROLQHUJLFQHXURQDOORVV
 
3ULRU&OLQLFDO([SHULHQFH
1HIODPDSLPRGKDVEHHQWHVWHGFOLQLFDOO\LQ$''/%DQGDOVRLQHDUOLHUVWXGLHVLQUKHXPDWRLGDUWKULWLV
DQGWKHULVNVWRGDWHDUHZHOOGRFXPHQWHG
&OLQLFDOVDIHW\GDWDWRVXSSRUWWKHXVHRIQHIODPDSLPRGPJ7,'LQWKHFXUUHQWFOLQLFDOWULDODUH
DYDLODEOHIURPIRXU3KDVHVWXGLHVRI!ZHHNVWUHDWPHQWGXUDWLRQVHH7DEOHRQHLQSDWLHQWVZLWK
UKHXPDWRLGDUWKULWLVDQGWKUHHLQUHOHYDQWGLVHDVHLQGLFDWLRQV$'DQG'/%

7DEOH
1HIODPDSLPRG3KDVH&OLQLFDO6WXGLHV!ZHHNV7UHDWPHQW'XUDWLRQ

6WXG\
3DWLHQW3RSXODWLRQ
'RVHV
UHJLPHQXVHGPJ
KRXUSODVPDGUXJ
H[SRVXUH
9;

5KHXPDWRLG$UWKULWLV
3ODFHERQ 
ELGQ 
IRUZHHNV
JKUP/
9;

0LOG$O]KHLPHU¶V'LVHDVH
'RVH
ௗPJELGQ 
'RVH
ௗPJELGQ 
±JKUP/
(,39;

0LOG$O]KHLPHU¶V'LVHDVH 3ODFHERQ PJ
ELGQ 
JKUP/
(,31)'

0LOGWR0RGHUDWH'HPHQWLD
ZLWK/HZ\%RGLHV'/%
3ODFHERQ 
ௗPJELGQ 
PJWLGQ ZHLJKW
EDVHG
±JKUP/


EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 19 of 58 
EIP Pharma, Inc. 
Confidential 
'XHWRWKHSURWHLQELQGLQJLQSODVPDZKLFKUHGXFHVSRWHQF\WKUHHIROGWKH3KDVHFOLQLFDOVWXG\LQ
UKHXPDWRLGDUWKULWLV5$ZDVFRQGXFWHGDWDVLJQLILFDQWO\KLJKHUGRVHOHYHOWKDQWKHVWXGLHVLQ&16
LQGLFDWLRQVZKLFKUHVXOWHGLQDKRXUSODVPDGUXJH[SRVXUHIROGKLJKHUWKDQWKHSODVPDGUXJ
H[SRVXUHDFKLHYHGZLWKPJ7,'7KHGRVHOLPLWLQJLQWKLVVWXG\ZDVHOHYDWLRQLQWUDQVDPLQDVH
$/7$67OHYHOVZKLFKZDVVHHQLQRIRISDWLHQWVZLWK*UDGHHOHYDWLRQLQVXEMHFWVDQG
*UDGHHOHYDWLRQLQVXEMHFWV7KHVHHOHYDWLRQVJHQHUDOO\VWDUWHGDWRUDURXQGZHHNRIWUHDWPHQW
UHYHUVHGXSRQWUHDWPHQWFHVVDWLRQDQGZHUHQRWDVVRFLDWHGZLWKELOLUXELQHOHYDWLRQV7KHPRVWFRPPRQ
WUHDWPHQWHPHUJHQWDGYHUVHHYHQWV7($(VLQWKHVWXG\LQQHIODPDSLPRGUHFLSLHQWVLQWKH5$VWXG\
ZHUHDEGRPLQDOSDLQLQFLGHQFHYVLQSODFHERDQGGLDUUKHDYVZKLFKJHQHUDOO\
ZHUHUHSRUWHGDVEHLQJUHODWHGWRVWXG\GUXJ
7KHLQFLGHQFH7($(VUHJDUGOHVVRIUHODWLRQVKLSIRUWKHWKUHH!ZHHNGXUDWLRQ3KDVHVWXGLHVLQ$'
RU'/%LVVKRZQLQ7DEOH1RWDEO\WKHLQFLGHQFHRIJDVWURLQWHVWLQDOHYHQWVLVORZHUWKDQUHSRUWHGLQ
WKHVWXG\LQ5$ZLWKDORZHULQFLGHQFHRIGLDUUKHDDQGRQO\RQHLQVWDQFHRIDEGRPLQDOSDLQLQWKHWULDOV
LQ$'DQG'/%QRWVKRZQLQWDEOH:LWKUHJDUGWRUHODWLRQVKLSLQWKHFDVHRIWKHWKUHHPRVWFRPPRQ
HYHQWVRIIDOOVZDVFRQVLGHUHGUHODWHGSRVVLEO\UHODWHGLQDSODFHERUHFLSLHQWRIWKHGLDUUKHD
HYHQWVZHUHFRQVLGHUHGUHODWHGDOOSRVVLEO\UHODWHGIRXULQQHIODPDSLPRGUHFLSLHQWVDQGRIWKH
KHDGDFKHHYHQWVZHUHFRQVLGHUHGUHODWHGDOOSRVVLEO\UHODWHGHLJKWLQQHIODPDSLPRGUHFLSLHQWV
$FURVVWKHWKUHHVWXGLHVWKHUHKDVEHHQRQHLQVWDQFHRIWUHDWPHQWGLVFRQWLQXDWLRQLQDQHIODPDSLPRG
UHFLSLHQWIRUDVWXG\GUXJUHODWHG7($(ZKLFKZDVDVXEMHFWLQWKHZHHNWUHDWPHQWVWXG\LQ$'ZKR
GLVFRQWLQXHGDWWKHHQGRIZHHNIRUDSRVVLEO\UHODWHGHYHQWRIPLOGQDXVHD7KHUHKDVEHHQQRVWXG\
GUXJUHODWHGVHULRXVDGYHUVHHYHQWVUHSRUWHGIURPWKHVHFOLQLFDOWULDOV

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 20 of 58 
EIP Pharma, Inc. 
Confidential 
7DEOH
,QFLGHQFHRI7UHDWPHQW(PHUJHQW$GYHUVH(YHQWV7($(VUHSRUWHGDW


!LQFLGHQFHLQ!ZHHNWUHDWPHQWGXUDWLRQVWXGLHVLQ$'RU'/%

3ODFHER
1 
1HIODPDSLPRG
1 
&RPELQHG
1 
)DOOV



'LDUUKHD



+HDGDFKH



&RPPRQ
&ROG85,



1DXVHD



6RPQROHQFH



9RPLWLQJ



)DWLJXH




:LWKUHJDUGWRODERUDWRU\DEQRUPDOLWLHVWKHUHKDVEHHQRQHLQVWDQFHRID*UDGHHOHYDWLRQLQ$/7$67
HOHYDWLRQVDFURVVWKHWKUHH3KDVHFOLQLFDOWULDOV7KHHOHYDWLRQZDVQRWHGLQDURXWLQHSHUVWXG\SURWRFRO
ODERUDWRU\WHVWHYDOXDWLRQDW:HHNDQGZDVDVVRFLDWHGZLWKVXEMHFWUHSRUWHGPRGHUDWHXQLWVSHU
ZHHNDOFRKROLQWDNH2IQRWHWKHVXEMHFWZKRZDVUHFHLYLQJQHIODPDSLPRGPJ%,'LQWKHZHHN
$'VWXG\FRQWLQXHGWRWDNHVWXG\GUXJIRURQHZHHNDIWHUWKHILUVWODEWHVWZDVWDNHQDQGDUHSHDW
HYDOXDWLRQVKRZHGDUHGXFWLRQLQ$/7$67OHYHOVGXULQJFRQWLQXHGQHIODPDSLPRGLQWDNH$WWKDW
WLPHVWXG\GUXJZDVGLVFRQWLQXHGDQGWKHVXEMHFWZLWKGUHZIURPWKHVWXG\DQGQRIXUWKHUIROORZXS
LQIRUPDWLRQLVDYDLODEOH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 21 of 58 
EIP Pharma, Inc. 
Confidential 
 
2%-(&7,9(6
 
3ULPDU\2EMHFWLYH
7KHSULPDU\REMHFWLYHLVWRGHPRQVWUDWHWKHHIILFDF\RIQHIODPDSLPRGFRPSDUHGWRSODFHERDVDWUHDWPHQW
IRU'/%DVDVVHVVHGE\WKH&OLQLFDO'HPHQWLD5DWLQJ6FDOH6XPRI%R[HV&'56%
 
6HFRQGDU\2EMHFWLYHV
7KHVHFRQGDU\REMHFWLYHVDUHWR
x 
'HPRQVWUDWHWKDW QHIODPDSLPRGLPSURYHVPRWRUIXQFWLRQFRPSDUHGWRSODFHERDVDVVHVVHGE\
WKH7LPHG8SDQG*R7HVW78*
x 
'HPRQVWUDWHWKDWQHIODPDSLPRGLPSURYHVFRJQLWLRQFRPSDUHGWRSODFHERDVDVVHVVHGE\D'/%
VSHFLILF1HXURSV\FKRORJLFDO7HVW%DWWHU\17%7KH17%LVFRPSULVHGRI
o &RJVWDWH'HWHFWLRQWHVW'(7
o &RJVWDWH,GHQWLILFDWLRQWHVW,'1
o &RJVWDWH2QH&DUG/HDUQLQJWHVW2&/
o &RJVWDWH2QH%DFNWHVW21%
o /HWWHU)OXHQF\7HVW
x 
'HPRQVWUDWHWKDWQHIODPDSLPRGLPSURYHVJOREDOFRJQLWLRQIXQFWLRQDQGEHKDYLRUGLVHDVHVWDWXV
DVHYDOXDWHGE\DFOLQLFLDQZLWKFDUHJLYHULQSXWFRPSDUHGWRSODFHERDVDVVHVVHGE\WKH
$O]KHLPHU¶V'LVHDVH&RRSHUDWLYH6WXG\±&OLQLFDO*OREDO,PSUHVVLRQRI&KDQJH$'&6&*,&
 
([SORUDWRU\2EMHFWLYHV
7KHH[SORUDWRU\REMHFWLYHVLQFOXGH
x 
&KDQJHLQ'HPHQWLD&RJQLWLYH)OXFWXDWLRQV6FDOH'&)6
x 
6HOHFWGRPDLQVRIWKHLWHP1HXURSV\FKLDWULF,QYHQWRU\13,LQFOXGLQJGHSUHVVLRQ
G\VSKRULDDSDWK\KDOOXFLQDWLRQVDQGDJLWDWLRQDJJUHVVLRQ
x 
&KDQJHLQKDOOXFLQDWLRQVIUHTXHQF\[VHYHULW\VFRUHZLWKLQWKH13,LQVXEMHFWVZKRUHSRUW
KDOOXFLQDWLRQVDWEDVHOLQH
x 
&KDQJHLQVOHHSDQGQLJKWWLPHEHKDYLRUFKDQJHZLWKLQWKH13,
x 
&KDQJHLQ0'683'56PRWRUH[DPLQDWLRQ3DUW,,,VFRUH
x 
&KDQJHLQEHWDIXQFWLRQDOFRQQHFWLYLW\DQGLQDOSKDUHDFWLYLW\RQTXDQWLWDWLYH((*
x 
%DVDOIRUHEUDLQDWURSK\E\VWUXFWXUDO05,

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 22 of 58 
EIP Pharma, Inc. 
Confidential 
 
,19(67,*$7,21$/3/$1
 
2YHUDOO6WXG\'HVLJQDQG3ODQ
7KLVLVD3KDVHEPXOWLFHQWHUUDQGRPL]HGGRXEOHEOLQGSODFHERFRQWUROOHGVWXG\RIQHIODPDSLPRG
YHUVXVPDWFKLQJSODFHERUDQGRPL]HGDGPLQLVWHUHGZLWKIRRGIRUZHHNVLQVXEMHFWVZLWK'/%
6XEMHFWVZLOOUHFHLYHFDSVXOHVSHUGD\7,'ZLWKIRRGLHZLWKWKHPRUQLQJPLGGD\DQGHYHQLQJ
PHDOVHLWKHUQHIODPDSLPRGPJRUSODFHER'RVHVVKRXOGEHDGPLQLVWHUHGDWOHDVWKRXUVDSDUW
 
6XEMHFW5HFUXLWPHQW
6XEMHFWVPD\EHUHFUXLWHGWRSDUWLFLSDWHLQWKLVVWXG\YLDDQXPEHURIPHWKRGVEDVHGRQHDFKVLWH¶V
SUHIHUHQFH7\SLFDOUHFUXLWPHQWPHWKRGVLQFOXGHDGYHUWLVLQJORFDOO\RURQZHEVLWHVRFLDOPHGLDUHIHUUDOV
IURPRWKHUSK\VLFLDQVDQGWKHVLWH¶VH[LVWLQJSDWLHQWSRRO
 
6FUHHQLQJ
)ROORZLQJFRPSOHWLRQRILQIRUPHGFRQVHQWSURFHGXUHVVXEMHFWVZLOOHQWHUWKH6FUHHQLQJSKDVHRIWKH
VWXG\
2QHWRWZR6FUHHQLQJYLVLWVDUHSODQQHGGXULQJZKLFKVDIHW\VFUHHQLQJPHDVXUHVZLOOEHXQGHUWDNHQDV
ZHOODVVRPHFRJQLWLYHDVVHVVPHQWVSHU6FKHGXOHRI$VVHVVPHQWV$SODVPDVDPSOHIRUS7DX
DQDO\VLVZLOODOVREHREWDLQHGDW6FUHHQLQJDQGDQDO\]HGIRUHOLJLELOLW\SXUSRVHV6FUHHQLQJZLOOEH
FRQGXFWHGZLWKLQGD\VEHIRUH%DVHOLQH'D\,ID'D7VFDQLVUHTXLUHGWRGHWHUPLQHVWXG\
HOLJLELOLW\6FUHHQLQJPD\EHH[WHQGHGWRGD\V
 
7UHDWPHQW3HULRG
2QFHHOLJLELOLW\LVFRQILUPHGGXULQJWKH6FUHHQLQJSHULRGDQGEHIRUHWKHILUVWGRVHRIVWXG\GUXJVXEMHFWV
ZLOOEHVWUDWLILHGE\EDFNJURXQGGHPHQWLDWKHUDS\RQHRIWKUHHVWUDWDQRFKROLQHVWHUDVHLQKLELWRUWKHUDS\
FKROLQHVWHUDVHLQKLELWRUWKHUDS\DORQHRUFKROLQHVWHUDVHLQKLELWRUWKHUDS\SOXVPHPDQWLQHWKHUDS\DQG
WKHQEHUDQGRPO\DVVLJQHGRQDEDVLVWRSODFHERRUQHIODPDSLPRGIRUWKHZHHNWUHDWPHQWSHULRG
,QYHVWLJDWRUVDQGVXEMHFWVZLOOEHEOLQGHGWRWKHWUHDWPHQWDVVLJQPHQW
'RVLQJZLOOVWDUWRQ'D\IROORZLQJFRPSOHWLRQRIDOOEDVHOLQHSURFHGXUHV'XULQJWKHZHHNWUHDWPHQW
SHULRGVXEMHFWVZLOOUHWXUQWRWKHFOLQLFHYHU\ZHHNVIRUWKHILUVWPRQWKDQGWKHQHYHU\ZHHNV
WKHUHDIWHU$)LQDO6WXG\9LVLWLH)ROORZ8S9LVLWZLOOEHFRQGXFWHGZHHNVGD\VDIWHU
FRPSOHWLRQRIVWXG\GUXJRUDIWHUWKH(DUO\7HUPLQDWLRQ(7YLVLW6HHWKH6FKHGXOHRI$VVHVVPHQWVIRU
GHWDLOVUHJDUGLQJZKHQDVVHVVPHQWVDUHFRQGXFWHG
 
(DUO\7HUPLQDWLRQ(7
6XEMHFWVZKRSUHPDWXUHO\GLVFRQWLQXHVWXG\GUXJIRUDQ\UHDVRQZLOOEHDVNHGWRUHWXUQWRWKHFOLQLFIRUDQ
(DUO\7HUPLQDWLRQ(7YLVLWZLWKLQGD\VIROORZLQJWKHODVWVWXG\GUXJGRVHLILWLVGHWHUPLQHGWKDWWKH
VXEMHFWZLOOGLVFRQWLQXHVWXG\GUXJZKLOHDWWKHVWXG\FHQWHUIRUDVFKHGXOHGYLVLWWKHQWKH(7YLVLWVKRXOG
EHFRQGXFWHGDWWKDWWLPH7KHVHVXEMHFWVZLOODOVREHDVNHGWRUHWXUQWRWKHFOLQLFIRUD)ROORZXS9LVLW
ZHHNVGD\VIROORZLQJWKHODVWVWXG\GUXJGRVH,ISRVVLEOHWKHVXEMHFWZLOODOVREHDVNHGWRUHWXUQWR
WKHFOLQLFDW:HHNIRUWKHLUHQGRIVWXG\YLVLWLIWKH)ROORZXSYLVLWLVSULRUWR:HHN
(YHU\HIIRUWVKRXOGEHPDGHWRHQVXUHDVXEMHFWUHWXUQVIRUWKHVHYLVLWV
5HIHUWR6HFWLRQIRUGHWDLOVUHJDUGLQJUHPRYDORIVXEMHFWVIURPWUHDWPHQW

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 23 of 58 
EIP Pharma, Inc. 
Confidential 
 
([WHQVLRQ7UHDWPHQW
$OOVXEMHFWVZKRFRPSOHWHWKHZHHNWUHDWPHQWSKDVHZLOOEHRIIHUHGWKHRSSRUWXQLW\WRFRQWLQXHLQDQ
RSHQODEHOH[WHQVLRQWUHDWPHQWZKHUHWKH\ZLOOEHSURYLGHGQHIODPDSLPRG7,'IRUDQDGGLWLRQDO
ZHHNV3DWLHQWVZKRHQWHUWKHH[WHQVLRQSKDVHZLOOUHPDLQEOLQGHGWRWKHLUSUHYLRXVWUHDWPHQWXQWLOWKH
GDWDEDVHKDVEHHQORFNHGDQGUHVXOWVDUHFRPSLOHGLQWKHSDUHQWVWXG\%DVHGRQWKHUHVXOWVRIWKHGRXEOH
EOLQGWUHDWPHQWSKDVHRIWKHVWXG\(,33KDUPDZLOOZRUNZLWKHDFKFRXQWU\WRSURYLGHDFFHVVWR
WUHDWPHQWDIWHUFRPSOHWLRQRIWKHH[WHQVLRQSKDVHLIWKHUHLVDFOHDUEHQHILW
 
'LVFXVVLRQRI6WXG\'HVLJQ
7KHVWXG\LVEHLQJFRQGXFWHGWRFRQILUPWKHFOLQLFDOILQGLQJVLQWKHH[SORUDWRU\K\SRWKHVLVJHQHUDWLQJ
3KDVHDFOLQLFDOVWXG\RIQHIODPDSLPRGLQ'HPHQWLDZLWK/HZ\ERGLHVLQDODUJHUK\SRWKHVLVWHVWLQJ
3KDVHEFOLQLFDOVWXG\$VVXFKWKHVWXG\GHVLJQLVVLPLODUWRWKH3KDVHDVWXG\HJZHHN
WUHDWPHQWGXUDWLRQEXWZLWKUHILQHPHQWVEDVHGRQOHDUQLQJVREWDLQHGLQSKDVHD6SHFLILFDOO\WKH
SULPDU\RXWFRPHPHDVXUHIRUWKHFXUUHQWVWXG\ZLOOEHWKH&'56%DQHQGSRLQWWKDWGHPRQVWUDWHGKLJKHU
VHQVLWLYLW\IRUWUHDWPHQWHIIHFWVLQWKHSKDVHDVWXG\WKDQWKHQHXURSV\FKRORJLFDOWHVWEDWWHU\DVVHVVLQJ
DWWHQWLRQH[HFXWLYHIXQFWLRQDQGYLVXRVSDWLDOIXQFWLRQZKLFKZDVWKHSULPDU\RXWFRPHPHDVXUHLQSKDVH
D7KHEHWWHUSHUIRUPDQFHRI&'56%UHODWLYHWRWKDWRIWKH1HXURSV\FKRORJLFDO7HVW%DWWHU\17%LV
SRWHQWLDOO\GXHWRDQXPEHURIIDFWRUVLQFOXGLQJWKHDELOLW\RIWKH&'56%WRFDSWXUHHIIHFWVRQERWK
FRJQLWLYHDQGPRWRUIXQFWLRQWKH&'56%EHLQJSULPDULO\EDVHGRQFDUHJLYHULQSXWZKLFKPD\EH
OHVVSURQHWKDQFRJQLWLYHWHVWLQJRIWKHSDWLHQWWRH[WHUQDOIDFWRUVHJSDQGHPLFDQGGD\WRGD\
IOXFWXDWLRQDQGWKURXJKWKHIXQFWLRQDOGRPDLQVDVZHOOWKHRSHQHQGHGTXHVWLRQVZLWKLQWKHFRJQLWLYH
GRPDLQVWKHDELOLW\WRFDSWXUHFRJQLWLYHGRPDLQVWKDWDUHQRWDVVHVVHGE\WKHWHVWVZLWKLQWKH17%ZKLFK
E\GHVLJQDUHPHDQWWRFDSWXUHHIIHFWVRQVSHFLILFFRJQLWLYHGRPDLQV
7KHLQFOXVLRQH[FOXVLRQFULWHULDDUHODUJHO\WKHVDPHDVLQSKDVHD7ZRDGGLWLRQVWRWKH
LQFOXVLRQH[FOXVLRQFULWHULDDUHGHVLJQHGWRUHGXFHKHWHURJHQHLW\ZLWKLQWKHSRSXODWLRQUDQGRPL]HG)LUVW
RQO\SDWLHQWVZLWKJOREDO&'5VFRUHV&'5*6RIDQGZLOOEHHQUROOHG,Q3KDVHDSDUWLFLSDQWV
ZLWK&'5*6ZHUHDOVRHQUROOHGWKRXJKRQO\RIWKHSDUWLFLSDQWVUDQGRPL]HGKDGDEDVHOLQH
&'5*6RI:LWKLQWKDWVPDOOQXPEHUWKHUHZDVDQLPSUHVVLRQWKDWWKHWUHDWPHQWUHVSRQVHZDV
PLQLPDOLQWKHSDUWLFLSDQWVZLWKEDVHOLQH&'5*6RI7KHPRUHLPSRUWDQWUHILQHPHQWRIWKH
SRSXODWLRQWREHHQUROOHGLVWKDWSDWLHQWVZLWKEDVHOLQHSODVPDSWDXJUHDWHUWKDQDWKUHVKROGDVVRFLDWHG
ZLWK$O]KHLPHU¶VGLVHDVH$'FRSDWKRORJ\ZLOOEHH[FOXGHG(OHYDWHGSODVPDSWDXSUHGLFWVWKH
SUHVHQFHRIWHPSRUDOOREHWDXSDWKRORJ\+DOOHWDODQGLVDVVRFLDWHGZLWKPRUHDGYDQFHGGLVHDVH
DQGPRUHUDSLGFRJQLWLYHGHFOLQH*RQ]DOHVHWDO,QWKH3KDVHDVWXG\HOHYDWHGSODVPDSWDX
ZDVDVVRFLDWHGZLWKORZHUHIIHFWVL]HIRUQHIODPDSLPRGYVSODFHERZKLOHWKHHIIHFWVL]HIRU
QHIODPDSLPRGYVSODFHERLQSDWLHQWVZLWKRXWHOHYDWHGSODVPDSWDXZDVIRUHDFKRI&'56%DQG
78*DQGIRUWKH17%FRJQLWLYHWHVWEDWWHU\
7KHFRPELQHGHIIHFWRIQRWHQUROOLQJSDWLHQWVZLWK&'5*6RIDQGH[FOXGLQJSDWLHQWVZLWKHOHYDWHG
SODVPDSWDXZLOOEHWRHQUROOSDWLHQWVDWDOHVVDGYDQFHGVWDJHRIGLVHDVHWKDQLQSKDVHDSDWLHQWVZKR
PD\EHPRUHOLNHO\QRWWREHUHFHLYLQJFKROLQHVWHUDVHLQKLELWRUWKHUDS\$VVXFKDVRSSRVHGWRSKDVHD
ZKHUHDOOSDWLHQWVZHUHUHFHLYLQJFKROLQHVWHUDVHLQKLELWRUWKHUDS\SDWLHQWVZKRDUHQRWUHFHLYLQJ
FKROLQHVWHUDVHLQKLELWRUWKHUDS\ZLOOQRWEHH[FOXGHGLQWKHFXUUHQWVWXG\

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 24 of 58 
EIP Pharma, Inc. 
Confidential 
:LWKUHVSHFWWRWKH((*EHWDIXQFWLRQDOFRQQHFWLYLW\LVWKHSULPDU\RXWFRPHPHDVXUHDQG(\HV&ORVHG
(&WR(\HV2SHQ(2DOSKDUHDFWLYLW\LVWKHRQHVHFRQGDU\((*HQGSRLQW%HWDIXQFWLRQDO
FRQQHFWLYLW\LVWKHSULPDU\((*HQGSRLQWEHFDXVHWKHUHZDVDVLJQDOIRUDWUHDWPHQWHIIHFWLQWKH3KDVHD
VWXG\((*DVVHVVPHQWVZHUHLQFOXGHGLQRXU3KDVHDVWXG\EXWXQIRUWXQDWHO\FRXOGQRWEHREWDLQHGLQ
DOOSDWLHQWVDWWKHSODQQHGZHHNWLPHSRLQWEHFDXVHRI&29,'UHODWHGUHVWULFWLRQVQRQHWKHOHVV
VLJQLILFDQWDIWHUFRUUHFWLRQIRUPXOWLSOLFLW\GRVHGHSHQGHQWLPSURYHPHQWLQEHWDIXQFWLRQDOFRQQHFWLYLW\
ZDVREVHUYHGZLWKQRRWKHUHYLGHQWHIIHFWVWKDWVXUYLYHGDGMXVWPHQWIRUPXOWLSOHWHVWLQJ:HKRSHWR
FRQILUPWKLVILQGLQJLQWKHSURSRVHG3KDVHEVWXG\(&WR(2DOSKDUHDFWLYLW\ZDVQRWHYDOXDWHGLQWKH
3KDVHDVWXG\EXWLVLQFOXGHGDVVHFRQGDU\((*HQGSRLQWEHFDXVHDQHZUHSRUW6FKXPDFKHUHWDO
-HQQLQJVHWDOSXEOLVKHGDIWHUWKH3KDVHDVWXG\ZDVFRQGXFWHGLQGLFDWHVWKDWDOSKD
UHDFWLYLW\LVDVSHFLILFPHDVXUHIRU'/%DQGDPHDVXUHRI³FKROLQHUJLFLQWHJULW\´LQERWK'/%DQG$'
7KHFXUUHQWVWXG\ZLOODOVRLQFOXGHVWUXFWXUDODQGIXQFWLRQDO05,WRHYDOXDWHWKHHIIHFWVRQDWURSK\RIWKH
EDVDOIRUHEUDLQFKROLQHUJLFV\VWHPDVZHOOWKHLQWHJULW\RIWKHIXQFWLRQDOFRQQHFWLYLW\SDWKZD\VRIWKH
EDVDOIRUHEUDLQ&KROLQHUJLFQHXURQDOGHJHQHUDWLRQLQWKHEDVDOIRUHEUDLQLVSURPLQHQWLQ'/%DQG
QHIODPDSLPRGKDVGHPRQVWUDWHGSRWHQWLDOWRLPSDFWWKHGHJHQHUDWLYHSURFHVVLQWKHEDVDOIRUHEUDLQ-LDQJ
HWDO7KHLQFOXVLRQRI05,VWXGLHVLVWKHPDMRUGLIIHUHQFHEHWZHHQWKLVWKHH[86YHUVLRQDQG
WKHSURWRFROZLWKLQWKH86
7KHILQDOFKDQJHIURP3KDVHDLVWKDWDOOSDUWLFLSDQWVLQWKHFXUUHQWVWXG\ZLOOUHFHLYHPJ7,'LI
UDQGRPL]HGWRQHIODPDSLPRGZKLOHLQ3KDVHDWKRVHZLWKZHLJKWNJUHFHLYHGPJ%,'6HHWKH
QH[WVHFWLRQIRUIXUWKHUGLVFXVVLRQIRUWKHVHOHFWLRQRIPJ7,'IRUWKHFXUUHQWVWXG\
 
5DWLRQDOHIRU'RVH6HOHFWLRQ
 
(IILFDF\&RQVLGHUDWLRQV
PJQHIODPDSLPRGFDSVXOHVWKUHHWLPHVGDLO\7,'WDNHQZLWKIRRGLVWKHGRVHDQGUHJLPHQWKDWZLOO
EHXWLOL]HGLQWKLVVWXG\7KLVGRVHDQGUHJLPHQGHPRQVWUDWHGFOLQLFDOHIILFDF\LQWKHDIRUHPHQWLRQHG
3KDVHDFOLQLFDOVWXG\LQ'/%(,31)'6WXG\VHH6HFWLRQ7KHRWKHUGRVHUHJLPHQ
XWLOL]HGLQWKHVWXG\PJQHIODPDSLPRG%,'GHPRQVWUDWHGKHWHURJHQRXVHIIHFWVRQWKHPDMRUHQGSRLQWV
LQWKH6WXG\LQFOXGLQJOLWWOHWRQRHIIHFWRQWKHSULPDU\RXWFRPHPHDVXUHWKH17%7KHPDJQLWXGH
RI WKH HIILFDF\ LQ 6WXG\  SDUWLFXODUO\ ZLWKUHVSHFW WRWKH &'56% LV VXFK WKDW D KLJKHU GRVH LV
FRQVLGHUHGQRWQHFHVVDU\WRHYDOXDWH
7KHGRVHUHVSRQVHVHHQLQLVFRQVLVWHQWZLWKDWKUHVKROGHIIHFWRIWURXJKSODVPDGUXJFRQFHQWUDWLRQV
RQHIILFDF\GHULYHGIURPWKHFOLQLFDOWULDOVLQ$O]KHLPHU¶VGLVHDVH$'7KHFOLQLFDOHQGSRLQWLQWKH$'
WULDOVWKDWLVPRVWFRPSDUDEOHWRWKH17%XWLOL]HGLQWKH3KDVH'/%VWXG\6WXG\LVWKH:HFKVOHU
0HPRU\ 6FDOH :06 ,PPHGLDWH DQG 'HOD\HG 5HFDOO  7KH :06 ,PPHGLDWH'HOD\HG 5HFDOO DOVR
FRQVLVWVRIVL[FRJQLWLYHWHVWVDQGZKLOHLWVSULPDU\IRFXVLVWRPHDVXUHHIIHFWVRQHSLVRGLFPHPRU\LWLV
DOVRGHSHQGHQWRQDWWHQWLRQH[HFXWLYHIXQFWLRQDQGYLVXRVSDWLDOIXQFWLRQVDVLVWKHFDVHZLWKWKH'/%
VSHFLILF17%,QWKHZHHNSODFHERFRQWUROOHGVWXG\LQHDUO\$'³5(9(56(6'´VWXG\3ULQVHWDO
 DQ HIIHFW RQ :06 ,PPHGLDWH'HOD\HG 5HFDOO ZLWK  PJ %,' ZDV RQO\ VHHQ LQ SDWLHQWV RQ
EDFNJURXQGWKHUDS\ZKRDFKLHYHGSODVPDGUXJOHYHOV!QJP/OHYHOVWKDWZRXOGEHH[SHFWHGZLWK
PJ7,'EXWQRWZLWKPJ%,',QDGGLWLRQWKHUHZHUHSRVLWLYHWUHQGVWRZDUGVOHVVZRUVHQLQJFRPSDUHG
WRSODFHERRQWKH&'56%LQWKH5(9(56(6'VWXG\3ULQVHWDO,QWKHVL[ZHHNVWXG\LQ3KDVH
DDVLPLODUSODVPDGUXJFRQFHQWUDWLRQGHSHQGHQWWKUHVKROGHIIHFWRQDELRPDUNHUFHUHEURVSLQDOIOXLG,/
OHYHOVZDVDOVRGHPRQVWUDWHG

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 25 of 58 
EIP Pharma, Inc. 
Confidential 
 
6DIHW\&RQVLGHUDWLRQV
%DVHGRQWKHFOLQLFDOH[SHULHQFHWRGDWHDWKLJKHUGRVHVWKH7,'UHVXOWVLQWKHVWXG\DVZHOODVWKH3.
UHVXOWVQRWHGDERYHQHIODPDSLPRGGRVHRIPJ7,'LVZHOOWROHUDWHGDQGKDVDORZULVNRIGUXJ
WR[LFLW\
7KHH[SHFWHGWKHHVWLPDWHGDYHUDJH$8&WKDWZLOOUHVXOWZLWKWKHPJ7,'GRVHUHJLPHQWREH
XWLOL]HGLQWKHVWXG\LVDSSUR[LPDWHO\JKUP/7KLVH[SRVXUHZLOOSURYLGHJUHDWHUWKDQDIROG
PDUJLQWRWKHQRHIIHFWH[SRVXUHOHYHOLQWKHFKURQLFUHSHDWGRVHVWXGLHVLQUDWDQGWKHGRJVHH
,QYHVWLJDWRU%URFKXUH)URPDFOLQLFDOVDIHW\VWDQGSRLQWWKHGRVLQJUHJLPHQDQGH[SRVXUHOHYHODUH
VXSSRUWHGE\VDIHW\GDWDREWDLQHGIURPDSSUR[LPDWHO\KHDOWK\YROXQWHHUVDQGSDWLHQWVZKRKDYH
UHFHLYHGQHIODPDSLPRGIRUXSWRVL[PRQWKV7KHKLJKHVWSODVPDGUXJH[SRVXUHOHYHOVREWDLQHGLQSDWLHQW
EDVHGFOLQLFDOVWXGLHVZDVLQUKHXPDWRLGDUWKULWLV5$ZKHUHPJ%,'IRUGD\V1 UHVXOWHGLQ
$8&VWHDG\VWDWHRIaJKUP/DQGPJ%,'IRUXSWRZHHNV1 UHVXOWLQJLQ$8&
DWVWHDG\VWHDG\VWDWHJKUP/7KHGRVHOLPLWLQJDGYHUVHHIIHFWDFURVVWKHVHVWXGLHVZHUHUHYHUVLEOH
WUDQVDPLQDVHHOHYDWLRQPRVWHYLGHQWDWPJ%,'IRUZHHNVLQSDWLHQWVZLWK5$ZKHUHRI
SDWLHQWVGHYHORSHG!*UDGHHOHYDWLRQLQ$/7DQGRU$67,QWKHUHOHYDQWSDWLHQWSRSXODWLRQVRI$'DQG
'/%WRGDWH*UDGHHOHYDWLRQRI$/7$67ZDVVHHQLQRQHRISDWLHQWVWKHRQHHOHYDWLRQ
GHYHORSHGDWZHHNZKRUHFHLYHGPJ%,'IRUXSWRZHHNVRISDWLHQWVZKRUHFHLYHGPJ
%,'IRUZHHNVDQGRISDWLHQWVZKRUHFHLYHGPJ7,'IRUZHHNV7KLVVWXG\ZLOOLQFOXGHD
PRQLWRULQJSODQIRU$/7$67HOHYDWLRQDQGVSHFLILFFULWHULDIRUGRVHLQWHUUXSWLRQDQGGRVH
GLVFRQWLQXDWLRQIRUDEQRUPDOLWLHVLQWKHVHSDUDPHWHUV$EURDGHUVXPPDU\RIWKHFOLQLFDOVDIHW\
H[SHULHQFHWRGDWHZLOOEHSURYLGHGLQWKH,QYHVWLJDWRU%URFKXUH
,QWKHUHFHQWO\FRPSOHWHG'/%6WXG\QHIODPDSLPRGZDVZHOOWROHUDWHG1RQHZVDIHW\VLJQDOVZHUH
LGHQWLILHGLQWKLVVWXG\7KHUHZHUHWHQHDUO\WUHDWPHQWGLVFRQWLQXDWLRQVGXHWRDGYHUVHHYHQWV
DQGRUGLVHDVHZRUVHQLQJLQSODFHER%,'DQGLQQHIODPDSLPRG%,'UHFLSLHQWVGXHWRZLWKGUDZDO
RIFRQVHQWLQSODFHER%,'DQGLQQHIODPDSLPRG%,'GXHWRGHDWKLQSODFHER%,'DQGGXHWR
SK\VLFLDQGHFLVLRQLQSODFHER7,'7KHUHZHUHVHULRXVDGYHUVHHYHQWV6$(VUHSRUWHGLQWKHSODFHER
JURXSKHPDWRFKH]LDLQWUDSDUHQFK\PDOKHPRUUKDJHLQWHUQDOEOHHGLQJDQGDVWKPDH[DFHUEDWLRQDQGLQ
QHIODPDSLPRG%,'UHFLSLHQWVQHZEUDLQOHVLRQVEUDLQWXPRUKHDGLQMXU\DOORIZKLFKZHUHFRQVLGHUHG
XQUHODWHGWRVWXG\GUXJDGPLQLVWUDWLRQ7KHUHZHUHQR6$(VRUHDUO\WUHDWPHQWGLVFRQWLQXDWLRQVDPRQJVW
PJQHIODPDSLPRG7,'UHFLSLHQWVWKHGRVHOHYHOLQWKHFXUUHQWSURWRFRO2QHSDWLHQWGHFUHDVHGGRVH
IURP7,'WR%,'GXHWRZRUVHQLQJRIRUWKRVWDWLFK\SRWHQVLRQ
7UHDWPHQWHPHUJHQW DGYHUVH HYHQWV 7($(V UHJDUGOHVV RI UHODWLRQVKLS UHSRUWHG LQ JUHDWHU WKDQ RQH
QHIODPDSLPRGVXEMHFWVDUHDVIROORZVLQFLGHQFHLQQHIODPDSLPRGSODFHER)DOOV+HDGDFKH
'LDUUKHD1DXVHD&RPPRQFROG+HDGLQMXU\/LJKW
KHDGHGQHVV0HPRU\,PSDLUPHQW



EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 26 of 58 
EIP Pharma, Inc. 
Confidential 
 
6(/(&7,212)678'<3238/$7,21
 
,QFOXVLRQ&ULWHULD
6XEMHFWVPHHWLQJDOORIWKHIROORZLQJFULWHULDDUHHOLJLEOHIRUHQUROOPHQWLQWKLVVWXG\
 0HQDQGZRPHQDJHG\HDUV
 6XEMHFWLVZLOOLQJDQGDEOHWRSURYLGHZULWWHQLQIRUPHGFRQVHQW
 3UREDEOH'/%E\FRQVHQVXVFULWHULD0F.HLWKHWDOLQFOXGLQJDSRVLWLYH'D7VFDQ,I
WKH'D7VFDQLVQHJDWLYHEXWWKHVXEMHFWKDVKLVWRULFDOSRO\VRPQRJUDSK\36*YHULILHG5(0
VOHHSEHKDYLRUDOGLVRUGHU5%'WKLVZLOODOVRTXDOLI\DVSUREDEOH'/%
 &'5*OREDO6FRUHRIOHVVWKDQDW6FUHHQLQJ
 ,IWKHSDWLHQWLVFXUUHQWO\UHFHLYLQJFKROLQHVWHUDVHLQKLELWRUWKHUDS\WKHSDWLHQWPXVWKDYH
UHFHLYHGVXFKWKHUDS\IRUJUHDWHUWKDQPRQWKVDQGRQDVWDEOHGRVHIRUDWOHDVWZHHNVDWWKH
WLPHRIUDQGRPL]DWLRQ([FHSWIRUUHGXFLQJWKHGRVHIRUWROHUDELOLW\UHDVRQVWKHGRVHRI
FKROLQHVWHUDVHLQKLELWRUPD\QRWEHPRGLILHGGXULQJWKHVWXG\,IWKHSDWLHQWLVQRWFXUUHQWO\
UHFHLYLQJFKROLQHVWHUDVHLQKLELWRUWKHUDS\EXWUHFHLYHGVXFKWKHUDS\SUHYLRXVO\WKDWWKHUDS\
PXVWKDYHEHHQGLVFRQWLQXHGDWOHDVWPRQWKVSULRUWRUDQGRPL]DWLRQ0HPDQWLQHWKHUDS\LV
DOORZHGLILWKDGEHHQVWDUWHGDWOHDVWPRQWKVSULRUWRUDQGRPL]DWLRQDQGWKHSDWLHQWVLVDOVR
UHFHLYLQJFKROLQHVWHUDVHLQKLELWRUWKHUDS\PHPDQWLQHPRQRWKHUDS\LHZLWKRXWFRQFRPLWDQW
FKROLQHVWHUDVHLQKLELWRUWKHUDS\LVH[FOXGHG
 1RUPDORUFRUUHFWHGH\HVLJKWDQGDXGLWRU\DELOLWLHVVXIILFLHQWWRSHUIRUPDOODVSHFWVRIWKH
FRJQLWLYHDQGIXQFWLRQDODVVHVVPHQWV
 1RKLVWRU\RIOHDUQLQJGLIILFXOWLHVWKDWPD\LQWHUIHUHZLWKWKHLUDELOLW\WRFRPSOHWHWKH
FRJQLWLYHWHVWV
 5HFHLYHGYDFFLQDWLRQIRU6$56&R9XQOHVVPHGLFDOFRQWUDLQGLFDWLRQVSUHYHQWEHLQJ
YDFFLQDWHGRUKDVDKLVWRU\RIQDWXUDOLQIHFWLRQ
 0XVWKDYHUHOLDEOHLQIRUPDQWRUFDUHJLYHU
 
([FOXVLRQ&ULWHULD
6XEMHFWVPHHWLQJDQ\RIWKHIROORZLQJFULWHULDDUHQRWHOLJLEOHIRUHQUROOPHQWLQWKLVVWXG\
 'LDJQRVLVRIDQ\RWKHURQJRLQJ&16FRQGLWLRQRWKHUWKDQ'/%LQFOXGLQJEXWQRWOLPLWHG WR
SRVWVWURNHGHPHQWLDYDVFXODUGHPHQWLD$'RU3'
 3ODVPDSWDXUHVXOWDERYHWKHWKUHVKROGWKDWLQGLFDWHVHYLGHQFHRISDWKRORJ\DVVRFLDWHGZLWK
$O]KHLPHU¶VGLVHDVHDW6FUHHQLQJ
 6XLFLGDOLW\GHILQHGDVDFWLYHVXLFLGDOWKRXJKWVZLWKLQPRQWKVEHIRUH6FUHHQLQJRUDW%DVHOLQH
GHILQHGDVDQVZHULQJ\HVWRLWHPVRURQWKH&ROXPELD6XLFLGH6HYHULW\5DWLQJ6FDOH
&6656RUKLVWRU\RIVXLFLGHDWWHPSWLQSUHYLRXV\HDUVRULQWKH,QYHVWLJDWRU¶VRSLQLRQDW
VHULRXVULVNRIVXLFLGH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 27 of 58 
EIP Pharma, Inc. 
Confidential 
 2QJRLQJPDMRUDQGDFWLYHSV\FKLDWULFGLVRUGHUDQGRURWKHUFRQFXUUHQWPHGLFDOFRQGLWLRQWKDWLQ
WKHRSLQLRQRIWKH,QYHVWLJDWRUPLJKWFRPSURPLVHVDIHW\DQGRUFRPSOLDQFHZLWKVWXG\
UHTXLUHPHQWV
 'LDJQRVLVRIDOFRKRORUGUXJDEXVHZLWKLQWKHSUHYLRXV\HDUV
 3RRUO\FRQWUROOHGFOLQLFDOO\VLJQLILFDQWPHGLFDOLOOQHVVVXFKDV K\SHUWHQVLRQEORRGSUHVVXUH
!PP+JV\VWROLFRUPP+J GLDVWROLFP\RFDUGLDOLQIDUFWLRQZLWKLQPRQWKV
XQFRPSHQVDWHG FRQJHVWLYHKHDUWIDLOXUHRURWKHUVLJQLILFDQWFDUGLRYDVFXODUSXOPRQDU\ UHQDO
OLYHULQIHFWLRXVGLVHDVHLPPXQHGLVRUGHURU PHWDEROLFHQGRFULQHGLVRUGHUVRURWKHUGLVHDVHWKDW
ZRXOGLQWHUIHUHZLWKDVVHVVPHQWRIGUXJVDIHW\
 $VSDUWDWHDPLQRWUDQVIHUDVH$67RUDODQLQHDPLQRWUDQVIHUDVH$/7!îWKHXSSHUOLPLWRI
QRUPDO8/1WRWDOELOLUXELQ!î8/1 DQGRU,QWHUQDWLRQDO1RUPDOL]HG5DWLR,15!
 .QRZQKXPDQLPPXQRGHILFLHQF\YLUXVKHSDWLWLV%RUDFWLYH KHSDWLWLV&YLUXVLQIHFWLRQ
 3DUWLFLSDWHGLQDVWXG\RIDQLQYHVWLJDWLRQDOGUXJOHVVWKDQZHHNVRUKDOIOLYHVRIDQ
LQYHVWLJDWLRQDOGUXJZKLFKHYHULVORQJHU EHIRUHHQUROOPHQWLQWKLVVWXG\
 +LVWRU\RISUHYLRXVQHXURVXUJHU\WRWKHEUDLQZLWKLQWKHSDVWILYH\HDUV
 ,IPDOHZLWKIHPDOHSDUWQHUVRIFKLOGEHDULQJSRWHQWLDOXQZLOOLQJRUXQDEOHWRDGKHUHWR
FRQWUDFHSWLRQUHTXLUHPHQWVVSHFLILHG LQWKHSURWRFRO
 ,IIHPDOHZKRKDVQRWKDVQRWUHDFKHGPHQRSDXVH!\HDUSUHYLRXVO\RUKDVQRWKDGD
K\VWHUHFWRP\RUELODWHUDORRSKRUHFWRP\VDOSLQJRRRSKRUHFWRP\KDVDSRVLWLYHSUHJQDQF\WHVW
UHVXOWGXULQJ6FUHHQLQJDQGRULVXQZLOOLQJRUXQDEOHWRDGKHUHWRWKHFRQWUDFHSWLRQUHTXLUHPHQWV
VSHFLILHGLQWKHSURWRFRO
 
5HPRYDORI6XEMHFWVIURP7UHDWPHQW
,QDFFRUGDQFHZLWKWKHFXUUHQWUHYLVLRQRIWKH'HFODUDWLRQRI+HOVLQNLDQGRWKHUDSSOLFDEOHUHJXODWLRQVD
VXEMHFWKDVWKHULJKWWRZLWKGUDZIURPWKHVWXG\DWDQ\WLPHDQGIRUDQ\UHDVRQZLWKRXWSUHMXGLFHWRKLVRU
KHUIXWXUHPHGLFDOFDUHE\WKHSK\VLFLDQRUDWWKHLQVWLWXWLRQ$VXEMHFW¶VSDUWLFLSDWLRQPD\DOVREH
GLVFRQWLQXHGE\WKH,QYHVWLJDWRURU6SRQVRUGXHWRFRPSOLDQFHVDIHW\RURWKHUDGPLQLVWUDWLYHUHDVRQVHH
DOVR6HFWLRQ
7KHVXEMHFWPXVWEHGLVFRQWLQXHGIURPVWXG\GUXJWUHDWPHQWIRUWKHRFFXUUHQFHRIDQXQDFFHSWDEOH
WR[LFLW\LQFOXGLQJDQ\RIWKHIROORZLQJ
x 
$Q\FOLQLFDOO\VLJQLILFDQWLQIHFWLRQ&OLQLFDOO\VLJQLILFDQWLVGHILQHGDVDQ\LQIHFWLRQUHTXLULQJ
KRVSLWDOL]DWLRQDQGRULQWUDYHQRXVDQWLELRWLFVDQGRUFRQVLGHUHGWREHRSSRUWXQLVWLF
x 
(OHYDWHG$/7RU$67LQFOXGLQJ
o $/7RU$67!î8/1
o $/7RU$67!î8/1IRU!ZHHNV
o $/7RU$67!î8/1DQGWRWDOELOLUXELQ!î8/1RU,15![8/1
o $/7RU$67!î8/1ZLWKWKHDSSHDUDQFHRIZRUVHQLQJRIIDWLJXHQDXVHDYRPLWLQJ
ULJKWXSSHUTXDGUDQWSDLQRUWHQGHUQHVVIHYHUUDVKRUHRVLQRSKLOLD

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 28 of 58 
EIP Pharma, Inc. 
Confidential 
5HIHUWR6HFWLRQIRUGHWDLOVUHJDUGLQJIROORZXSDIWHUHDUO\GLVFRQWLQXDWLRQ$GGLWLRQDOFDUHDQG
WUHDWPHQWZLOOEHSURYLGHGWRVXEMHFWVRQFHVWXG\GLVFRQWLQXDWLRQLQFOXGLQJDQ\UHTXLUHGIROORZXSYLVLWV
IRUUHVROXWLRQIRUVWXG\UHODWHG$(VLVFRPSOHWHG

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 29 of 58 
EIP Pharma, Inc. 
Confidential 
 
75($70(176$'0,1,67(5('
$OOVXEMHFWVZLOOEHDGPLQLVWHUHGFDSVXOHRIQHIODPDSLPRGPJFDSVXOHVRUPDWFKLQJSODFHERRUDOO\
7,'ZLWKIRRGLHZLWKWKHPRUQLQJPLGGD\DQGHYHQLQJPHDOVIRUZHHNV7KHLQLWLDOWUHDWPHQW
SKDVHRIWKHVWXG\ZLOOEHEOLQGHG3DWLHQWVZKRFRPSOHWHWKHSDUHQWVWXG\PD\EHHOLJLEOHIRUDIXUWKHU
ZHHNVRIWUHDWPHQWQHIODPDSLPRGPJ7,'LQDQRSHQODEHOH[WHQVLRQ
'RVHVPXVWEHWDNHQZLWKLQPLQXWHVIROORZLQJDPHDORUVQDFN'RVHVVKRXOGEHWDNHQDW
DSSUR[LPDWHO\VDPHWLPHVHDFKGD\WKURXJKRXWWKHVWXG\DQGDWOHDVWKRXUVDSDUW
 
'RVLQJ
7KHILUVWGRVHRIVWXG\GUXJRQ%DVHOLQH'D\ZLOOEHDGPLQLVWHUHGDWWKHVWXG\FHQWHU7KH,QYHVWLJDWRU
RURWKHUGHVLJQDWHGTXDOLILHGVLWHSHUVRQQHOVKRXOGUHYLHZGRVLQJLQVWUXFWLRQVZLWKWKHVXEMHFWSULRUWRWKH
VXEMHFWOHDYLQJWKHVLWH6XEMHFWVZLOOEHLQVWUXFWHGWRUHWXUQDOOVWXG\FRQWDLQHUVUHJDUGOHVVRIZKHWKHU
HPSW\RUFRQWDLQLQJXQXVHGVWXG\GUXJ
,IWKHVXEMHFW¶V'D\YLVLWLVLQWKHDIWHUQRRQWKHVXEMHFWVKRXOGRQO\DGPLQLVWHUGRVHVLQVWHDGRIRQ
'D\
,IDVXEMHFWPLVVHVVWXG\GUXJGRVHLHFDSVXOHWKHVXEMHFWVKRXOGUHVXPHGRVLQJDWWKHQH[W
VFKHGXOHGDGPLQLVWUDWLRQWLPHDWZKLFKWLPHERWKWKHPLVVHGGRVHDQGWKHFXUUHQWGRVHLHFDSVXOHV
DUHWREHWDNHQ,IWKHVXEMHFWPLVVHVVWXG\GUXJGRVHVLHFDSVXOHVWKHVXEMHFWVKRXOGWDNHGRVHV
LHFDSVXOHVDWWKHQH[WVFKHGXOHGDGPLQLVWUDWLRQWLPHDQGWKHQUHVXPHUHJXODUGRVLQJLH
FDSVXOHDWWKHQH[WVFKHGXOHGDGPLQLVWUDWLRQWLPH6XEMHFWVVKRXOGQRWWDNHPRUHWKDQGRVHVLH
FDSVXOHVDWDQ\JLYHQDGPLQLVWUDWLRQWLPH
 
'RVH0RGLILFDWLRQV,QWHUUXSWLRQVRU'LVFRQWLQXDWLRQ
)RUWROHUDELOLW\UHDVRQVDIWHUDWOHDVWWZRZHHNVRIWUHDWPHQWWKH,QYHVWLJDWRUPD\UHTXHVWDQGUHFHLYH
DSSURYDOIURPWKH0HGLFDO0RQLWRUWRPRGLI\IURPPJ7,'WRPJ%,'LQVXEMHFWVZLWKZHLJKWOHVV
WKDQNJ1RRWKHUGRVHPRGLILFDWLRQVDUHSHUPLWWHGGXULQJWKHVWXG\,IDVXEMHFWLVXQDEOHWRWROHUDWH
WKHDVVLJQHGVWXG\GUXJGRVHWKHQWKHVXEMHFWVKRXOGEHGLVFRQWLQXHGIURPVWXG\GUXJWUHDWPHQW
6HFWLRQ
 
3DFNDJLQJDQG/DEHOLQJ
(,33KDUPDZLOOVXSSO\SODFHERRUQHIODPDSLPRGFDSVXOHVYLDEOLVWHUSDFNVRQDQLQGLYLGXDOVXEMHFW
EDVLV%RWKQHIODPDSLPRGDQGSODFHERFDSVXOHVDUHUHGLQFRORU
/DEHOGHWDLOVZLOOEHLQDFFRUGDQFHZLWKORFDODQGQDWLRQDOUHTXLUHPHQWV
 
6WXG\'UXJ6XSSO\6WRUDJHDQG+DQGOLQJ
6WXG\GUXJZLOOEHVXSSOLHGWRVLWHVRQDQLQGLYLGXDOVXEMHFWEDVLV1HIODPDSLPRGFDSVXOHVVKRXOGEH
VWRUHGDWURRPWHPSHUDWXUH
:KLOHDWWKHFOLQLFDOVLWHVWXG\GUXJDFFHVVVKRXOGEHOLPLWHGWRWKH,QYHVWLJDWRUDQGRWKHUTXDOLILHGVLWH
SHUVRQQHO

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 30 of 58 
EIP Pharma, Inc. 
Confidential 
 
'UXJ$FFRXQWDELOLW\'LVSRVDO5HWXUQRU5HWHQWLRQ6WXG\'UXJ
7KHVLWHGHVLJQDWHGSKDUPDFLVWRURWKHUTXDOLILHGSHUVRQQHOZLOOGRFXPHQWUHFHLSWIURP6SRQVRU
GLVSHQVLQJWRVXEMHFWVDQGUHWXUQWRWKHVWXG\FHQWHUIURPVXEMHFWYLDGUXJDFFRXQWDELOLW\ORJV
6XEMHFWVZLOOEHLQVWUXFWHGWRUHWXUQDOOEOLVWHUSDFNVWRWKHVWXG\FHQWHUUHJDUGOHVVRIZKHWKHUHPSW\RU
FRQWDLQLQJXQXVHGVWXG\GUXJ(,33KDUPDRUGHVLJQHHZLOOUHYLHZDFFRXQWDELOLW\UHFRUGVWKURXJKRXWWKH
FRQGXFWRIWKHVWXG\
7KHVLWHVKRXOGPDLQWDLQDOOVWXG\GUXJFRQWDLQHUVXVHGDQGXQXVHGXQWLOILQDOUHYLHZRIDFFRXQWDELOLW\LV
FRQGXFWHGE\WKH(,33KDUPDRUGHVLJQHHDQGLQVWUXFWLRQVUHJDUGLQJUHWXUQRUGLVSRVDODVDSSOLFDEOHDUH
SURYLGHG
 
7UHDWPHQW&RPSOLDQFH
7UHDWPHQWFRPSOLDQFHZLOOEHDVVHVVHGE\UHYLHZLQJWKHFRXQWRIUHWXUQHGFDSVXOHVDWHDFKYLVLW$Q\
DSSDUHQWGLVFUHSDQFLHVEHWZHHQTXDQWLW\RIFDSVXOHVUHWXUQHGDQGWKHQXPEHUH[SHFWHGEDVHGRQGRVLQJ
VFKHGXOHZLOOEHGLVFXVVHGZLWKWKHVXEMHFWWRHQVXUHDQXQGHUVWDQGLQJRIGRVLQJLQVWUXFWLRQV
&RPSOLDQFHLVGHILQHGDV!DWHDFKYLVLW,IFRPSOLDQFHLVWKLVLVDSURWRFROGHYLDWLRQ
5HSHDWHGQRQFRPSOLDQFHZLWKGRVLQJLQVWUXFWLRQVPD\QHFHVVLWDWHGLVFRQWLQXDWLRQIURPWKHVWXG\EDVHG
RQWKH,QYHVWLJDWRU¶VMXGJPHQW6HFWLRQ
 
0HWKRGRI$VVLJQLQJ6XEMHFWVWR7UHDWPHQW*URXS
2QFHHOLJLELOLW\LVFRQILUPHGVXEMHFWVZLOOEHVWUDWLILHGE\EDFNJURXQGGHPHQWLDWKHUDS\RQHRIWKUHH
VWUDWDQRFKROLQHVWHUDVHLQKLELWRUWKHUDS\FKROLQHVWHUDVHLQKLELWRUWKHUDS\DORQHRUFKROLQHVWHUDVH
LQKLELWRUWKHUDS\SOXVPHPDQWLQHDQGWKHQUDQGRPL]HGRQDEDVLVLQDEOLQGHGPDQQHUWRUHFHLYH
HLWKHUSODFHERRUPJQHIODPDSLPRGXWLOL]LQJDQDXWRPDWLFDOO\JHQHUDWHGUDQGRPFRGH5DQGRPL]DWLRQ
ZLOOEHDGPLQLVWHUHGYLD,QWHUDFWLYH5HVSRQVH7HFKQRORJ\,57
 
6WXG\%OLQGLQJDQG%UHDNLQJWKH%OLQG
6XEMHFWVDQGVLWHSHUVRQQHODVVRFLDWHGZLWKVWXG\FRQGXFWZLOOEHEOLQGHGWRWUHDWPHQWDVVLJQPHQW
'XULQJWKHFRQGXFWRIWKHVWXG\WKHEOLQGVKRXOGEHEURNHQRQDQLQGLYLGXDOVXEMHFWEDVLVLQWKHHYHQWRI
DQHPHUJHQF\ZKHUHLWLVQHFHVVDU\IRUWKH,QYHVWLJDWRUWRNQRZZKLFKWUHDWPHQWWKHVXEMHFWLVUHFHLYLQJ
EHIRUHWKHVXEMHFWFDQEHWUHDWHG7KHEOLQGPD\DOVREHEURNHQLIVRPHRQHQRWLQWKHVWXG\XVHVVWXG\
GUXJHJLIDFKLOGLQWKHSDUWLFLSDQW¶VKRXVHKROGWDNHVVWXG\GUXJWKHEOLQGPD\EHEURNHQWRGHWHUPLQH
WUHDWPHQWIRUWKHFKLOG
:KHQLWLVQHFHVVDU\WREUHDNWKHEOLQGWKH,QYHVWLJDWRUPD\XQEOLQGWKHWUHDWPHQWLPPHGLDWHO\
LHZLWKRXWSULRUQRWLFHWRWKH0HGLFDO0RQLWRU6SRQVRURURWKHUEXWPXVWQRWLI\WKH,QGHSHQGHQW
(WKLFV&RPPLWWHH,(&SHUORFDOUHJXODWLRQVDQG6SRQVRUDVVRRQDVSRVVLEOHSUHIHUDEO\E\WHOHSKRQH
DQGWKHQLQZULWLQJUHJDUGLQJWKHQHFHVVLW\RIFRGHEUHDNLQJ
,IWKHFRGHLVEURNHQIRUDVXEMHFWWKLVPXVWEHGRFXPHQWHGLQWKHHOHFWURQLFFDVHUHSRUWIRUPH&5)DQG
VRXUFHGRFXPHQWVWRJHWKHUZLWKWKHUHDVRQVIRUEUHDNLQJWKHFRGH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 31 of 58 
EIP Pharma, Inc. 
Confidential 
 
3ULRUDQG&RQFRPLWDQW7KHUDS\
$Q\PHGLFDWLRQVWDNHQIURP6FUHHQLQJWKURXJKWKH)LQDO6WXG\9LVLWLH)ROORZ8S9LVLWLQFOXGLQJDOO
SUHVFULSWLRQDQGRYHUWKHFRXQWHUPHGLFDWLRQVDVZHOODVVXSSOHPHQWVZLOOEHGRFXPHQWHGLQWKHVXEMHFW¶V
VRXUFHGRFXPHQWDQGLQWKHH&5)
:KLOHGUXJGUXJLQWHUDFWLRQVWXGLHVKDYHQRWEHHQFRQGXFWHGLQYLWURWHVWLQJLQGLFDWHVWKDWQHIODPDSLPRG
LVPHWDEROL]HGE\R[LGDWLRQLQWKHOLYHUE\WKHF\WRFKURPH3&<3V\VWHPFRPELQDWLRQRI&<3$
DQG&<3&LVR]\PHV8QWLOWKHPHWDEROLVPLVEHWWHUFKDUDFWHUL]HGFRQFRPLWDQWVWURQJLQKLELWRUVRI
&<3$DUHSURKLELWHGDQGVWURQJLQGXFHUVRI&<3$VKRXOGEHXVHGZLWKFDXWLRQLQVXEMHFWV
UHFHLYLQJQHIODPDSLPRGDVWKHXVHRIVXFKGUXJVFRXOGLPSDFWQHIODPDSLPRGPHWDEROLVPLQVXEMHFWV
ZKRKDYHDQXQGHUO\LQJ&<3&JHQRW\SLFYDULDQWWKDWLPSDFWVDFWLYLW\RIWKDW&<3&
7KHIROORZLQJPHGLFDWLRQVDUHSURKLELWHGGXULQJVWXG\SDUWLFLSDWLRQ
x 
6WURQJ&<3$LQKLELWRUVVHH7DEOH
x 
$Q\RWKHULQYHVWLJDWLRQDOGUXJ,IDVXEMHFWKDVSUHYLRXVO\SDUWLFLSDWHGLQDVWXG\RIDQ
LQYHVWLJDWLRQDOGUXJODVWGRVLQJPXVWKDYHRFFXUUHGPRQWKVRUKDOIOLYHVRIWKHLQYHVWLJDWLRQ
GUXJZKLFKHYHULVORQJHUEHIRUHHQUROOPHQWLQWKLVVWXG\
7KH0HGLFDO0RQLWRUVKRXOGEHFRQWDFWHGZLWKDQ\TXHVWLRQVUHJDUGLQJFRQFRPLWDQWXVHRIPHGLFDWLRQV
WKDWDUHWKRXJKWWRPRGXODWH&<3$DFWLYLW\

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 32 of 58 
EIP Pharma, Inc. 
Confidential 
7DEOH
&<3$,QKLELWRUV
3URKLELWHG
6WURQJ,QKLELWRUV
IROGLQFUHDVHLQ$8&
RU!GHFUHDVHLQ&/
$OORZHG
0RGHUDWHLQKLELWRUV
EXWIROGLQFUHDVHLQ$8&
RUGHFUHDVHLQ&/
$OORZHG
:HDNLQKLELWRUV
EXWIROGLQFUHDVHLQ$8&
RUGHFUHDVHLQ&/
ERFHSUHYLU
FRELFLVWDW
FODULWKURP\FLQ
FRQLYDSWDQ
GDQRSUHYLUULWRQDYLU
GLOWLD]HP
HOYLWHJUDYLUULWRQDYLU
JUDSHIUXLWMXLFH
LGHODOLVLE
LQGLQDYLUULWRQDYLU
LWUDFRQD]ROH
NHWRFRQD]ROH
ORSLQDYLUULWRQDYLU
QHID]RGRQH
QHOILQDYLU
SDULWDSUHYLUULWRQDYLURPELWDVYLU
SRVDFRQD]ROH
ULWRQDYLU
VDTXLQDYLUULWRQDYLU
WHODSUHYLU
WLSUDQDYLUULWRQDYLU
WUROHDQGRP\FLQ
YRULFRQD]ROH
$SUHSLWDQW
FLPHWLGLQH
FLSURIOR[DFLQ
FORWULPD]ROH
FUL]RWLQLE
F\FORVSRULQH
GURQHGDURQH
HU\WKURP\FLQ
IOXFRQD]ROH
IOXYR[DPLQH
LPDWLQLE
WRILVRSDP
YHUDSDPLO
FKORU]R[D]RQH
FLORVWD]RO
IRVDSUHSLWDQW
LVWUDGHI\OOLQH
LYDFDIWRU
ORPLWDSLGH
UDQLWLGLQH
UDQROD]LQH
WDFUROLPXV
WLFDJUHORU

$EEUHYLDWLRQV$8&DUHDXQGHUWKHFRQFHQWUDWLRQWLPHFXUYH&/FOHDUDQFH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 33 of 58 
EIP Pharma, Inc. 
Confidential 
7DEOH
&<3$,QGXFHUV
8VHZLWK&DXWLRQ
6WURQJ,QGXFHUV
GHFUHDVHLQ$8&
$OORZHG
0RGHUDWH,QGXFHUV
GHFUHDVHLQ$8&
$OORZHG
:HDN,QGXFHUV
GHFUHDVHLQ$8&
FDUEDPD]HSLQHHQ]DOXWDPLGH
PLWRWDQH
SKHQ\WRLQ
ULIDPSLQ
6W-RKQ¶VZRUW
ERVHQWDQ
HIDYLUHQ]
HWUDYLULQH
PRGDILQLO

DUPRGDILQLO
UXILQDPLGH
$EEUHYLDWLRQV$8&DUHDXQGHUWKHFRQFHQWUDWLRQWLPHFXUYH
 
&RQWUDFHSWLRQDQG3UHJQDQF\
7KLVVHFWLRQVKRXOGEHUHDGLQFRQMXQFWLRQZLWKWKHVHOHFWLRQFULWHULDWKDWUHODWHWRDJHDQGFRQWUDFHSWLRQ
x 
([FOXVLRQFULWHULDDQG6HFWLRQ
1RVLJQVRIHPEU\RIHWDOWR[LFLW\RUWHUDWRJHQLFHIIHFWVRIQHIODPDSLPRGZHUHREVHUYHGLQUDWV7HVWLQJLQ
UDEELWVZDVQRWSHUIRUPHGGXHWRODFNRIH[SRVXUHIROORZLQJDGPLQLVWUDWLRQRIWKHQHIODPDSLPRG
IRUPXODWLRQ1RKXPDQVWXGLHVRIHIIHFWVRIQHIODPDSLPRGRQFRQFHSWLRQSUHJQDQF\RUODFWDWLRQKDYH
EHHQSHUIRUPHG)HPDOHVVKRXOGQRWEHH[SRVHGWRQHIODPDSLPRGLISUHJQDQWEUHDVWIHHGLQJRU
DWWHPSWLQJWRFRQFHLYH7KHIROORZLQJJXLGHOLQHVIRUFRQWUDFHSWLRQVKRXOGEHIROORZHGIURPEHIRUHILUVW
GRVHRQ'D\WKURXJKGD\VIROORZLQJWKHODVWGRVHRIVWXG\GUXJ
 
)HPDOH&RQWUDFHSWLRQ
)HPDOHVXEMHFWVRIFKLOGEHDULQJSRWHQWLDOKDYHQRWH[SHULHQFHGPHQRSDXVHDQGKDYHQRWKDGD
K\VWHUHFWRP\RUELODWHUDORRSKRUHFWRP\VDOSLQJRRRSKRUHFWRP\RUIHPDOHVXEMHFWVZKRKDYH
H[SHULHQFHGPHQRSDXVHZLWKLQWKHSUHYLRXV\HDUPXVWKDYHDQHJDWLYHSUHJQDQF\WHVWGXULQJ6FUHHQLQJ
DQGPXVWXVHDWOHDVWRIWKHIROORZLQJFRQWUDFHSWLYHPHWKRGV
x 
&RPSOHWHDEVWLQHQFHUHJDUGOHVVRIPHQVWUXDOF\FOHWLPLQJ
x 
&RQWUDFHSWLYHRUDOWUDQVGHUPDOLQMHFWDEOHRULPSODQWDEOHLQWUDXWHULQHGHYLFHRUEDUULHU
PHWKRGRIFRQWUDFHSWLRQ
 
0DOH&RQWUDFHSWLRQ
0DOHVXEMHFWVZLWKIHPDOHSDUWQHUVRIFKLOGEHDULQJSRWHQWLDOPXVWXVHDWOHDVWRIWKHIROORZLQJ
FRQWUDFHSWLYHPHWKRGV
x 
+RUPRQDOFRQWUDFHSWLYHVRUDOLQMHFWDEOHSDWFKLQWUDXWHULQHGHYLFHV
x 
0DOHVWHULOL]DWLRQ
x 
7RWDODEVWLQHQFHIURPKHWHURVH[XDOLQWHUFRXUVHZKHQWKLVLVWKHSUHIHUUHGDQGXVXDOOLIHVW\OHRI
WKHVXEMHFW

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 34 of 58 
EIP Pharma, Inc. 
Confidential 
o $EVWLQHQFHLVGHILQHGDVUHIUDLQLQJIURPKHWHURVH[XDOLQWHUFRXUVHGXULQJWKHHQWLUHSHULRG
RIULVNDVVRFLDWHGZLWKWKHVWXG\WUHDWPHQWVZKHQWKLVLVWKHSUHIHUUHGDQGXVXDOOLIHVW\OH
RIWKHVXEMHFW
o 1RWHWKDWSHULRGLFDEVWLQHQFHFDOHQGDUV\PSWRWKHUPDOSRVWRYXODWLRQPHWKRGV
ZLWKGUDZDOFRLWXVLQWHUUXSWXVVSHUPLFLGHVRQO\DQGODFWDWLRQDODPHQRUUKRHDPHWKRG
DUHQRWDFFHSWDEOHPHWKRGVRIFRQWUDFHSWLRQ
 
3UHJQDQF\
$Q\SUHJQDQF\VKRXOGEHUHSRUWHGWRWKH,QYHVWLJDWRUDQGLQWXUQWKHSUHJQDQF\VKRXOGEHUHSRUWHGWR
WKH6SRQVRURUGHVLJQHHZLWKLQKRXUVRIWKH,QYHVWLJDWRU¶VDZDUHQHVVRIWKHSUHJQDQF\,IDIHPDOH
VXEMHFWEHFRPHVSUHJQDQWVWXG\GUXJZLOOEHSHUPDQHQWO\GLVFRQWLQXHGDQGWKHVXEMHFWZLOOEH
GLVFRQWLQXHGIURPWKHVWXG\
:LWKSURSHULQIRUPHGFRQVHQWVHSDUDWHSUHJQDQF\LQIRUPHGFRQVHQWIRUPWKHVXEMHFWRUSDUWQHUZLOOEH
IROORZHGWKURXJKWKHFRPSOHWLRQRIWKHSUHJQDQF\DQGRXWFRPHRIWKHSUHJQDQF\UHSRUWHGDQGWKHLQIDQW
ZLOOEHIROORZHGIRUPRQWKVDIWHUELUWK

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 35 of 58 
EIP Pharma, Inc. 
Confidential 
 
678'<$66(660(176$1'352&('85(6
 
6FKHGXOHRI$VVHVVPHQWV
7DEOH
6FKHGXOHRI$VVHVVPHQWV7UHDWPHQW3KDVH
$VVHVVPHQW

6FUHHQLQJ
P
7UHDWPHQW3KDVH

(DUO\
7HUPLQDWLRQ
)ROORZ
8S
6FUHHQLQJ
9LVLWPD
%DVHOLQH

:HHN

:HHN

:HHN

:HHN
:HHN

(79LVLWF
)ROORZ
8S9LVLWPG
:LWKLQGD\V
RI'D
'PE
 
'

'

'


'


'

:LWKLQGD\V
DIWHUODVWGRVH
:LWKLQGD\V
RIODVWGRVH
,QIRUPHG&RQVHQW
;PH





;PH


0HGLFDOKLVWRU\
UHYLHZ
;








006(
;








3K\VLFDOH[DPLQDWLRQPI
;





;
;
;
9LWDOVLJQVJ
;
;
;
;
;
;
;
;
;
3UHJQDQF\WHVWLQJ
;PKK








+HPDWRORJ\DQG
FKHPLVWU\PL
;
;

;
;
;
;
;

&RDJXODWLRQVWXGLHVPL
;





;
;

OHDG
HOHFWURFDUGLRJUDPM
;








'D7VFDQLI
QHHGHG
;N








05,
;PO
;P




;P


&6656
;
;

;
;
;
;
;

&'56%
;
;

;
;
;
;
;

17%Q
;
;

;
;
;
;
;

78*
;
;


;
;
;
;

$'&6&*,&

;




;
;

'&)6
;
;

;
;
;
;
;

13,

;



;
;
;

0'683'563DUW
,,,

;


;

;
;

((*R

;




;S
;

'LVSHQVHVWXG\GUXJ

;
;
;
;
;
;T



EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 36 of 58 
EIP Pharma, Inc. 
Confidential 
$VVHVVPHQW

6FUHHQLQJ
P
7UHDWPHQW3KDVH

(DUO\
7HUPLQDWLRQ
)ROORZ
8S
6FUHHQLQJ
9LVLWPD
%DVHOLQH

:HHN

:HHN

:HHN

:HHN
:HHN

(79LVLWF
)ROORZ
8S9LVLWPG
:LWKLQGD\V
RI'D
'PE
 
'

'

'


'


'

:LWKLQGD\V
DIWHUODVWGRVH
:LWKLQGD\V
RIODVWGRVH
3KDUPDFRNLQHWLF3.
VDPSOLQJ


;U






3ODVPDVDPSOHIRU
S7DX
;V








3ODVPDVDPSOHIRU
SURWHLQELRPDUNHU
WHVWLQJ
;
;



;
;
;

3ULRUFRQFRPLWDQW
PHGLFDWLRQ
;
;
;
;
;
;
;
;
;
$GYHUVHHYHQW
UHFRUGLQJ
;
;
;
;
;
;
;
;
;
)LQDOVWXG\GUXJ
UHFRQFLOLDWLRQ






;
;



$'&6&*,&$O]KHLPHU¶V'LVHDVH&RRSHUDWLYH6WXG\±&OLQLFDO*OREDO,PSUHVVLRQRI&KDQJH
&'56%&OLQLFDO'HPHQWLD5DWLQJ6FDOH6XPRI%R[HV
&7&RPSXWHGWRPRJUDSK\
'GD\
'&)6'HPHQWLD&RJQLWLYH)OXFWXDWLRQV6FDOH
0'683'560RYHPHQW'LVRUGHU6RFLHW\±8QLILHG3DUNLQVRQ¶V'LVHDVH5DWLQJ6FDOH±3DUW,,,
006(0LQLPHQWDOVWDWHH[DP
05,0DJQHWLFUHVRQDQFHLPDJLQJ
13,LWHP1HXURSV\FKLDWULF,QYHQWRU\
17%1HXURSV\FKRORJLFDO7HVW%DWWHU\
D 
2QHWRWZR6FUHHQLQJYLVLWVDUHSODQQHGGXULQJZKLFKVDIHW\VFUHHQLQJSURFHGXUHVDUHWREHFRPSOHWHGDQGUHYLHZHG
LQFOXGLQJDWOHDVWWZRSUDFWLFH17%HYDOXDWLRQVDQGWKHUHTXLUHGGLDJQRVWLFDQGFRJQLWLYHLPSDLUPHQWSURFHGXUHV
6FUHHQLQJZLOOEHFRQGXFWHGZLWKLQGD\VEHIRUH%DVHOLQH'D\LID'D7VFDQDQGRU05,LVUHTXLUHGWRGHWHUPLQH
VWXG\HOLJLELOLW\6FUHHQLQJPD\EHH[WHQGHGWRGD\V,IQHFHVVDU\DVHFRQGYLVLWPD\EHFRQGXFWHGRQDGLIIHUHQWGD\WR
DOORZIRUVFKHGXOLQJSXUSRVHV
E 
2Q'D\DOOSURFHGXUHVVKRXOGEHFRQGXFWHGSULRUWRILUVWGRVHRIVWXG\GUXJ
F 
6XEMHFWVZKRSUHPDWXUHO\GLVFRQWLQXHVWXG\GUXJIRUDQ\UHDVRQZLOOEHDVNHGWRUHWXUQWRWKHVWXG\FHQWHUIRUDQ(DUO\
7HUPLQDWLRQ(7YLVLWZLWKLQGD\VIROORZLQJWKHODVWVWXG\GUXJGRVHLILWLVGHWHUPLQHGWKDWWKHVXEMHFWZLOOGLVFRQWLQXH
VWXG\GUXJZKLOHDWWKHVWXG\FHQWHUIRUDVFKHGXOHGYLVLWWKHQWKH(7YLVLWVKRXOGEHFRQGXFWHGDWWKDWWLPH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 37 of 58 
EIP Pharma, Inc. 
Confidential 
G 
7KH)ROORZXS9LVLWVKRXOGEHFRQGXFWHGZLWKLQGD\VRIWKHODVWGRVHRIVWXG\GUXJIRUVXEMHFWVZKRFRPSOHWHWKH
PDLQVWXG\RUGLVFRQWLQXHHDUO\,IVXEMHFWVDUHFRQWLQXLQJLQWKH([WHQVLRQ3KDVHWKH)ROORZ8S9LVLWGRHVQRWQHHG
WREHFRQGXFWHGIROORZLQJWKHLUFRPSOHWLRQLQWKH7UHDWPHQW3KDVHVLQFHWKH\ZLOOEHFRQWLQXLQJRQVWXG\GUXJ
H 
,QIRUPHGFRQVHQWSURFHGXUHVLQFOXGLQJVLJQLQJRILQIRUPHGFRQVHQWPXVWEHFRPSOHWHGEHIRUHDQ\VWXG\VSHFLILF
SURFHGXUHVDUHSHUIRUPHG,IVXEMHFWLVFRQWLQXLQJWR([WHQVLRQ3KDVHFRQVHQWVKRXOGEHFRPSOHWHGDWWKH:HHNYLVLWRI
WKH7UHDWPHQW3KDVHSULRUWRDQ\VWXG\VSHFLILFSURFHGXUHVIRUWKH([WHQVLRQ3KDVHDUHSHUIRUPHG
I 
5HIHUWR6HFWLRQIRUGHWDLOVUHJDUGLQJSK\VLFDOH[DPLQDWLRQ
J 
9LWDOVLJQVLQFOXGHEORRGSUHVVXUHSXOVHUHVSLUDWRU\UDWHDQGERG\WHPSHUDWXUH9LWDOVLJQVVKRXOGEHPHDVXUHGDIWHUWKH
VXEMHFWKDVEHHQLQVLWWLQJSRVLWLRQIRUPLQXWHV
K 
)HPDOHVXEMHFWVRIFKLOGEHDULQJSRWHQWLDORUZKRKDYHUHDFKHGPHQRSDXVHLQWKHSUHYLRXV\HDUPXVWKDYHDVHUXPRUXULQH
SUHJQDQF\WHVWSHUIRUPHGGXULQJ6FUHHQLQJVXEMHFWVZLWKSRVLWLYHUHVXOWVDUHQRWHOLJLEOHIRUVWXG\SDUWLFLSDWLRQ
L 
'HWDLOVRIFOLQLFDOODERUDWRU\VDPSOLQJIRUFKHPLVWU\KHPDWRORJ\DQGFRDJXODWLRQVWXGLHVDUHGLVFXVVHGLQ6HFWLRQ
M 
'HWDLOVRIOHDG(&*DVVHVVPHQWDUHGLVFXVVHGLQ6HFWLRQ
N 
6XEMHFWVDUHUHTXLUHGWRKDYHDSULRU'D7VFDQ,ID'D7VFDQKDVQRWEHHQSHUIRUPHGZLWKLQWKHSUHYLRXV\HDUVLWLVWREH
SHUIRUPHGGXULQJ6FUHHQLQJRQO\DIWHUVXEMHFWKDVEHHQGHHPHGHOLJLEOHEDVHGRQDOORWKHULQFOXVLRQH[FOXVLRQFULWHULDHJ
PHGLFDOKLVWRU\ODERUDWRU\WHVWLQJDQGSULRUWRUDQGRPL]DWLRQ1RWHWKDWLI'D7VFDQUHVXOWVDUHQHJDWLYHLHQRHYLGHQFH
RIUHGXFHGXSWDNHLQWKHEDVDOJDQJOLDWKHVXEMHFWLVUHTXLUHGWRKDYHKLVWRULFDO36*YHULILHG5%'WREHHOLJLEOHIRUVWXG\
SDUWLFLSDWLRQ
O 
,I05,RU&7KDVQRWEHHQSHUIRUPHGZLWKLQ\HDUVEHIRUH6FUHHQLQJDQGRUUHVXOWVDUHQRWDYDLODEOHD05,PXVWEH
SHUIRUPHGWRH[FOXGHRWKHUGLVHDVHDVSDUWRI6FUHHQLQJRQO\DIWHUVXEMHFWKDVEHHQGHHPHGHOLJLEOHEDVHGRQDOORWKHU
LQFOXVLRQH[FOXVLRQFULWHULDHJPHGLFDOKLVWRU\ODERUDWRU\WHVWLQJDQGSULRUWRUDQGRPL]DWLRQVHH6HFWLRQ7KLV
05,ZLOODOVREHFRQVLGHUHGWKHVXEMHFW¶V%DVHOLQH05,
P )RUVLWHVRXWVLGHWKH86D05,ZLOOEHSHUIRUPHGDW%DVHOLQHSUHGRVHLIRQHZDVQRWGRQHDW6FUHHQLQJ$05,ZLOODOVR
EHSHUIRUPHGDW:HHNLQWKH7UHDWPHQW3KDVHDQG:HHNLQWKH([WHQVLRQ3KDVH
Q 
5HIHUWR6HFWLRQIRUGHWDLOVUHJDUGLQJWKH17%ZKLFKZLOOLQFOXGHDOOWHVWVLQWKHVHFRQGDU\HQGSRLQWDVZHOOWKH
&DWHJRU\)OXHQF\7HVW&)7DQGWKH,QWHUQDWLRQDO6KRSSLQJ/LVW7HVW,6/7
R 
,QWKH7UHDWPHQW3KDVHDQ((*GRHVQRWQHHGWREHSHUIRUPHGDWWKH(7YLVLWIRUVXEMHFWVZKRGLVFRQWLQXHSULRUWR:HHN
'D\5HIHUWR6HFWLRQIRUIXUWKHUGHWDLOVUHJDUGLQJ((*DVVHVVPHQWV
S 
7KH((*DW:HHNFDQEHFRPSOHWHGDQ\WLPHEHWZHHQ:HHNVDQG((*ZLOOQRWEHFRQGXFWHGDWVLWHVWKDWGRQRW
KDYHDFFHVVWRDQ((*IDFLOLW\
T 
,IVXEMHFWLVFRQWLQXLQJLQRSHQODEHOH[WHQVLRQWUHDWPHQWRSHQODEHOQHIODPDSLPRGVWXG\GUXJVKRXOGEHGLVSHQVHG
DW:HHNYLVLW7KLVYLVLWZLOODOVREHWKH'D\YLVLWRIWKHH[WHQVLRQWUHDWPHQW
U 
$WWKH:HHNYLVLWLQWKH7UHDWPHQW3KDVHRQH3.SODVPDVDPSOHVZLOOEHREWDLQHGpre-dose6XEMHFWVZLOOEH
LQVWUXFWHGWRQRWWDNHWKHLUILUVWGRVHRQWKHPRUQLQJVRIWKH:HHNYLVLWDQGLQVWHDGWDNHWKHLUGRVHZLWKDVQDFNDWWKHVLWH
DIWHUWKHSUHGRVH3.VDPSOHLVREWDLQHG5HIHUWR6HFWLRQIRUIXUWKHUGHWDLOVUHJDUGLQJ3.VDPSOLQJ
V 
$SODVPDVDPSOHIRUS7DXDQDO\VLVZLOOEHREWDLQHGDW6FUHHQLQJDQGHYDOXDWHGIRUHOLJLELOLW\SXUSRVHV5HIHUWR
6HFWLRQIRUIXUWKHUGHWDLOVUHJDUGLQJS7DXVDPSOLQJDQGDQDO\VLV



EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023
Page 38 of 58
EIP Pharma, Inc.
Confidential
7DEOH
6FKHGXOHRI$VVHVVPHQWV([WHQVLRQ3KDVH
$VVHVVPHQW
:HHN

:HHN
:HHN
:HHN

:HHN

(79LVLWF
)ROORZ
8S9LVLWW
'

'

'

'

'

:LWKLQGD\V
DIWHUODVWGRVH
:LWKLQ
GD\VRI
ODVWGRVH
3K\VLFDOH[DPLQDWLRQPII
;
;
;
9LWDOVLJQVJ
;
;
;
;
;
;
+HPDWRORJ\DQG
FKHPLVWU\PL
;
;
;
;
;
&RDJXODWLRQVWXGLHVPL
;
;
&6656
;
;
;
;
&'56%
;
;
;
;
17%Q
;
;
;
;
78*
;
;
;
;
$'&6&*,&
;
;
;
;
'&)6
;
;
;
;
13,
;
;
;
;
0'683'563DUW
,,,
;
;
;
;
05,
;
((*R
;
'LVSHQVHVWXG\GUXJ
;
;
;
3KDUPDFRNLQHWLF3.
VDPSOLQJ
;X
3ODVPDVDPSOHIRU
SURWHLQELRPDUNHU
WHVWLQJ
;
;
;
3ULRUFRQFRPLWDQW
PHGLFDWLRQ
;
;
;
;
;
;
;
$GYHUVHHYHQW
UHFRUGLQJ
;
;
;
;
;
;
;
)LQDOVWXG\GUXJ
UHFRQFLOLDWLRQ
;
;
:HHNLQWKH([WHQVLRQ3KDVHZLOOEHDWHOHSKRQHFDOOWRLQTXLUHDERXWDGYHUVHHYHQWVDQGDQ\QHZFRQFRPLWDQWPHGLFDWLRQV
)ROORZLQJWKHWHOHSKRQHFDOOVXEMHFWVPD\EHVHHQLQFOLQLFDWWKH,QYHVWLJDWRU¶VGLVFUHWLRQ

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 39 of 58 
EIP Pharma, Inc. 
Confidential 
F
6XEMHFWVZKRSUHPDWXUHO\GLVFRQWLQXHVWXG\GUXJIRUDQ\UHDVRQZLOOEHDVNHGWRUHWXUQWRWKHVWXG\FHQWHUIRUDQ(DUO\
7HUPLQDWLRQ(7YLVLWZLWKLQGD\VIROORZLQJWKHODVWVWXG\GUXJGRVHLILWLVGHWHUPLQHGWKDWWKHVXEMHFWZLOOGLVFRQWLQXH
VWXG\GUXJZKLOHDWWKHVWXG\FHQWHUIRUDVFKHGXOHGYLVLWWKHQWKH(7YLVLWVKRXOGEHFRQGXFWHGDWWKDWWLPH
I
5HIHUWR6HFWLRQIRUGHWDLOVUHJDUGLQJSK\VLFDOH[DPLQDWLRQ
J
9LWDOVLJQVLQFOXGHEORRGSUHVVXUHSXOVHUHVSLUDWRU\UDWHDQGERG\WHPSHUDWXUH9LWDOVLJQVVKRXOGEHPHDVXUHGDIWHUWKH
VXEMHFWKDVEHHQLQVLWWLQJSRVLWLRQIRUPLQXWHV
L
'HWDLOVRIFOLQLFDOODERUDWRU\VDPSOLQJIRUFKHPLVWU\KHPDWRORJ\DQGFRDJXODWLRQVWXGLHVDUHGLVFXVVHGLQ6HFWLRQ
Q
5HIHUWR6HFWLRQIRUGHWDLOVUHJDUGLQJWKH17%ZKLFKZLOOLQFOXGHDOOWHVWVLQWKHVHFRQGDU\HQGSRLQWDVZHOOWKH
&DWHJRU\)OXHQF\7HVW&)7DQGWKH,QWHUQDWLRQDO6KRSSLQJ/LVW7HVW,6/7
R
5HIHUWR6HFWLRQIRUIXUWKHUGHWDLOVUHJDUGLQJ((*DVVHVVPHQWV((*ZLOOQRWEHFRQGXFWHGDWVLWHVWKDWGRQRWKDYH
DFFHVVWRDQ((*IDFLOLW\
W
7KH)ROORZ8S9LVLWVKRXOGEHFRQGXFWHGZLWKLQGD\VRIWKHODVWGRVHRIVWXG\GUXJIRUVXEMHFWVZKRFRPSOHWHWKH
([WHQVLRQVWXG\RUGLVFRQWLQXHHDUO\
X
$WWKH:HHNYLVLWLQWKH([WHQVLRQ3KDVHRQH3.SODVPDVDPSOHVZLOOEHREWDLQHGpre-dose6XEMHFWVZLOOEH
LQVWUXFWHGWRQRWWDNHWKHLUILUVWGRVHRQWKHPRUQLQJVRIWKH:HHNYLVLWDQGLQVWHDGWDNHWKHLUGRVHZLWKDVQDFNDWWKHVLWH
DIWHUWKHSUHGRVH3.VDPSOHLVREWDLQHG5HIHUWR6HFWLRQIRUIXUWKHUGHWDLOVUHJDUGLQJ3.VDPSOLQJ




EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023  
Page 40 of 58 
 
EIP Pharma, Inc. 
Confidential 
 
6WXG\$VVHVVPHQWV
7KHVXEMHFWPXVWSURYLGHZULWWHQLQIRUPHGFRQVHQWEHIRUHWKHSHUIRUPDQFHRIDQ\VWXG\UHODWHG
SURFHGXUHV
7KHDVVHVVPHQWVEHORZZLOOEHFRQGXFWHGDWWKHWLPHSRLQWVVSHFLILHGLQ7DEOHDQG7DEOH
 
%DVHOLQHDQG'LVHDVH&KDUDFWHULVWLFV
'HWDLOVUHJDUGLQJ'/%KLVWRU\LQFOXGLQJPHWKRGVRIGLDJQRVLVZLOOEHFROOHFWHGGXULQJ6FUHHQLQJDV
VSHFLILHGLQWKHH&5)6XEMHFWVZLWKRXWGRFXPHQWDWLRQRISULRUGLDJQRVWLF'/%WHVWV'D7VFDQDQGRU
NQRZQDP\ORLGELRPDUNHUVWDWXVDUHWRKDYHVXFKWHVWVSHUIRUPHGGXULQJ6FUHHQLQJVHH6HFWLRQ
 
0DJQHWLF5HVRQDQFH,PDJLQJ05,
$Q05,VWUXFWXUDODQGUHVWLQJVWDWHIXQFWLRQDOZLOOEHSHUIRUPHGDVSDUWRI%DVHOLQH6FUHHQLQJDQGDW
:HHNRIWKH7UHDWPHQW3KDVHDQG:HHNRIWKH([WHQVLRQ3KDVHWRORRNDWFKDQJHVLQDWURSK\RI
WKHEDVDOIRUHEUDLQDVZHOODVLWVIXQFWLRQDOFRQQHFWLYLW\7KH05,DWVFUHHQLQJLVWRDOVRWRH[FOXGHRWKHU
QHXURGHJHQHUDWLYHRUEUDLQGLVHDVHWKDWFRXOGDFFRXQWIRUWKHLUFRJQLWLYHV\PSWRPV
,IWKHVXEMHFWLVXQDEOHRUXQZLOOLQJWRGRDQ05,DWHQWU\DQG:HHNWKHVXEMHFWPXVWKDYHKDG05,
RU&7VFDQZLWKLQ\HDUVRI6FUHHQLQJZLWKILQGLQJVQHJDWLYHIRUHYLGHQFHRIRWKHUQHXURGHJHQHUDWLYHRU
RWKHUEUDLQGLVHDVHWKDWFRXOGDFFRXQWIRUWKHLUFRJQLWLYHV\PSWRPV05,&7UHVXOWVVKRXOGEHDYDLODEOH
DQGUHYLHZHGEHIRUH6FUHHQLQJGLDJQRVWLFWHVWVDUHSHUIRUPHG
 
'D7VFDQLIUHTXLUHG
6XEMHFWVDUHUHTXLUHGWRKDYHDSULRU'D7VFDQLHVLQJOHSKRWRQHPLVVLRQFRPSXWHGWRPRJUDSK\
>63(&7@ZLWK,RIOXSDQH,,QMHFWLRQWREHHOLJLEOHIRUVWXG\SDUWLFLSDWLRQ
7KH'D7VFDQLVDUDGLRSKDUPDFHXWLFDOLQGLFDWHGIRUVWULDWDOGRSDPLQHWUDQVSRUWHUYLVXDOL]DWLRQXVLQJ
63(&7EUDLQLPDJLQJ,RIOXSDQH,,QMHFWLRQLVWREHDGPLQLVWHUHGDQG63(&7LPDJLQJLVWREH
SHUIRUPHGDQGLQWHUSUHWHGSHUWKHSUHVFULELQJLQIRUPDWLRQ,ID'D7VFDQKDVQRWEHHQSHUIRUPHGZLWKLQ
WKHSUHYLRXV\HDUVLWLVWREHSHUIRUPHGGXULQJ6FUHHQLQJRQO\DIWHUVXEMHFWKDVEHHQGHHPHGHOLJLEOH
EDVHGRQDOORWKHULQFOXVLRQH[FOXVLRQFULWHULDHJPHGLFDOKLVWRU\ODERUDWRU\WHVWLQJDQGSULRUWR
UDQGRPL]DWLRQ
127(,I'D7VFDQUHVXOWVDUHQHJDWLYHLHQRHYLGHQFHRIUHGXFHGXSWDNHLQWKHEDVDOJDQJOLDWKH
VXEMHFWLVUHTXLUHGWRKDYHKLVWRULFDO36*YHULILHG5%'WREHHOLJLEOHIRUVWXG\SDUWLFLSDWLRQ
 
&OLQLFDO2XWFRPH(YDOXDWLRQV
 
&OLQLFDO'HPHQWLD5DWLQJ6FDOH±6XPRI%R[HV&'56%
7KH&OLQLFDO'HPHQWLD5DWLQJ6FDOH&'5+XJKHVLVDVHPLVWUXFWXUHGLQWHUYLHZUHVXOWLQJLQD
VHPLTXDQWLWDWLYHVFRULQJRIFRJQLWLYHLPSDLUPHQWLQPLOGHUDQGPRUHSURJUHVVHGIRUPVRIGHPHQWLD7KH
&'5\LHOGVERWKDJOREDOVFRUH&'5*6DQG6XPRI%R[HVVFRUH&'56%:KLOHWKH&'5*6LV
W\SLFDOO\XWLOL]HGIRUVWDJLQJSXUSRVHVWKH&'56%VFRUHLVDPRUHGHWDLOHGTXDQWLWDWLYHJHQHUDOLQGH[
WKDQWKH&'5*62¶%U\DQWHWDODOORZLQJWKH&'56%WREHXWLOL]HGDVDQRXWFRPHPHDVXUHLQ
FOLQLFDOWULDOV7KRXJKWKHUHLVOLPLWHGH[SHULHQFHZLWKWKH&'56%LQ'/%LWKDVEHHQXWLOL]HG
H[WHQVLYHO\LQERWKORQJLWXGLQDODQGWUHDWPHQWWULDOVLQERWK$'GHPHQWLDDQG0LOG&RJQLWLYH,PSDLUPHQW
DQGLVDUHJXODWRU\HQGSRLQWIRUDSSURYDOUHFRJQL]HGE\WKH)'$LQWKRVHFRQWH[WV

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 41 of 58 
EIP Pharma, Inc. 
Confidential 
7KH&'5LQWHUYLHZLVWREHFRQGXFWHGZLWKWKHVXEMHFWDQGFDUHJLYHUE\DQH[SHULHQFHGDQGFHUWLILHG
FOLQLFLDQ
 
1HXURSV\FKRORJLFDO7HVW%DWWHU\17%
7KH1HXURSV\FKRORJLFDO7HVW%DWWHU\LQFOXGHV
x 
&RJVWDWH'HWHFWLRQWHVW'(77KH'(7LVDPHDVXUHRISV\FKRPRWRUIXQFWLRQDQGXVHVD
ZHOOYDOLGDWHGVLPSOHUHDFWLRQWLPHSDUDGLJPZLWKSOD\LQJFDUGVWLPXOL
x 
&RJVWDWH,GHQWLILFDWLRQWHVW,'17KH,'1LVDPHDVXUHRIYLVXDODWWHQWLRQDQGXVHVDZHOO
YDOLGDWHGFKRLFHUHDFWLRQWLPHSDUDGLJPZLWKSOD\LQJFDUGVWLPXOL
x 
&RJVWDWH2QH&DUG/HDUQLQJWHVW2&/7KH2&/LVDPHDVXUHRIYLVXDOOHDUQLQJDQGXVHVD
ZHOOYDOLGDWHGSDWWHUQVHSDUDWLRQSDUDGLJPZLWKSOD\LQJFDUGVWLPXOL
x 
&RJVWDWH2QH%DFNWHVW21%7KH21%LVDPHDVXUHRIZRUNLQJPHPRU\DQGH[HFXWLYH
IXQFWLRQWKDWXVHVDZHOOYDOLGDWHGQEDFNSDUDGLJPZLWKSOD\LQJFDUGVWLPXOL
x 
/HWWHU)OXHQF\7HVW7KH/HWWHU)OXHQF\7HVWLVDPHDVXUHRISKRQHPLFIOXHQF\7KHWHVWXVHV
WKHOHWWHUVHWRI)$DQG6RU&)DQG/WRDVVHVVSKRQHPLFIOXHQF\,QGLYLGXDOVDUHJLYHQ
PLQXWHWRQDPHDVPDQ\ZRUGVDVSRVVLEOHEHJLQQLQJZLWKRQHRIWKHOHWWHUV7KHSURFHGXUH
LVWKHQUHSHDWHGIRUWKHUHPDLQLQJWZROHWWHUV7KHDGPLQLVWUDWLRQRISKRQHPLFDQGVHPDQWLF
IOXHQF\WDNHVDSSUR[LPDWHO\PLQXWHV$GPLVVLEOHUHVSRQVHVDUHVXPPHGDQGFRPSDUHGWRD
QRUPDWLYHVDPSOH
$GGLWLRQDOO\WKH&)7DQG,6/7ZLOOEHSHUIRUPHGDWWKHVDPHWLPHDVWKH17%
x 
&DWHJRU\)OXHQF\7HVW&)77KH&)7LVDPHDVXUHRIYHUEDOIOXHQF\DQGLVVRPHWLPHV
FDOOHGVHPDQWLFIOXHQF\,QWKHVWDQGDUGYHUVLRQRIWKHWDVNSDUWLFLSDQWVDUHJLYHQPLQXWHWR
SURGXFHDVPDQ\XQLTXHZRUGVDVSRVVLEOHZLWKLQDFDWHJRU\7KHVXEMHFW
VVFRUHLVWKH
QXPEHURIXQLTXHFRUUHFWZRUGV
x 
,QWHUQDWLRQDO6KRSSLQJ/LVW7HVW,6/77KH,6/7LVDPHDVXUHRIYHUEDOOHDUQLQJDQGXVHVD
ZHOOYDOLGDWHGOLVWOHDUQLQJSDUDGLJP7KHVXEMHFWLVUHDGDVKRSSLQJOLVWE\WKHWHVW
VXSHUYLVRUDQGPXVWUHPHPEHUDQGUHFDOODVPDQ\LWHPVIURPWKHOLVWDVSRVVLEOH
7KH'(7,'12&/21%DQG,6/7DUHDGPLQLVWHUHGYLDDFRPSXWHURU&KURPHERRN7KH/HWWHU
)OXHQF\7HVWDQG&)7DUHDGPLQLVWHUHGYLDSDSHUVFDOHV)RUSXUSRVHVRIWKHSULPDU\DQDO\VHVRQO\
WKHILUVWILYHWHVWVDUHLQFOXGHG
 
7LPHG8SDQG*R7HVW78*
7KH7LPHG8SDQG*R7HVW78*LVGHVLJQHGWRDVVHVVPRELOLW\,WPHDVXUHVWKHWLPHLQVHFRQGVIRUD
SHUVRQWRULVHIURPVLWWLQJIURPDVWDQGDUGDUPFKDLUZDONPHWHUVWXUQZDONEDFNWRWKHFKDLUDQGVLW
GRZQ7KHVXEMHFWZHDUVUHJXODUIRRWZHDUDQGXVHVKLVKHUFXVWRPDU\ZDONLQJDLG$VFRUHRI!
VHFRQGVLQGLFDWHVFOLHQWKDVLQFUHDVHGULVNRIIDOOV
 
$O]KHLPHU¶V'LVHDVH&RRSHUDWLYH6WXG\±&OLQLFDO*OREDO,PSUHVVLRQRI&KDQJH$'&6
*&,&
7KH$'&6*&,&VFDOHFRQVLVWVRIDIRUPDWZLWKZKLFKDFOLQLFLDQPD\DGGUHVVFOLQLFDOO\UHOHYDQWRYHUDOO
FKDQJHLQFOXGLQJDUHDVXQGHUWKHGRPDLQVRIFRJQLWLRQEHKDYLRUDQGVRFLDODQGGDLO\IXQFWLRQLQJ
7KHUDWHUDWEDVHOLQHLQWHUYLHZVWKHVXEMHFWVDQGFDUHJLYHULQIRUPDQWXVLQJDIRUPWKDWFRPSUHKHQVLYHO\

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 42 of 58 
EIP Pharma, Inc. 
Confidential 
OLVWVUHOHYDQWV\PSWRPVSRWHQWLDOO\XVHIXOLQMXGJLQJFKDQJHDQGPDNHVQRWHVIRUIXWXUHUHIHUHQFH%\
DOORZLQJUDWHUVWRXVHWKHIRUPVLQDQXQVWUXFWXUHGPDQQHUWKLVVFDOHPD\IDFLOLWDWHFOLQLFDOMXGJPHQWV
ZLWKIDFHYDOLGLW\$WIROORZXSYLVLWVWKHFOLQLFLDQXVHVDVLPLODUVHWRIIRUPVWRUHLQWHUYLHZWKHSDWLHQW
DQGFDUHJLYHULQIRUPDQW7KH$'&6*&,&UDWLQJLVPDGHRQDSRLQWVFDOHVLPLODUWRRWKHUJOREDO
FKDQJHVFDOHVZKHUHDKLJKHUVFRUHLQGLFDWHGPDUNHGLPSURYHPHQW7KH$'&6*&,&ZDVDGGHGWR
FRPSOHPHQWWKH&'56%DVVHYHUDOGRPDLQVDIIHFWVLQ'/%HJVOHHSEHKDYLRUIOXFWXDWLRQVPRWRU
DUHQRWDGHTXDWHO\FDSWXUHGLQWKH&'5GRPDLQV
 
'HPHQWLD&RJQLWLYH)OXFWXDWLRQV6FDOH'&)6
&RJQLWLYHIOXFWXDWLRQVDUHFRPPRQLQ'/%DUHDFRUHV\PSWRPLQWKHGLDJQRVWLFFULWHULDDQGFRQWULEXWH
VLJQLILFDQWO\WRFDUHJLYHUVWUHVV7KH'&)6KDVEHHQYDOLGDWHGDQGVKRZQWRGHWHFWGLVHDVHZRUVHQLQJ
 
LWHP1HXUR3V\FKLDWULF,QYHQWRU\13,
7KH13,LVGHVLJQHGWRDVVHVVSV\FKRSDWKRORJ\LQWKHSHUVRQZLWKGHPHQWLDDQGWRKHOSGLVWLQJXLVK
EHWZHHQWKHGLIIHUHQWFDXVHVRIGHPHQWLD7KH13,H[DPLQHVVXEGRPDLQVRIEHKDYLRUDO
IXQFWLRQLQJGHOXVLRQVKDOOXFLQDWLRQVDJLWDWLRQDJJUHVVLRQG\VSKRULDGHSUHVVLRQDQ[LHW\HXSKRULD
DSDWK\GLVLQKLELWLRQLUULWDELOLW\ODELOLW\DEHUUDQWPRWRUDFWLYLW\VOHHSDQGQLJKWWLPHEHKDYLRUFKDQJH
DQGDSSHWLWHDQGHDWLQJFKDQJH2IWKHGRPDLQVKDOOXFLQDWLRQVDUHRISDUWLFXODULQWHUHVWDVYLVXDO
KDOOXFLQDWLRQVDUHSUHVHQWLQRISDWLHQWVZLWKGHPHQWLDZLWK/HZ\ERGLHVDWSUHVHQWDWLRQ
7KH13,LVDGPLQLVWUDWHGWRFDUHJLYHUVRIGHPHQWLDVXEMHFWV$VFUHHQLQJTXHVWLRQLVDVNHGDERXWHDFK
LQFOXGHGVXEGRPDLQ,IWKHUHVSRQVHVWRWKHVHTXHVWLRQVLQGLFDWHWKDWWKHVXEMHFWKDVSUREOHPVZLWKD
SDUWLFXODUVXEGRPDLQRIEHKDYLRUWKHFDUHJLYHULVRQO\WKHQDVNHGDOOWKHTXHVWLRQVDERXWWKDWGRPDLQ
UDWLQJWKHIUHTXHQF\RIWKHV\PSWRPVRQDSRLQWVFDOHWKHLUVHYHULW\RQDSRLQWVFDOHDQGWKHGLVWUHVV
WKHV\PSWRPFDXVHVWKHPRQDSRLQWVFDOH
 
0RYHPHQW'LVRUGHU6RFLHW\±8QLILHG3DUNLQVRQ¶V'LVHDVH5DWLQJ6FDOH±3DUW,,,06'
83'56
7KH0'683'56LVDJROGVWDQGDUGDVVHVVPHQWRI3DUNLQVRQ¶VGLVHDVHZLWKWKHPRWRUH[DPLQDWLRQ
HYDOXDWLQJDVSHFWVRIWKHGLVHDVHWKDWDUHRYHUODSSLQJZLWKIHDWXUHVRI'/%7KHPRWRUH[DPLQDWLRQ3DUW
,,,DVVHVVHVPRWRUV\PSWRPVDQGVLJQVZLWKVFRUHVUDQJHIURPZLWKKLJKHUVFRUHVVXSSRUWLQJ
PRUHVHYHUHV\PSWRPV
 
0LQL0HQWDO6WDWH([DPLQDWLRQ006(
7KH006(FRQVLVWVRIWHVWVRIRULHQWDWLRQPHPRU\UHFHQWDQGLPPHGLDWHFRQFHQWUDWLRQODQJXDJH
DQGSUD[LV6FRUHVUDQJHIURPWRZLWKORZHUVFRUHVLQGLFDWLQJJUHDWHUFRJQLWLYHLPSDLUPHQW
 
&ROXPELD6XLFLGH6HYHULW\5DWLQJ6FDOH&6656
7KH&6656LVDFOLQLFLDQDGPLQLVWHUHGLQVWUXPHQWWKDWDVVHVVHVVXLFLGDOLGHDWLRQDQGEHKDYLRU38T3RVQHUHW
DO38T7KH³%DVHOLQH´YHUVLRQRIWKHLQVWUXPHQWZLOOEHDGPLQLVWHUHGWRVXEMHFWVGXULQJ6FUHHQLQJDQG
WKH³6LQFH/DVW9LVLW´YHUVLRQZLOOEHXVHGDWVXEVHTXHQWWLPHSRLQWVVSHFLILHGLQ7DEOHDQG7DEOH
,IWKHUHLVDQLQFUHDVHGULVNIRUVXLFLGDOLGHDWLRQDQGEHKDYLRUWKHLQYHVWLJDWRUVKRXOGUHIHUWKHVXEMHFWWRD
SV\FKLDWULFGRFWRURUVHUYLFHIRUDGGLWLRQDOKHOSDQGVKRXOGFRQVLGHULIGLVFRQWLQXDWLRQIURPWUHDWPHQWLV
UHFRPPHQGHG

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 43 of 58 
EIP Pharma, Inc. 
Confidential 
 
3K\VLFDO([DPLQDWLRQDQG9LWDO6LJQV
3K\VLFDOH[DPLQDWLRQZLOOLQFOXGHDUHYLHZRIDOOERG\V\VWHPVDQGPHDVXUHPHQWRIZHLJKWSHUHDFK
,QYHVWLJDWRUVVWDQGDUGSUDFWLFH3K\VLFDOH[DPLQDWLRQILQGLQJVZLOOEHGRFXPHQWHGLQWKHVXEMHFW¶VVRXUFH
GRFXPHQWV
9LWDOVLJQVLQFOXGHPHDVXUHPHQWRIEORRGSUHVVXUHSXOVHUHVSLUDWRU\UDWHDQGERG\WHPSHUDWXUH9LWDO
VLJQVDUHWREHPHDVXUHGZLWKWKHVXEMHFWLQDVLWWLQJSRVLWLRQDIWHUPLQXWHV
$Q\SK\VLFDOH[DPLQDWLRQILQGLQJRUYLWDOVLJQPHDVXUHPHQWWKDWUHSUHVHQWVDZRUVHQLQJIURP%DVHOLQH
FRQGLWLRQDQGLVFRQVLGHUHGE\WKH,QYHVWLJDWRUWREHFOLQLFDOO\VLJQLILFDQWZLOOEHUHFRUGHGDVDQ$(VHH
6HFWLRQ
 
(OHFWURHQFHSKDORJUDSK\((*
4XDQWLWDWLYHHOHFWURHQFHSKDORJUDSK\T((*ZLOOEHSHUIRUPHGZLWKWKHVXEMHFWDZDNHLQDFFRUGDQFH
ZLWKWKH,QWHUQDWLRQDO6\VWHPRI(OHFWURGHSODFHPHQWDWWKHWLPHSRLQWVVSHFLILHGLQ7DEOH
DFFRUGLQJWRDVWDQGDUGSURWRFROWKDWZLOOEHSURYLGHGLQDVHSDUDWH((*PDQXDO6ORZLQJRIWKHGRPLQDQW
IUHTXHQF\EDQGE\T((*RYHUSRVWHULRUDVSHFWVRIWKHEUDLQKDVEHHQUHFRJQL]HGWREHSURPLQHQWLQ'/%
3HUD]DHWDODQGYDULRXVSDWWHUQVKDYHEHHQLGHQWLILHGWRGLIIHUHQWLDWH'/%IURP$'((*KDV
DOVREHHQUHFRJQL]HGWREHSRWHQWLDOELRPDUNHUIRU'/%LQWKHPRVWUHFHQWFRQVHQVXVUHSRUWRIWKH'/%
FRQVRUWLXP0F.HLWKHWDO,QDGGLWLRQDOSKDUHDFWLYLW\ZDVUHFHQWO\UHSRUWHG6FKXPDFKHUHWDO
-HQQLQJVHWDODVDVSHFLILFPHDVXUHIRU'/%DQGDPHDVXUHRI³FKROLQHUJLFLQWHJULW\´LQ
ERWK'/%DQG$',IDVLWHRUDFDQQRWRUZLOOQRWSHUIRUP((*DVVHVVPHQWVWKLVGRHVQRWFRQVWLWXWHD
GHYLDWLRQDQGWKHSDWLHQWFDQHQUROODQGWKHVLWHFDQSDUWLFLSDWHZLWKRXW((*DVVHVVPHQWV
 
/HDG(OHFWURFDUGLRJUDP
$OHDG(&*ZLOOEHSHUIRUPHGGXULQJ6FUHHQLQJXVLQJYDOLGDWHGPDFKLQHU\DYDLODEOHORFDOO\WRHDFK
FOLQLFDOVLWH(&*SDUDPHWHUVWREHFDSWXUHGLQFOXGHKHDUWUDWHESP35LQWHUYDO456GXUDWLRQ47
LQWHUYDOFRUUHFWHG47LQWHUYDOXVLQJ)ULGHULFLD¶VIRUPXODDQG55LQWHUYDO(DFKUHSRUWZLOOEHUHYLHZHG
E\WKH,QYHVWLJDWRURUTXDOLILHGVXELQYHVWLJDWRUDQGDVVHVVHGDVQRUPDODEQRUPDO±QRWFOLQLFDOO\
VLJQLILFDQWRUDEQRUPDO±FOLQLFDOO\VLJQLILFDQW$EQRUPDOFOLQLFDOO\VLJQLILFDQWILQGLQJVDUHWREH
UHSRUWHGDVSDUWRIWKHVXEMHFW¶VPHGLFDOKLVWRU\
 
&OLQLFDO/DERUDWRU\$VVHVVPHQWV
%ORRGVDPSOHVZLOOEHFROOHFWHGDWWKHWLPHSRLQWVVSHFLILHGLQ7DEOHDQG7DEOHIRUDVVHVVPHQWRI
URXWLQHFKHPLVWU\DQGKHPDWRORJ\DQDO\WHV$GGLWLRQDOEORRGVDPSOHVZLOOEHFROOHFWHGIRUFRDJXODWLRQ
VWXGLHVDWWKHWLPHSRLQWVVSHFLILHGLQ7DEOHDQG7DEOH
$OOVDPSOHVZLOOEHDQDO\]HGYLDDFHQWUDOODERUDWRU\6DPSOHVZLOOEHGHVWUR\HGLPPHGLDWHO\IROORZLQJ
DQDO\VLV

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 44 of 58 
EIP Pharma, Inc. 
Confidential 
7DEOH
&OLQLFDO/DERUDWRU\$QDO\WHV
6HUXP&KHPLVWU\
+HPDWRORJ\
x 
$OEXPLQ
x 
$ONDOLQHSKRVSKDWDVH
x 
$/7
x 
$67
x 
%LOLUXELQWRWDODQGGLUHFW
x 
*OXFRVH
x 
%ORRGXUHDQLWURJHQ
x 
&DOFLXP
x 
%LFDUERQDWH&DUERQ'LR[LGH
x 
&KORULGH
x 
7RWDOFKROHVWHURO
x 
7ULJO\FHULGHV
x 
&UHDWLQLQH
x 
*DPPDJOXWDP\OWUDQVIHUDVH
x 
/DFWDWHGHK\GURJHQDVH
x 
3KRVSKDWH
x 
3RWDVVLXP
x 
6RGLXP
x 
7RWDOSURWHLQ
x 
8ULFDFLG
x 
'LIIHUHQWLDODEVROXWHDQGSHUFHQW
x 
%DVRSKLOV
x 
(RVLQRSKLOV
x 
/\PSKRF\WHV
x 
0RQRF\WHV
x 
1HXWURSKLOV
x 
(U\WKURF\WHV
x 
0HDQFRUSXVFXODUKHPRJORELQ
x 
0HDQFRUSXVFXODUKHPRJORELQFRQFHQWUDWLRQ
x 
0HDQFRUSXVFXODUYROXPH
x 
+HPRJORELQ
x 
/HXNRF\WHV
x 
3ODWHOHWV
&RDJXODWLRQ6WXGLHV
x 
3URWKURPELQWLPH
x 
3DUWLDOWKURPERSODVWLQWLPH
x 
,15
&OLQLFDOODERUDWRU\ILQGLQJVWKDWUHSUHVHQWDZRUVHQLQJIURP%DVHOLQHYDOXHDQGDUHFRQVLGHUHGE\WKH
,QYHVWLJDWRUWREHFOLQLFDOO\VLJQLILFDQWZLOOEHUHFRUGHGDVDQ$(UHIHUWR6HFWLRQ
 
3KDUPDFRNLQHWLFV3.
%ORRGVDPSOHVIRU3.ZLOOEHREWDLQHGDWWKH:HHNYLVLWLQWKH7UHDWPHQW3KDVHDQG:HHNLQWKH
([WHQVLRQ3KDVHSULRUWRWKHPRUQLQJGRVHIRUGHWHUPLQDWLRQRIWURXJKSODVPDGUXJFRQFHQWUDWLRQDV
VSHFLILHGLQ7DEOHDQG7DEOH6DPSOHVZLOOEHDQDO\]HGDQGVWRUHGDWDFHQWUDOELRDQDO\WLFDOODE
XQWLOWKHHQGRIWKHVWXG\DQGZLOOWKHQEHWUDQVIHUUHGWRDELRUHSRVLWRU\IRUORQJWHUPVWRUDJHXQWLO
\HDUVDIWHUWKHGDWHRIPDUNHWLQJDSSOLFDWLRQRUGLVFRQWLQXDWLRQRIWKHSURGXFW
 
%LRPDUNHU7HVWLQJ
$SODVPDVDPSOHIRUS7DXDQDO\VLVZLOOEHREWDLQHGDW6FUHHQLQJDQGHYDOXDWHGIRUHOLJLELOLW\SXUSRVHV
$GGLWLRQDOSODVPDVDPSOHVIRUSURWHLQELRPDUNHUDVVHVVPHQWDUHWREHFROOHFWHGDWWKHWLPHSRLQWV
VSHFLILHGLQ7DEOHDQG7DEOH6DPSOHVZLOOEHVWRUHGIRUIXWXUHSURWHLQELRPDUNHUWHVWLQJRQFH
DSSOLFDEOHDVVD\VDUHLGHQWLILHGRUGHYHORSHGQRWHWKDWVXFKVDPSOHVZLOOQRWEHXVHGIRUJHQHWLFWHVWLQJ

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 45 of 58 
EIP Pharma, Inc. 
Confidential 
S7DXVDPSOHVZLOOEHDQDO\]HGDQGVWRUHGDWDFHQWUDOELRPDUNHUODEXQWLOWKHHQGRIWKHVWXG\DQGZLOO
WKHQEHWUDQVIHUUHGWRDELRUHSRVLWRU\IRUORQJWHUPVWRUDJHXQWLO\HDUVDIWHUWKHGDWHRIPDUNHWLQJ
DSSOLFDWLRQRUGLVFRQWLQXDWLRQRIWKHSURGXFW
%LRPDUNHUVDPSOHVZLOOEHVKLSSHGDQGVWRUHGDWWKHFHQWUDOODERUDWRU\XQWLOWKHHQGRIWKHVWXG\DQGZLOO
WKHQEHWUDQVIHUUHGWRDELRUHSRVLWRU\IRUORQJWHUPVWRUDJHDQGIXWXUHDQDO\VLVXQWLO\HDUVDIWHUWKHGDWH
RIPDUNHWLQJDSSOLFDWLRQRUGLVFRQWLQXDWLRQRIWKHSURGXFW
 
:LWKGUDZDORI6XEMHFWV
$VXEMHFWPD\EHGLVFRQWLQXHGIURPVWXG\WUHDWPHQWDWDQ\WLPHLIWKHVXEMHFWWKH,QYHVWLJDWRURUWKH
6SRQVRUIHHOVWKDWLWLVQRWLQWKHVXEMHFW¶VEHVWLQWHUHVWWRFRQWLQXH7KHIROORZLQJLVDOLVWRISRVVLEOH
UHDVRQVIRUVWXG\WUHDWPHQWGLVFRQWLQXDWLRQ
x 
6XEMHFWZLWKGUDZDORIFRQVHQWRUZLWKGUDZDORIVXUURJDWHFRQVHQW
x 
6XEMHFWLVQRWFRPSOLDQWZLWKVWXG\SURFHGXUHV
x 
3URWRFROYLRODWLRQUHTXLULQJGLVFRQWLQXDWLRQRIVWXG\WUHDWPHQW
x 
$(WKDWLQWKHRSLQLRQRIWKH,QYHVWLJDWRUZRXOGEHLQWKHEHVWLQWHUHVWRIWKHVXEMHFWWR
GLVFRQWLQXHVWXG\WUHDWPHQW
x 
6XEMHFWGHYHORSVVXLFLGDOLGHDWLRQVRUDWWHPSWVVXLFLGH
x 
6XEMHFWEHFRPHVLQFDSDFLWDWHGLHORVHVWKHFDSDFLW\WRFRQVHQWGXHWRFRJQLWLYHGHFOLQHLQWKH
RSLQLRQRIWKHLQYHVWLJDWRU
x 
/RVWWRIROORZXS
x 
6SRQVRUUHTXHVWIRUHDUO\WHUPLQDWLRQRIVWXG\
,IDVXEMHFWLVZLWKGUDZQIURPWUHDWPHQWGXHWRDQ$(WKHVXEMHFWZLOOEHIROORZHGDQGWUHDWHGE\WKH
,QYHVWLJDWRUXQWLOWKHDEQRUPDOSDUDPHWHURUV\PSWRPKDVUHVROYHGRUVWDELOL]HG
$VXEMHFWPD\EHZLWKGUDZQIURPWKHVWXG\DWDQ\WLPHLIWKHVXEMHFWWKH,QYHVWLJDWRURUWKH6SRQVRU
IHHOVWKDWLWLVQRWLQWKHVXEMHFW¶VEHVWLQWHUHVWWRFRQWLQXH
$OOVXEMHFWVDUHIUHHWRZLWKGUDZIURPSDUWLFLSDWLRQDWDQ\WLPHIRUDQ\UHDVRQVSHFLILHGRUXQVSHFLILHG
DQGZLWKRXWSUHMXGLFH
5HDVRQDEOHDWWHPSWVZLOOEHPDGHE\WKH,QYHVWLJDWRUWRSURYLGHDUHDVRQIRUVXEMHFWZLWKGUDZDOV7KH
UHDVRQIRUWKHVXEMHFW¶VZLWKGUDZDOIURPWKHVWXG\ZLOOEHVSHFLILHGLQWKHVXEMHFW¶VVRXUFHGRFXPHQWV
5HIHUWRWKH6FKHGXOHRI$VVHVVPHQWVIRUDVVHVVPHQWVWREHSHUIRUPHGIRUVXEMHFWVZKRSUHPDWXUHO\
GLVFRQWLQXHVWXG\GUXJ

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 46 of 58 
EIP Pharma, Inc. 
Confidential 
 
$'9(56((9(176$1'6(5,286$'9(56(
(9(1766$)(7<5(3257,1*
7KH,QYHVWLJDWRULVUHVSRQVLEOHIRUUHSRUWLQJRIHYHQWVPHHWLQJWKHFULWHULDDQGGHILQLWLRQRIDQ$(RU6$(
DVSURYLGHGLQWKLVSURWRFRO
 
'HILQLWLRQVDQG&ULWHULD
 
$GYHUVH(YHQWV
3HU,QWHUQDWLRQDO&RXQFLOIRU+DUPRQLVDWLRQ,&+($$Q$(LVDQ\XQWRZDUGPHGLFDORFFXUUHQFHLQD
SDWLHQWRUFOLQLFDOLQYHVWLJDWLRQVXEMHFWDGPLQLVWHUHGDSKDUPDFHXWLFDOSURGXFWDQGZKLFKGRHVQRW
QHFHVVDULO\KDYHWRKDYHDFDXVDOUHODWLRQVKLSZLWKWKLVWUHDWPHQW$Q$(FDQWKHUHIRUHEHDQ\
XQIDYRUDEOHDQGXQLQWHQGHGVLJQLQFOXGLQJDQDEQRUPDOODERUDWRU\ILQGLQJIRUH[DPSOHV\PSWRPRU
GLVHDVHWHPSRUDOO\DVVRFLDWHGZLWKWKHXVHRIDPHGLFLQDOSURGXFWZKHWKHURUQRWFRQVLGHUHGUHODWHGWR
WKHPHGLFLQDOSURGXFW
0HGLFDOLQWHUYHQWLRQVVXFKDVVXUJHULHVGLDJQRVWLFSURFHGXUHVDQGWKHUDSHXWLFSURFHGXUHVDUHQRW$(V
EXWWKHDFWLRQWDNHQWRWUHDWWKHPHGLFDOFRQGLWLRQ7KH\VKRXOGEHUHFRUGHGDVWUHDWPHQWRIWKH$(V
 
6HULRXV$GYHUVH(YHQWV
$Q6$(RUUHDFWLRQLVDQ\XQWRZDUGPHGLFDORFFXUUHQFHWKDWDWDQ\GRVH
x 
5HVXOWVLQGHDWK
x 
,VOLIHWKUHDWHQLQJ
x 
5HTXLUHVLQSDWLHQWKRVSLWDOL]DWLRQRUSURORQJDWLRQRIH[LVWLQJKRVSLWDOL]DWLRQ
x 
5HVXOWVLQSHUVLVWHQWRUVLJQLILFDQWGLVDELOLW\RULQFDSDFLW\
x 
,VDFRQJHQLWDODQRPDO\RUELUWKGHIHFW
x 
,VDQLPSRUWDQWPHGLFDOHYHQWHJLQWHQVLYHWUHDWPHQWLQDQHPHUJHQF\URRPRUDWKRPHIRU
DOOHUJLFEURQFKRVSDVPEORRGG\VFUDVLDVRUFRQYXOVLRQVWKDWGRQRWUHVXOWLQKRVSLWDOL]DWLRQRU
GHYHORSPHQWRIGUXJGHSHQGHQF\RUGUXJDEXVHPDOLJQDQF\
1RWH7KHWHUP³OLIHWKUHDWHQLQJ´LQWKHGHILQLWLRQRI³VHULRXV´UHIHUVWRDQHYHQWLQZKLFKWKHVXEMHFWZDV
DWULVNRIGHDWKDWWKHWLPHRIWKHHYHQWLWGRHVQRWUHIHUWRDQHYHQWWKDWK\SRWKHWLFDOO\PLJKWKDYHFDXVHG
GHDWKLILWZHUHPRUHVHYHUH
0HGLFDODQGVFLHQWLILFMXGJHPHQWVKRXOGEHH[HUFLVHGLQGHFLGLQJZKHWKHUH[SHGLWHGUHSRUWLQJLV
DSSURSULDWHLQRWKHUVLWXDWLRQVVXFKDVLPSRUWDQWPHGLFDOHYHQWVWKDWPD\QRWEHLPPHGLDWHO\OLIH
WKUHDWHQLQJRUUHVXOWLQGHDWKRUKRVSLWDOL]DWLRQEXWPD\MHRSDUGL]HWKHVXEMHFWRUPD\UHTXLUH
LQWHUYHQWLRQWRSUHYHQWRQHRIWKHRWKHURXWFRPHVOLVWHGLQWKHGHILQLWLRQDERYH7KHVHVKRXOGDOVRXVXDOO\
EHFRQVLGHUHGVHULRXV
([DPSOHVRIVXFKHYHQWVDUHLQWHQVLYHWUHDWPHQWLQDQHPHUJHQF\URRPRUDWKRPHIRUDOOHUJLF
EURQFKRVSDVPEORRGG\VFUDVLDVRUFRQYXOVLRQVWKDWGRQRWUHVXOWLQKRVSLWDOL]DWLRQRUGHYHORSPHQWRI
GUXJGHSHQGHQF\RUGUXJDEXVH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 47 of 58 
EIP Pharma, Inc. 
Confidential 
6HULRXVQHVVQRWVHYHULW\VHUYHVDVDJXLGHIRUGHILQLQJUHJXODWRU\UHSRUWLQJREOLJDWLRQV$Q6$(LVQRW
QHFHVVDULO\VHYHUHHJDQRYHUQLJKWKRVSLWDOL]DWLRQIRUDGLDJQRVWLFSURFHGXUHPXVWEHUHSRUWHGDVDQ
6$(HYHQWKRXJKWKHRFFXUUHQFHLVQRWPHGLFDOO\VHULRXV%\WKHVDPHWRNHQDVHYHUH$(LVQRW
QHFHVVDULO\VHULRXVQDXVHDRIVHYHUDOKRXUV¶GXUDWLRQPD\EHUDWHGDVVHYHUHEXWPD\QRWEHFRQVLGHUHG
VHULRXV
7KHIROORZLQJKRVSLWDOL]DWLRQVDUHQRWFRQVLGHUHGVHULRXV
x 
$YLVLWWRWKHHPHUJHQF\URRPRURWKHUKRVSLWDOGHSDUWPHQWKRXUVWKDWGRHVQRWUHVXOWLQ
DGPLVVLRQXQOHVVFRQVLGHUHGµLPSRUWDQWPHGLFDOHYHQW¶RUHYHQWOLIHWKUHDWHQLQJ
x 
(OHFWLYHVXUJHU\SODQQHGSULRUWRVLJQLQJWKHLQIRUPHGFRQVHQWIRUP,&)
x 
0HGLFDOVXUJLFDODGPLVVLRQIRUSXUSRVHRWKHUWKDQUHPHG\LQJLOOKHDOWKVWDWHDQGZDVSODQQHG
SULRUWRHQWU\LQWRWKHVWXG\
x 
$GPLVVLRQHQFRXQWHUHGIRUDQRWKHUOLIHFLUFXPVWDQFHWKDWFDUULHVQREHDULQJRQKHDOWKVWDWXVDQG
UHTXLUHVQRPHGLFDOVXUJLFDOLQWHUYHQWLRQHJODFNRIKRXVLQJHFRQRPLFLQDGHTXDF\FDUHJLYHU
UHVSLWHIDPLO\FLUFXPVWDQFHVDGPLQLVWUDWLYH
 
8QH[SHFWHG$GYHUVH'UXJ5HDFWLRQV
$QXQH[SHFWHGDGYHUVHGUXJUHDFWLRQ$'5LVDUHDFWLRQIRUZKLFKWKHQDWXUHRUVHYHULW\LVQRWFRQVLVWHQW
ZLWKWKHDSSOLFDEOHSURGXFWLQIRUPDWLRQ,QYHVWLJDWRU¶V%URFKXUH3DFNDJH,QVHUWIRUPDUNHWHGSURGXFWV
8QWLOSURGXFWLQIRUPDWLRQLVDPHQGHGH[SHGLWHGUHSRUWLQJLVUHTXLUHGIRUDGGLWLRQDORFFXUUHQFHVRIWKH
UHDFWLRQ5HSRUWVWKDWDGGVLJQLILFDQWLQIRUPDWLRQRQVSHFLILFLW\RUVHYHULW\RIDNQRZQDOUHDG\
GRFXPHQWHG6$(FRQVWLWXWHXQH[SHFWHGHYHQWV)RUH[DPSOHDQHYHQWPRUHVSHFLILFRUPRUHVHYHUHWKDQ
GHVFULEHGLQWKH,QYHVWLJDWRU
V%URFKXUHZRXOGEHFRQVLGHUHGXQH[SHFWHG´6SHFLILFH[DPSOHVZRXOGEH
DDFXWHUHQDOIDLOXUHDVDODEHOHG$'5ZLWKDVXEVHTXHQWQHZUHSRUWRILQWHUVWLWLDOQHSKULWLVDQG
EKHSDWLWLVZLWKDILUVWUHSRUWRIIXOPLQDQWKHSDWLWLV
*XLGDQFHRQUHSRUWLQJ$(VDQG6$(VLVGHVFULEHGLQ6HFWLRQ
 
$EQRUPDO/DERUDWRU\9DOXHV
$Q\DEQRUPDOLW\LQDODERUDWRU\YDOXHWKDWLVQHZLQRQVHWRUZKLFKKDVZRUVHQHGLQVHYHULW\RUIUHTXHQF\
IURPWKHEDVHOLQHFRQGLWLRQDQGPHHWVRIWKHIROORZLQJFULWHULDZLOOEHUHFRUGHGRQWKH$(SDJHVRIWKH
H&5)
x 
5HTXLUHVWKHUDSHXWLFLQWHUYHQWLRQRUGLDJQRVWLFWHVWV
x 
/HDGVWRGLVFRQWLQXDWLRQRILQYHVWLJDWLRQDOSURGXFW
x 
+DVDFFRPSDQ\LQJRULQGXFLQJV\PSWRPVRUVLJQV
x 
,VMXGJHGE\WKH,QYHVWLJDWRUDVFOLQLFDOO\VLJQLILFDQW
 
$VVHVVLQJ,QWHQVLW\DQG5HODWLRQVKLS
$OO$(VZLOOEHDVVHVVHGRQGHVFULSWLYHSDUDPHWHUVLQWHQVLW\DQGUHODWLRQVKLSWRWKHLQYHVWLJDWLRQDO
SURGXFW
x 
,QWHQVLW\UHIHUVWRWKHVHYHULW\RIDQHYHQWDQGUHIHUHQFHVLPSDFWRQDVXEMHFW¶VIXQFWLRQLQJ

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 48 of 58 
EIP Pharma, Inc. 
Confidential 
x 
5HODWLRQVKLSUHIHUVWRWKHOLNHOLKRRGWKDWWKHHYHQWEHLQJDVVHVVHGZDVFDXVHGE\WKH
LQYHVWLJDWLRQDOSURGXFW
,QWHQVLW\
(DFK$(ZLOOEHFODVVLILHGDFFRUGLQJWRWKHIROORZLQJFULWHULD
0LOG
7KH$(GRHVQRWLQWHUIHUHLQDVLJQLILFDQWPDQQHUZLWKWKHVXEMHFW¶VQRUPDOOHYHORI
IXQFWLRQLQJ
0RGHUDWH
7KH$(SURGXFHVVRPHLPSDLUPHQWRIIXQFWLRQLQJEXWLVQRWKD]DUGRXVWRWKH
VXEMHFW¶VKHDOWK
6HYHUH
7KH$(SURGXFHVVLJQLILFDQWLPSDLUPHQWRIIXQFWLRQLQJRULQFDSDFLWDWLRQDQGLVD
GHILQLWHKD]DUGWRWKHVXEMHFW¶VKHDOWK
:KHQFKDQJHVLQWKHLQWHQVLW\RIDQ$(RFFXUPRUHIUHTXHQWO\WKDQRQFHDGD\WKHPD[LPXPLQWHQVLW\
IRUWKHH[SHULHQFHVKRXOGEHQRWHG,IWKHLQWHQVLW\FDWHJRU\FKDQJHVRYHUDQXPEHURIGD\VWKRVH
FKDQJHVVKRXOGEHUHFRUGHGVHSDUDWHO\ZLWKGLVWLQFWRQVHWGDWHV
5HODWLRQVKLS
(DFK$(ZLOOEHDVVHVVHGDVWRLWVUHODWLRQVKLSWRWKHLQYHVWLJDWLRQDOSURGXFWEDVHGRQWKHIROORZLQJ
FULWHULD$OWKRXJKWKHDWWULEXWLRQE\WKH,QYHVWLJDWRUZLOOEHFROOHFWHGIRUUHSRUWHGHYHQWVIRUDQDO\WLF
SXUSRVHVDWHPSRUDODVVRFLDWLRQZLWKWKHXVHRIWKHLQYHVWLJDWLRQDOSURGXFWZLOOEHDVVXPHGVXIILFLHQWIRU
DWOHDVWSODXVLEOHDVVRFLDWLRQ
1RWUHODWHG
1RFDXVDOUHODWLRQVKLSH[LVWVEHWZHHQWKHLQYHVWLJDWLRQDOSURGXFWDQGWKH$(EXWDQ
REYLRXVDOWHUQDWLYHFDXVHH[LVWVHJWKHVXEMHFW¶VXQGHUO\LQJPHGLFDOFRQGLWLRQRU
FRQFRPLWDQWWKHUDS\
3RVVLEO\UHODWHG
$FRQQHFWLRQZLWKWKHDGPLQLVWUDWLRQRIWKHLQYHVWLJDWLRQDOSURGXFWDSSHDUVXQOLNHO\
EXWFDQQRWEHUXOHGRXWZLWKFHUWDLQW\$Q$(PD\EHFRQVLGHUHGSRVVLEO\UHODWHGLI
RUZKHQLWPHHWVRIWKHIROORZLQJFULWHULDLWIROORZVDUHDVRQDEOHWHPSRUDO
VHTXHQFHIURPDGPLQLVWUDWLRQRIWKHLQYHVWLJDWLRQDOSURGXFWLWFRXOGQRWUHDGLO\
KDYHEHHQSURGXFHGE\WKHVXEMHFW¶VFOLQLFDOVWDWHHQYLURQPHQWDORUWR[LFIDFWRUVRU
RWKHUPRGHVRIWKHUDS\DGPLQLVWHUHGWRWKHVXEMHFWRULWIROORZVDNQRZQSDWWHUQ
RIUHVSRQVHWRWKHLQYHVWLJDWLRQDOSURGXFW
5HODWHG
7KHUHLVDUHDVRQDEOHSODXVLEOHSRVVLELOLW\WKDWWKH$(PD\KDYHEHHQFDXVHGE\WKH
LQYHVWLJDWLRQDOSURGXFW
:KHQDVVHVVLQJWKHUHODWLRQVKLSWRWKHLQYHVWLJDWLRQDOSURGXFWWKHIROORZLQJFULWHULDZLOOEHFRQVLGHUHG
x 
3RVLWLYHUHFKDOOHQJH
x 
3RVLWLYHGHFKDOOHQJHUHVROXWLRQXSRQVWRSSLQJVXVSHFWWKHLQYHVWLJDWLRQDOSURGXFWLQDEVHQFHRI
RWKHULQWHUYHQWLRQRUWUHDWPHQW
x 
.QRZQFODVVHIIHFW
x 
%LRORJLFDOSODXVLELOLW\
x 
/DFNRIDOWHUQDWLYHH[SODQDWLRQ²FRQFRPLWDQWGUXJRUGLVHDVH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 49 of 58 
EIP Pharma, Inc. 
Confidential 
 
5HSRUWLQJ3URFHGXUHVDQG5HTXLUHPHQWV
 
$GYHUVH(YHQWV$(
$(VRFFXUULQJIURPZKHQWKHVXEMHFWVLJQVWKH,&)XQWLOWKHODVWVWXG\HYHQWZLOOEHUHFRUGHG$Q\$(V
RFFXUULQJEHIRUHWKHVWDUWRIWUHDWPHQWLHEHIRUHWKHILUVWGRVHRIWKHLQYHVWLJDWLRQDOSURGXFWZLOOEH
UHFRUGHGLQWKHPHGLFDOKLVWRU\$OVRWKHVLJQV\PSWRPRUGLVHDVHSUHVHQWEHIRUHVWDUWLQJWKHWUHDWPHQW
SHULRGDUHRQO\FRQVLGHUHG$(VLIWKH\ZRUVHQDIWHUVWDUWLQJWKHWUHDWPHQWSHULRG
,IWKH,QYHVWLJDWRUGHWHFWVDQ$(LQDVWXG\VXEMHFWDIWHUWKHODVWVFKHGXOHGIROORZXSYLVLWDQGFRQVLGHUV
WKHHYHQWSRVVLEO\UHODWHGRUUHODWHGWRSULRUVWXG\WUHDWPHQWWKH,QYHVWLJDWRUVKRXOGUHSRUWLWWRWKH
6SRQVRURUGHVLJQHH
7KH,QYHVWLJDWRUVKRXOGUHSRUWDOO$(VRQWKH$(SDJHVRIWKHH&5)DQGVRXUFHGRFXPHQWVUHJDUGOHVV
RIVHULRXVQHVVVHYHULW\DQGFDXVDOLW\:KHQHYHUSRVVLEOHDQ$(ZLOOEHUHSRUWHGXVLQJDGLDJQRVWLFWHUP
UDWKHUWKDQV\PSWRPVHJ³FRPPRQFROG´RU³XSSHUUHVSLUDWRU\LQIHFWLRQ´UDWKHUWKDQ³UXQQ\QRVH
FRXJKPLOGIHYHU´DQGVKRXOGEHGHVFULEHGZLWKWKHDWWULEXWHVGHVFULEHGLQ6HFWLRQ
 
6HULRXV$GYHUVH(YHQWV6$(
(DFK$(ZLOOEHDVVHVVHGWRGHWHUPLQHZKHWKHULWPHHWVVHULRXVQHVVFULWHULD6HFWLRQ,IWKH$(LV
FRQVLGHUHGVHULRXVWKH,QYHVWLJDWRUVKRXOGUHSRUWWKLVHYHQWWRWKH6SRQVRURUGHVLJQHHDVRXWOLQHGEHORZ
DQGDOVRWRWKH,(&DFFRUGLQJWRLWVVWDQGDUGRSHUDWLQJSURFHGXUHV
7KH,QYHVWLJDWRUPXVWUHSRUWDOO6$(VYLDDQH&5)LQWKH('&V\VWHPZLWKLQKRXUVRIOHDUQLQJ
DERXWWKHHYHQWUHJDUGOHVVRIUHODWLRQVKLSWRVWXG\GUXJ
,IWKH,QYHVWLJDWRUVLWHH[SHULHQFHVDWHPSRUDU\GLVUXSWLRQRIWKH('&V\VWHPDEDFNXSSDSHU6$(
5HSRUW)RUPZLOOEHDYDLODEOHIRU,QYHVWLJDWRUVLWHVWDIIWRFRPSOHWH,IDSDSHU6$(5HSRUW)RUPLV
XWLOL]HGLWPXVWIROORZWKHVDPHWLPHOLQHVDQGEHHPDLOHGRUID[HGZLWKLQKRXUVRIOHDUQLQJDERXWWKH
HYHQWUHJDUGOHVVRIUHODWLRQVKLSWRVWXG\GUXJ
6$(5HSRUWLQJ
(PDLOGUXJVDIHW\#ZRUOGZLGHFRP
)D[86RU52:
,IQRWLILFDWLRQLVPDGHYLDHPDLORUID[VLWHVWDIIPXVWHQWHUWKH6$(LQIRUPDWLRQLQWRWKH('&V\VWHPDV
VRRQDVWKHV\VWHPEHFRPHVDYDLODEOH6KRXOGDSDSHU6$(IRUPEHXVHGWKHRULJLQDO6$(IRUPVKRXOG
EHNHSWDWWKHVLWH
(DFK6$(VKRXOGEHIROORZHGXSXQWLOUHVROXWLRQRUVWDELOL]DWLRQ)RUUHSRUWHGGHDWKVWKH,QYHVWLJDWRU
VKRXOGVXSSO\WKH6SRQVRURUGHVLJQHHDQGWKH,(&ZLWKDQ\DGGLWLRQDOUHTXHVWHGLQIRUPDWLRQHJ
DXWRSV\UHSRUWVDQGWHUPLQDOPHGLFDOUHSRUWV
7KH6SRQVRURUGHVLJQHHLVUHVSRQVLEOHIRUQRWLI\LQJWKHUHOHYDQWUHJXODWRU\DXWKRULWLHVRIFHUWDLQHYHQWV
,WLVWKH,QYHVWLJDWRU¶VUHVSRQVLELOLW\WRQRWLI\WKH,(&RIDOO6$(VWKDWRFFXUDWWKH,QYHVWLJDWRU¶VVLWH
,QYHVWLJDWRUVZLOODOVREHQRWLILHGRIDOOXQH[SHFWHGVHULRXVGUXJUHODWHGHYHQWV'D\6DIHW\
5HSRUWVWKDWRFFXUGXULQJWKHFOLQLFDOWULDO

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 50 of 58 
EIP Pharma, Inc. 
Confidential 
6$(VWKDWDUHRQJRLQJDWWKH)ROORZ8S9LVLWVKRXOGEHIROORZHGXQWLOUHVROXWLRQXQWLOWKHFRQGLWLRQ
VWDELOL]HVXQWLOWKHVXEMHFWLVORVWWRIROORZXSRURWKHUZLVHH[SODLQHG
,IWKH,QYHVWLJDWRUGHWHFWVDQ6$(LQDVWXG\VXEMHFWDIWHUWKHODVWVFKHGXOHGIROORZXSYLVLWDQGFRQVLGHUV
WKH6$(UHODWHGRUSRVVLEO\UHODWHGWRSULRUVWXG\WUHDWPHQWWKH,QYHVWLJDWRUVKRXOGUHSRUWLWWRWKH
6SRQVRU

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 51 of 58 
EIP Pharma, Inc. 
Confidential 
 
'$7$0$1$*(0(17$1'67$7,67,&$/$1$/<6,6
 
'DWD0DQDJHPHQWDQG4XDOLW\$VVXUDQFH&RQVLGHUDWLRQV
7KLVVWXG\ZLOOHPSOR\H&5)VYLDDQHOHFWURQLFGDWDFDSWXUH('&V\VWHP7KHVLWHZLOOEHWUDLQHGRQ
VSHFLILFIRUPVDQGSURFHGXUHVIRUVRXUFHGRFXPHQWDWLRQDQGPDLQWHQDQFHRIDQDXGLWWUDLORIWKHGDWDWKDW
LVHQWHUHGRQWKHH&5)SULRUWRVWXG\LQLWLDWLRQ
6WXG\SHUVRQQHODWHDFKVLWHZLOOHQWHUGDWDIURPVRXUFHGRFXPHQWVFRUUHVSRQGLQJWRDVXEMHFW¶VYLVLWLQWR
WKHSURWRFROVSHFLILFH&5)ZKHQWKHLQIRUPDWLRQFRUUHVSRQGLQJWRWKDWYLVLWLVDYDLODEOH6XEMHFWVZLOOQRW
EHLGHQWLILHGE\QDPHLQWKHVWXG\GDWDEDVHRURQDQ\VWXG\GRFXPHQWVWREHFROOHFWHGE\WKH6SRQVRURU
GHVLJQHHEXWZLOOEHLGHQWLILHGE\VXEMHFWQXPEHUGLJLWVWKHILUVWIRUWKHVWXG\FHQWHUDQGWKHODVW
IRUWKHVXEMHFW
7KH,QYHVWLJDWRUVZLOOSUHSDUHDQGPDLQWDLQDGHTXDWHDQGDFFXUDWHVRXUFHGRFXPHQWVGHVLJQHGWRUHFRUG
DOOREVHUYDWLRQVDQGRWKHUSHUWLQHQWGDWDIRUHDFKVXEMHFWWUHDWHGZLWKWKHVWXG\GUXJ
,IDFRUUHFWLRQLVUHTXLUHGIRUDQH&5)WKHWLPHDQGGDWHZLOOEHDXWRPDWLFDOO\UHFRUGHGE\WKH('&
V\VWHPLQGLFDWLQJWKHSHUVRQXSGDWLQJH&5)GDWDLQRUGHUWRFUHDWHDQDXGLWWUDLO7KH,QYHVWLJDWRULV
UHVSRQVLEOHIRUDOOLQIRUPDWLRQFROOHFWHGRQVXEMHFWVHQUROOHGLQWKLVVWXG\$OOGDWDFROOHFWHGGXULQJWKH
FRXUVHRIWKLVVWXG\PXVWEHUHYLHZHGDQGYHULILHGIRUFRPSOHWHQHVVDQGDFFXUDF\E\WKH,QYHVWLJDWRU
4XHULHVZLOOEHLVVXHGIRUDQ\LQFRQVLVWHQFLHVRPLVVLRQVDQGGLVFUHSDQFLHVDQGZLOOEHUHVROYHGE\WKH
DSSURSULDWHSDUWLHV
'DWDEDVHORFNZLOORFFXURQFHTXDOLW\DVVXUDQFHSURFHGXUHVKDYHEHHQFRPSOHWHG
7KHVWDWLVWLFDODQDO\VLVRIWKLVGDWDZLOOEHSHUIRUPHGE\WKH6SRQVRURUGHVLJQHH$OO$(VZLOOEHFRGHG
XVLQJWKHODWHVWYHUVLRQRIWKH0HGLFDO'LFWLRQDU\IRU5HJXODWHG$FWLYLWLHV0HG'5$&RQFRPLWDQW
PHGLFDWLRQVZLOOEHFRGHGXVLQJWKHODWHVWYHUVLRQRIWKH:RUOG+HDOWK2UJDQL]DWLRQ'UXJ:+2'UXJ
'LFWLRQDU\
$OOSURFHGXUHVIRUWKHKDQGOLQJDQGDQDO\VLVRIGDWDZLOOEHFRQGXFWHGXVLQJJRRGFRPSXWLQJSUDFWLFHV
PHHWLQJ8QLWHG6WDWHV)RRGDQG'UXJ$GPLQLVWUDWLRQ)'$(XURSHDQ0HGLFLQHV$JHQF\DQG,&+
JXLGHOLQHVIRUWKHKDQGOLQJDQGDQDO\VLVRIGDWDIRUFOLQLFDOVWXGLHV'DWDPDQDJHPHQWGHWDLOVZLOOEH
RXWOLQHGLQDVHSDUDWH'DWD0DQDJHPHQW3ODQ
 
6DPSOH6L]H
7KHSULPDU\K\SRWKHVLVIRUWKHWULDOLVWKDWQHIODPDSLPRGZLOOVLJQLILFDQWO\LPSURYHRXWFRPHYVSODFHER
RQWKH&'56%7RGHPRQVWUDWHWKLVHIIHFWDWRWDORIDSSUR[LPDWHO\VXEMHFWVDUHSODQQHGWREH
HQUROOHGRIZKRPDUHSODQQHGWRUHFHLYHQHIODPDSLPRGDQGDUHSODQQHGWRUHFHLYHSODFHER
6DPSOHVL]HZDVGHWHUPLQHGE\SRZHUDQDO\VLVYLDVLPXODWLRQVFRQGXFWHGE\XWLOL]LQJRXWFRPHVLQWKH
&'56%LQQHIODPDSLPRGPJ7,'DQGSODFHERJURXSVLQWKH3KDVHDFOLQLFDOWULDOLQ'/%6WXG\
WRJHQHUDWHIRUHDFKSDWLHQWDFKDQJHIURPEDVHOLQHLQWKH&'56%VFRUHDWLQGLYLGXDOYLVLWVRYHU
WKHFRXUVHRIWKHVLPXODWHGFOLQLFDOVWXG\DQGWKHQDQDO\]LQJWKHUHVXOWRIHDFKFOLQLFDOWULDOXWLOL]LQJWKH
OLQHDUPL[HGHIIHFWVPRGHOIRUUHSHDWHGPHDVXUHVWKDWZLOOEHXWLOL]HGWRDQDO\]HWKHFXUUHQWVWXG\%DVHG
RQWKHVLPXODWLRQRIFOLQLFDOWULDOVZLWKSDWLHQWVSHUWUHDWPHQWJURXSDQGDVVXPLQJDGURSRXW
UDWHWKHUHLVJUHDWHUWKDQSRZHUFRQILGHQFHLQWHUYDOWRWRGHWHFWDWUHDWPHQWHIIHFWDW
DQDOSKDOHYHORI1RWHLQWKHSKDVHDVWXG\WKHGLIIHUHQFHLQFKDQJHLQ&'56%EHWZHHQPJ

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 52 of 58 
EIP Pharma, Inc. 
Confidential 
7,'DQGSODFHERIURPWKH0050DQDO\VLVZDVFRQILGHQFHLQWHUYDO$QDO\VLV
6HWV
7KHVDIHW\DQDO\VLVVHWZLOOLQFOXGHDQ\VXEMHFWZKRUHFHLYHVDWOHDVWGRVHRIVWXG\GUXJ
7KHHIILFDF\DQDO\VLVVHWZLOOLQFOXGHDQ\VXEMHFWZKRUHFHLYHVDWOHDVWGRVHRIVWXG\GUXJDQGDWOHDVW
RQHSRVWGRVHFRJQLWLYHDVVHVVPHQW
$QDO\VHVZLOOEHIXOO\RXWOLQHGLQD6WDWLVWLFDO$QDO\VLV3ODQILQDOL]HGSULRUWRWKHHQGRIHQUROOPHQW
 
$QDO\VLV6HWV
7KHVDIHW\DQDO\VLVVHWZLOOLQFOXGHDQ\VXEMHFWZKRUHFHLYHVDWOHDVWGRVHRIVWXG\GUXJ
7KHHIILFDF\DQDO\VLVVHWZLOOLQFOXGHDQ\VXEMHFWZKRUHFHLYHVDWOHDVWGRVHRIVWXG\GUXJDQGDWOHDVW
RQHSRVWGRVHFRJQLWLYHDVVHVVPHQW
$QDO\VHVZLOOEHIXOO\RXWOLQHGLQD6WDWLVWLFDO$QDO\VLV3ODQILQDOL]HGSULRUWRWKHHQGRIHQUROOPHQW
 
6DIHW\
7KHLQFLGHQFHRIWUHDWPHQWHPHUJHQW$(DQG6$(VWKHFDXVDOUHODWLRQVKLSEHWZHHQDQ$(6$(DQGWKH
6WXG\'UXJDQGVHYHULW\ZLOOEHWDEXODWHGE\WUHDWPHQWGRVHJURXS
,QGLYLGXDOFOLQLFDOO\VLJQLILFDQWFKDQJHVLQFOLQLFDOODERUDWRU\DQG(&*SDUDPHWHUVZLOOEHOLVWHGDORQJ
ZLWKPHGLDQDQGPHDQDQGVWDQGDUGGHYLDWLRQE\WUHDWPHQWJURXS
 
(IILFDF\
7KHSULPDU\HIILFDF\YDULDEOHLV
x 
&KDQJHLQ&'56%LQQHIODPDSLPRGWUHDWHGVXEMHFWVFRPSDUHGWRSODFHERUHFLSLHQWV

6HFRQGDU\HIILFDF\YDULDEOHVDUH
x 
&KDQJHLQ78*LQQHIODPDSLPRGWUHDWHGVXEMHFWVFRPSDUHGWRSODFHERUHFLSLHQWV
x 
&KDQJHLQWKHFRPSRVLWHVFRUHRIWKH1HXURSV\FKRORJLFDO7HVW%DWWHU\17%LQFOXGLQJ
DVVHVVPHQWVRIDWWHQWLRQH[HFXWLYHIXQFWLRQDQGYLVXRVSDWLDOIXQFWLRQLQQHIODPDSLPRG
WUHDWHGVXEMHFWVDVFRPSDUHGWRWKHSODFHERWUHDWHGVXEMHFWV
x 
$'&6*&,&DW:HHNLQQHIODPDSLPRGWUHDWHGVXEMHFWVFRPSDUHGWRSODFHER
UHFLSLHQWV
$VH[SORUDWRU\HIILFDF\YDULDEOHVWKHHIIHFWVRIQHIODPDSLPRGUHODWLYHWRSODFHERZLOOEHHYDOXDWHGYLD
x 
&KDQJHLQ'HPHQWLD&RJQLWLYH)OXFWXDWLRQV6FDOH'&)6
x 
6HOHFWGRPDLQVRIWKHLWHP1HXURSV\FKLDWULF,QYHQWRU\13,LQFOXGLQJ
GHSUHVVLRQG\VSKRULDDSDWK\KDOOXFLQDWLRQVDQGDJLWDWLRQDJJUHVVLRQ
x 
&KDQJHLQKDOOXFLQDWLRQVIUHTXHQF\[VHYHULW\VFRUHZLWKLQWKH13,LQVXEMHFWVZKR
UHSRUWKDOOXFLQDWLRQVDWEDVHOLQH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 53 of 58 
EIP Pharma, Inc. 
Confidential 
x 
&KDQJHLQVOHHSDQGQLJKWWLPHEHKDYLRUFKDQJHZLWKLQWKH13,
x 
&KDQJHLQ0'683'56PRWRUH[DPLQDWLRQ3DUW,,,VFRUH
x 
&KDQJHLQEHWDIXQFWLRQDOFRQQHFWLYLW\DQGLQDOSKDUHDFWLYLW\RQTXDQWLWDWLYH((*

7KHSULPDU\HQGSRLQWZLOOEHDQDO\]HGXVLQJWKH0L[HG(IIHFWV0RGHOIRU5HSHDWHG0HDVXUHV0050
DQDO\VLVPHWKRGZLWKWKHFKDQJHIURPEDVHOLQHLQWKH&'56%DVWKHGHSHQGHQWYDULDEOHDQGZLOOXVHDQ
XQVWUXFWXUHGFRYDULDQFHPDWUL[7KLVDQDO\VLVZLOOEHSHUIRUPHGRQWKHHIILFDF\DQDO\VLVSRSXODWLRQ
ZKLFKZLOOLQFOXGHDOOVXEMHFWVZKRUHFHLYHDWOHDVWRQHGRVHRIVWXG\GUXJDQGSURYLGHDWOHDVWRQHSRVW
GRVHFRJQLWLYHDVVHVVPHQW$GGLWLRQDOFRYDULDWHVWREHLQFOXGHGLQWKH0050PRGHOZLOOEHSURYLGHGLQ
WKH6WDWLVWLFDO$QDO\VLV3ODQ6$3ZKLFKZLOOEHILQDOL]HGSULRUWRWKHHQGRIHQUROOPHQW)XUWKHU
GHVFULSWLRQVRIVHQVLWLYLW\DQDO\VHVDVZHOODVDQ\DGGLWLRQDOHIILFDF\SRSXODWLRQVWKDWPD\EHXVHGWR
DVVHVVHIILFDF\ZLOODOVREHSURYLGHGLQWKH6$37KH78*DQG17%HQGSRLQWVZLOODOVREHDQDO\]HG
XVLQJ0050DQDO\VLVPHWKRGWKRXJKWKHPRGHOPD\EHDGDSWHGWRWKHVSHFLILFHQGSRLQWVGHILQHGE\
6$3)RUWKH17%DSULPDU\FRPSRVLWH]VFRUHVZLOOEHFDOFXODWHGDQGXVHGLQRUGHUWRFUHDWH
VWDQGDUGL]HGFKDQJHVFRUHVWREHXVHGIRUWKHDQDO\VLV$GGLWLRQDOO\VHQVLWLYLW\DQDO\VHVZLOOEH
SHUIRUPHGRQWKHSULPDU\HQGSRLQWVSHFLILFDOO\WRDGGUHVVGLIIHUHQWPLVVLQJGDWDVFHQDULRVERWK0LVVLQJ
DW5DQGRPDQG0LVVLQJ1RWDW5DQGRP$'&6&*,&DW:HHNLQQHIODPDSLPRGYVSODFHERZLOOEH
FRPSDUHGXWLOL]LQJDWZRVLGHG0DQQ:KLWQH\WHVW7KHSULPDU\DQGVHFRQGDU\HQGSRLQWVLQFOXGLQJWKH
SULPDU\DQGVHFRQGDU\((*HQGSRLQWVZLOOEHDVVHVVHGIRUVWDWLVWLFDOVLJQLILFDQFHDWSYDOXHRI
([SORUDWRU\HQGSRLQWVZLOOQRWEHWHVWHGIRUVLJQLILFDQFHEXWSUHVHQWHGZLWKWUHDWPHQWHIIHFWYVSODFHER
ZLWKFRQILGHQFHLQWHUYDOV2WKHUDQDO\VHVLQFOXGLQJWKHDSSURDFKWRDQDO\]LQJH[SORUDWRU\
HQGSRLQWVZLOOEHLQFOXGHGLQWKH6$3
 
,QWHULP$QDO\VLV
1RLQWHULPDQDO\VLVLVSODQQHG7KHSULPDU\DQDO\VHVZLOOEHSHUIRUPHGDIWHUWKHEOLQGHGWUHDWPHQWSHULRG
RIZHHNV3DWLHQWVPD\JRRQWRDORQJWHUPRSHQODEHOH[WHQVLRQDQGDILQDODQDO\VLVZLOOEH
SHUIRUPHGZLWKWKHDGGLWLRQDOORQJWHUPGDWD

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 54 of 58 
EIP Pharma, Inc. 
Confidential 
 
678'<0$1$*(0(17
 
(WKLFVDQG&RQVHQW
 
5HJXODWLRQVDQG*XLGHOLQHV
7KHVWXG\ZLOOEHSHUIRUPHGLQDFFRUGDQFHZLWKWKLVSURWRFRO8QLWHG6WDWHV,QYHVWLJDWLRQDO1HZ
'UXJ$SSOLFDWLRQUHJXODWLRQV&)5RUORFDOQDWLRQDOODZVDVDSSOLFDEOHDQG,&+JXLGHOLQHV
IRU*RRG&OLQLFDO3UDFWLFH
 
,QGHSHQGHQW(WKLFV&RPPLWWHH
&RQGXFWRIWKHVWXG\PXVWEHDSSURYHGE\DQDSSURSULDWHO\FRQVWLWXWHG,(&$SSURYDOLVUHTXLUHGIRUWKH
VWXG\SURWRFROLQYHVWLJDWLRQDOGUXJEURFKXUHSURWRFRODPHQGPHQWV,&)VVXEMHFWLQIRUPDWLRQVKHHWV
DQGDGYHUWLVLQJPDWHULDOV1RLQYHVWLJDWLRQDOSURGXFWZLOOEHVKLSSHGWRDVLWHXQWLOZULWWHQ,(&
DXWKRUL]DWLRQKDVEHHQUHFHLYHGE\WKH6SRQVRURULWVGHVLJQHH
 
,QIRUPHG&RQVHQW
)RUHDFKVWXG\VXEMHFWZULWWHQLQIRUPHGFRQVHQWPXVWEHREWDLQHGIURPWKHVXEMHFWEHIRUHWKH
SHUIRUPDQFHRIDQ\SURWRFROUHODWHGDFWLYLWLHV$VSDUWRIWKLVSURFHGXUHWKH,QYHVWLJDWRURUDGHVLJQDWHG
UHSUHVHQWDWLYHPXVWH[SODLQRUDOO\DQGLQZULWLQJWKHQDWXUHGXUDWLRQDQGSXUSRVHRIWKHVWXG\DQGWKH
DFWLRQRIWKHLQYHVWLJDWLRQDOSURGXFWLQVXFKDPDQQHUWKDWWKHVXEMHFWLVDZDUHRIWKHSRWHQWLDOULVNV
LQFRQYHQLHQFHVRUDGYHUVHHIIHFWVWKDWPD\RFFXU6XEMHFWVVKRXOGEHLQIRUPHGWKDWWKH\PD\ZLWKGUDZ
IURPWKHVWXG\DWDQ\WLPH7KH\ZLOOUHFHLYHDOOLQIRUPDWLRQWKDWLVUHTXLUHGE\ORFDOUHJXODWLRQVDQG,&+
JXLGHOLQHV7KH,QYHVWLJDWRURUDGHVLJQDWHGUHSUHVHQWDWLYHZLOOSURYLGHWKH6SRQVRURULWVGHVLJQHHZLWKD
FRS\RIWKH,(&DSSURYHG,&)EHIRUHWKHVWDUWRIWKHVWXG\
 
,QGHPQLILFDWLRQ
7KH6SRQVRU¶VLQGHPQLILFDWLRQRIWKH,QYHVWLJDWRUDQGLQVWLWXWLRQGXULQJWKHFRQGXFWRIWKLVVWXG\LV
DGGUHVVHGLQDOHWWHURILQGHPQLILFDWLRQSURYLGHGDVDVHSDUDWHGRFXPHQW2WKHULQGHPQLILFDWLRQRU
LQVXUDQFHZLOOEHSURYLGHGDVQHFHVVDU\XQGHUORFDOUHJXODWLRQV
 
'LVFRQWLQXDWLRQRIWKH6WXG\E\WKH6SRQVRU
7KHSODQQHGVWXG\SHULRGLVDSSUR[LPDWHO\\HDUVXQWLOWKHODVWYLVLWRIWKHODVWVXEMHFWLQFOXGLQJWKH
IROORZXSYLVLW7KHSODQQHGVXEMHFWSDUWLFLSDWLRQLVXSWRZHHNVLQFOXGLQJZHHNVRIWUHDWPHQW
2QFHWKHVXEMHFWVKDYHHQGHGWKHLUSDUWLFLSDWLRQLQWKHVWXG\WKH\FDQUHWXUQWRWKHLUVWDQGDUGRIFDUH
WUHDWPHQWDVGHWHUPLQHGE\WKHLUSK\VLFLDQ6XEMHFWVZKRFRPSOHWHWKHZHHNWUHDWPHQWSKDVHZLOODOVR
EHRIIHUHGWKHRSSRUWXQLW\WRFRQWLQXHLQDZHHNRSHQODEHOH[WHQVLRQSKDVH
,IWKH6SRQVRURU,QYHVWLJDWRUGLVFRYHUVFRQGLWLRQVDULVLQJGXULQJWKHVWXG\WKDWVXJJHVWWKHVWXG\VKRXOG
EHKDOWHGWKHQWKLVFDQKDSSHQRQO\DIWHUDSSURSULDWHFRQVXOWDWLRQEHWZHHQWKH6SRQVRUDQG,QYHVWLJDWRU
&RQGLWLRQVWKDWPD\ZDUUDQWVWXG\WHUPLQDWLRQLQFOXGHEXWDUHQRWOLPLWHGWR
x 
7KHGLVFRYHU\RIDQ\XQH[SHFWHGVLJQLILFDQWRUXQDFFHSWDEOHULVNWRWKHVXEMHFWVHQUROOHGLQWKH
VWXG\
x 
)DLOXUHRIWKH,QYHVWLJDWRUWRHQWHUVXEMHFWVDWDQDFFHSWDEOHUDWH

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 55 of 58 
EIP Pharma, Inc. 
Confidential 
x 
8QVDWLVIDFWRU\ VXEMHFW HQUROOPHQW ZLWK UHVSHFW WR TXDOLW\ DQGRU TXDQWLW\ RU GDWD UHFRUGLQJ LV
LQDFFXUDWHDQGRULQFRPSOHWHRQDFKURQLFEDVLV
x 
,QVXIILFLHQWDGKHUHQFHWRWKHSURWRFROUHTXLUHPHQWV
x 
$GHFLVLRQRQWKHSDUWRIWKH6SRQVRUWRVXVSHQGRUGLVFRQWLQXHGHYHORSPHQWRIVWXG\GUXJ
6KRXOGWKHVWXG\EHWHUPLQDWHGDQGRUWKHVLWHFORVHGIRUZKDWHYHUUHDVRQDOOGRFXPHQWDWLRQDQG
LQYHVWLJDWLRQDOSURGXFWSHUWDLQLQJWRWKHVWXG\PXVWEHUHWXUQHGWRWKH6SRQVRURULWVGHVLJQHH
 
6WXG\'RFXPHQWDWLRQ
%\VLJQLQJDFRS\RI)RUP)'$RURWKHUFRXQWU\VSHFLILFUHJXODWRU\IRUPVWKH,QYHVWLJDWRU
DFNQRZOHGJHVWKDWKHVKHKDVUHFHLYHGDFRS\RIWKH,%RQQHIODPDSLPRGDQGDVVXUHVWKH6SRQVRUWKDW
KHVKHZLOOFRPSO\ZLWKWKHSURWRFRODQGWKHSURYLVLRQVVWDWHGLQ)RUP)'$DQGRWKHUFRXQWU\
VSHFLILFIRUPV1RFKDQJHVLQWKLVSURWRFROFDQEHPDGHZLWKRXWWKH6SRQVRU¶VZULWWHQDSSURYDO
 
6WXG\0RQLWRULQJDQG$XGLWLQJ
7KLVVWXG\ZLOOEHPRQLWRUHGIRUTXDOLW\DVVXUDQFHDWDOOVWDJHVRILWVGHYHORSPHQWE\WKHFOLQLFDOUHVHDUFK
SHUVRQQHOHPSOR\HGE\WKH6SRQVRURULWVGHVLJQHH0RQLWRULQJZLOOLQFOXGHSHUVRQDOYLVLWVDQGWHOHSKRQH
FRPPXQLFDWLRQWRDVVXUHWKDWWKHLQYHVWLJDWLRQLVFRQGXFWHGDFFRUGLQJWRWKHSURWRFROVWDQGDUGRSHUDWLQJ
SURFHGXUHV*XLGHOLQHVRI*RRG&OLQLFDO3UDFWLFHDQGDSSOLFDEOHUHJXODWRU\UHTXLUHPHQWV4XDOLW\FRQWURO
SURFHGXUHVZLOOEHDSSOLHGWRHDFKVWDJHRIGDWDKDQGOLQJWRHQVXUHWKDWDOOGDWDDUHUHOLDEOHDQGKDYHEHHQ
SURFHVVHGFRUUHFWO\2QVLWHUHYLHZRIH&5)VZLOOLQFOXGHDUHYLHZRIIRUPVIRUFRPSOHWHQHVVDQGFODULW\
DQGFRQVLVWHQF\ZLWKVRXUFHGRFXPHQWVDYDLODEOHIRUHDFKVXEMHFW
 
8VHRI6WXG\)LQGLQJV
%\VLJQLQJWKHVWXG\SURWRFROWKH,QYHVWLJDWRUDJUHHVWRWKHXVHRIUHVXOWVRIWKHVWXG\IRUWKHSXUSRVHVRI
QDWLRQDODQGLQWHUQDWLRQDOUHJLVWUDWLRQ,IQHFHVVDU\WKHDXWKRULWLHVZLOOEHQRWLILHGRIWKH,QYHVWLJDWRU¶V
QDPHDGGUHVVTXDOLILFDWLRQVDQGH[WHQWRILQYROYHPHQW5HSRUWVFRYHULQJFOLQLFDODQGELRPHWULFDVSHFWV
RIWKHVWXG\ZLOOEHSUHSDUHGE\WKH6SRQVRURULWVGHVLJQHH
 
3XEOLFDWLRQV
7KHFOLQLFDOVWXG\ZLOOEHUHJLVWHUHGDW38TZZZFOLQLFDOWULDOVJRY38TDQG38TZZZFOLQLFDOWULDOVUHJLVWHUHX38T7KH
SUHSDUDWLRQDQGVXEPLWWDOIRUSXEOLFDWLRQRIPDQXVFULSWVFRQWDLQLQJWKHVWXG\UHVXOWVVKDOOEHLQ
DFFRUGDQFHZLWKDSURFHVVGHWHUPLQHGE\PXWXDOZULWWHQDJUHHPHQWDPRQJWKHVWXG\6SRQVRUDQG
SDUWLFLSDWLQJLQVWLWXWLRQV7KHSXEOLFDWLRQRUSUHVHQWDWLRQRIDQ\VWXG\UHVXOWVVKDOOFRPSO\ZLWKDOO
DSSOLFDEOHSULYDF\ODZV
 
5HFRUGLQJ$FFHVVDQG5HWHQWLRQRI6RXUFH'DWD
7KH,QYHVWLJDWRUVPXVWPDNHVWXG\GDWDDFFHVVLEOHWRWKHPRQLWRURWKHUDXWKRUL]HGUHSUHVHQWDWLYHVRIWKH
6SRQVRURUGHVLJQHHDQG5HJXODWRU\$JHQF\LQVSHFWRUVXSRQUHTXHVW
$ILOHIRUHDFKVXEMHFWPXVWEHPDLQWDLQHGWKDWLQFOXGHVWKHVLJQHG,QIRUPHG&RQVHQWDQGFRSLHVRIDOO
VRXUFHGRFXPHQWDWLRQUHODWHGWRWKDWVXEMHFW7KH,QYHVWLJDWRUPXVWHQVXUHWKHUHOLDELOLW\DQGDYDLODELOLW\RI
VRXUFHGRFXPHQWVIURPZKLFKWKHLQIRUPDWLRQRQWKHH&5)ZDVGHULYHG

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 56 of 58 
EIP Pharma, Inc. 
Confidential 
$OOVWXG\GRFXPHQWVVXEMHFWILOHVVLJQHG,&)V6WXG\)LOH1RWHERRNHWFPXVWEHNHSWVHFXUHGIRUD
SHULRGRIWZR\HDUVIROORZLQJPDUNHWLQJRIWKHLQYHVWLJDWLRQDOSURGXFW7KHUHPD\EHRWKHUFLUFXPVWDQFHV
IRUZKLFKWKH6SRQVRULVUHTXLUHGWRPDLQWDLQVWXG\UHFRUGVDQGWKHUHIRUHWKH6SRQVRUVKRXOGEHFRQWDFWHG
SULRUWRUHPRYLQJVWXG\UHFRUGVIRUDQ\UHDVRQ
 
3URWRFRO9LRODWLRQV
$SURWRFROYLRODWLRQRFFXUVZKHQWKHVXEMHFW,QYHVWLJDWRURU6SRQVRUIDLOVWRDGKHUHWRVLJQLILFDQW
SURWRFROUHTXLUHPHQWVDIIHFWLQJWKHLQFOXVLRQH[FOXVLRQVXEMHFWVDIHW\DQGSULPDU\HQGSRLQWFULWHULD
3URWRFROYLRODWLRQVIRUWKLVVWXG\LQFOXGHEXWDUHQRWOLPLWHGWRWKHIROORZLQJ
x 
)DLOXUHWRPHHWLQFOXVLRQH[FOXVLRQFULWHULD
x 
8VHRIDSURKLELWHGFRQFRPLWDQWPHGLFDWLRQ
)DLOXUHWRFRPSO\ZLWK*RRG&OLQLFDO3UDFWLFHJXLGHOLQHVZLOODOVRUHVXOWLQDSURWRFROYLRODWLRQ7KH
6SRQVRUZLOOGHWHUPLQHLIDSURWRFROYLRODWLRQZLOOUHVXOWLQZLWKGUDZDORIDVXEMHFW
:KHQDSURWRFROYLRODWLRQRFFXUVLWZLOOEHGLVFXVVHGZLWKWKH,QYHVWLJDWRUDQGD3URWRFRO9LRODWLRQ)RUP
GHWDLOLQJWKHYLRODWLRQZLOOEHJHQHUDWHG7KLVIRUPZLOOEHVLJQHGE\D6SRQVRUUHSUHVHQWDWLYHDQGWKH
,QYHVWLJDWRU$FRS\RIWKHIRUPZLOOEHILOHGLQWKHVLWH¶VUHJXODWRU\ELQGHUDQGLQWKH6SRQVRU¶VILOHV
 
'DWDDQG6DIHW\0RQLWRULQJ%RDUG'60%
7KHUHZLOOEHD'DWDDQG6DIHW\0RQLWRULQJ%RDUG'60%UHVSRQVLEOHIRURYHUVHHLQJWKHVDIHW\RI
KXPDQVXEMHFWVLQWKLVFOLQLFDOWULDO7KH'60%ZLOOLQFOXGHDWOHDVWWKUHHPHPEHUVWZRFOLQLFLDQV
ZLWKH[SHULHQFHZLWKGHPHQWLDFOLQLFDOWULDOVRQHRIZKLFKZLOOEHWKHFKDLUDQGRQHVWDWLVWLFLDQ
0HPEHUVRIWKH'60%ZLOOEHVHSDUDWHIURPWKHVWXG\WHDPDQGVLWHWHDPV7KH'60%&KDUWHUZLOOEH
UHYLHZHGDQGDGRSWHGE\WKH'60%LWZLOOEHDVWDQGDORQHGRFXPHQW

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 57 of 58 
EIP Pharma, Inc. 
Confidential 
 
5()(5(1&(6
$ODP-6HOHFWLYH%UDLQ7DUJHWHG$QWDJRQLVPRIS0$3.ĮUHGXFHVKLSSRFDPSDO,/ȕ/HYHOVDQG
LPSURYHV0RUULV:DWHU0D]HSHUIRUPDQFHLQDJHGUDWVJ Alzheimers Dis
&DYDOOL9HWDO7KH6WUHVV,QGXFHG0$3.LQDVHS5HJXODWHV(QGRF\WLF7UDIILFNLQJYLDWKH*',5DE
&RPSOH[Molecular Cell
'LFNLQVRQ$QVRQ+HWDO$FHW\OFKROLQH6HFUHWLQJ&HOOV,PSURYH$JH,QGXFHG0HPRU\'HILFLWV
Molecular Therapy
)XMLVKLUR+HWDO'HSOHWLRQRIFKROLQHUJLFQHXURQVLQWKHQXFOHXVRIWKHPHGLDOVHSWXPDQGWKHYHUWLFDO
OLPERIWKHGLDJRQDOEDQGLQGHPHQWLDZLWK/HZ\ERGLHVActa Neuropathol
*RQ]DOHV0&HWDO$VVRFLDWLRQRI3ODVPDSWDXDQGSWDX&RQFHQWUDWLRQV:LWK&RJQLWLYH'HFOLQH
LQ3DWLHQWV:LWK3UREDEOH'HPHQWLD:LWK/HZ\%RGLHVJAMA Neurology 
+DOO6HWDO3ODVPD3KRVSKR7DX,GHQWLILHV$O]KHLPHU¶V&R3DWKRORJ\LQ3DWLHQWVZLWK/HZ\%RG\
'LVHDVHWiley Online Library
+XJKHV&3HWDO$QHZFOLQLFDOVFDOHIRUWKHVWDJLQJRIGHPHQWLDBr J Psychiatry
-HQQLQJV-/HWDO,QYHVWLJDWLQJWKHSRZHURIH\HVRSHQUHVWLQJVWDWH((*IRUDVVLVWLQJLQGHPHQWLD
GLDJQRVLVAlzheimer’s Research & Therapy
-LDQJ<HWDO3DUWLDO%$&(UHGXFWLRQLQD'RZQV\QGURPHPRXVHPRGHOEORFNV$O]KHLPHUUHODWHG
HQGRVRPDODQRPDOLHVDQGFKROLQHUJLFQHXURGHJHQHUDWLRQUROHRI$33&7)Neurobiology of Aging

-LDQJ<HWDO³3UHFOLQLFDODQG5DQGRPL]HG&OLQLFDO(YDOXDWLRQRIWKHSĮ.LQDVH,QKLELWRU
1HIODPDSLPRGIRU%DVDO)RUHEUDLQ&KROLQHUJLF'HJHQHUDWLRQ´1DWXUH&RPPXQLFDWLRQV$UWLFOH
QXPEHU
/DZVRQ6.HWDOSĮPLWRJHQDFWLYDWHGSURWHLQNLQDVHGHSOHWLRQDQGUHSUHVVLRQRIVLJQDOWUDQVGXFWLRQWR
WUDQVODWLRQPDFKLQHU\E\PL5DQGLQQHXURQVMol Cell Biol 
0DFH*HWDO3KRVSKRU\ODWLRQRI(($E\S0$3NLQDVHUHJXODWHVPRSLRLGUHFHSWRUHQGRF\WRVLVThe 
EMBO Journal
0F.HLWK,*'LDJQRVLVDQGPDQDJHPHQWRIGHPHQWLDZLWK/HZ\ERGLHV)RXUWKFRQVHQVXVUHSRUWRIWKH
'/%&RQVRUWLXPNeurology
0XHOOHU&HWDO7KHSURJQRVLVRIGHPHQWLDZLWK/HZ\ERGLHVLancet Neurol 
1L[RQ5$P\ORLGSUHFXUVRUSURWHLQDQGHQGRVRPDOO\VRVRPDOG\VIXQFWLRQLQ$O]KHLPHU¶VGLVHDVH
LQVHSDUDEOHSDUWQHUVLQDPXOWLIDFWRULDOGLVHDVHThe FASEB Journal
2¶%U\DQW6(HWDO9DOLGDWLRQRIWKH1HZ,QWHUSUHWLYH*XLGHOLQHVIRUWKH&OLQLFDO'HPHQWLD5DWLQJ6FDOH
6XPRI%R[HV6FRUHLQWKH1$&&'DWDEDVHArch Neurol
3HQVDOILQL$HWDO(QGRVRPDO'\VIXQFWLRQ,QGXFHGE\'LUHFWO\2YHUDFWLYDWLQJ5DE5HFDSLWXODWHV
3URGURPDODQG1HXURGHJHQHUDWLYH)HDWXUHVRI$O]KHLPHU¶V'LVHDVHCell Reports 

EIP21-NFD-504, Version 2.0 Ex-US, 20Jun2023 
Page 58 of 58 
EIP Pharma, Inc. 
Confidential 
3HUD]D/5HWDO(OHFWURHQFHSKDORJUDSKLFGHULYHGQHWZRUNGLIIHUHQFHVLQ/HZ\ERG\GHPHQWLDFRPSDUHG
WR$O]KHLPHU
VGLVHDVHSDWLHQWVSci Rep
3RVQHU.HWDO7KH&ROXPELD6XLFLGH6HYHULW\5DWLQJ6FDOHLQLWLDOYDOLGLW\DQGLQWHUQDOFRQVLVWHQF\
ILQGLQJVIURPWKUHHPXOWLVLWHVWXGLHVZLWKDGROHVFHQWVDQGDGXOWVAm J Psychiatry
3ULHWRHWDO6\QDSVHVSHFLILF,/UHFHSWRUVXEXQLWUHFRQILJXUDWLRQDXJPHQWVYXOQHUDELOLW\WR,/ȕLQWKH
DJHGKLSSRFDPSXVProc Natl Acad Sci U S A(
3ULQVHWDO$SKDVHGRXEOHEOLQGSODFHERFRQWUROOHGZHHNWUHDWPHQWFOLQLFDOVWXG\RIWKHSDOSKD
NLQDVHLQKLELWRUQHIODPDSLPRGLQPLOG$O]KHLPHU¶VGLVHDVHAlzheimer's Research & 
Therapy
6FKXPDFKHU-HWDO((*DOSKDUHDFWLYLW\DQGFKROLQHUJLFV\VWHPLQWHJULW\LQ/HZ\ERG\GHPHQWLDDQG
$O]KHLPHU¶VGLVHDVHAlzheimer’s Research & Therapy
;X:HWDO'\VUHJXODWLRQRI5DEPHGLDWHGHQGRF\WLFSDWKZD\VLQ$O]KHLPHU¶VGLVHDVHTraffic

